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Technological advancement and globalization have led to the spread of foods to
countries where the food does not yet have a documented history of consumption, in
other words, novel foods. Novel foods also encompass truly novel foods, foods that have
been processed in a novel manner, and novel means of exposure. With novel foods comes
the potential of food allergens that pose an uncharacterized risk to those with food
allergies. Food allergies are an increasingly important facet of public health. Therefore, a
deeper understanding of novel foods as well as methods to evaluate consumers’ potential
risk is necessary. Literature reviews and experimental evaluations leveraging liquid
chromatography-electrospray ionization-mass spectrometry were used to explore the risks
posed by novel sources of food allergens. Subject sources of allergens included Acheta
domesticus, the house cricket, Tenebrio molitor, the yellow mealworm; extensively
thermally processed walnut hulls and peanuts, as well as smoke from the wood of tree nut
trees, and vapor from E-cigarette liquids. Novel methodologies to interpret complex mass
spectrometry data were developed, allowing resultant information to be used in the
assessment of allergenic risk. The methodologies developed in this research expand upon
the utility of mass spectrometry to evaluate potentially allergenic proteins from poorly

characterized sources. Broader characterization of the hazards and risks posed by food
allergens permits stakeholders to be more adequately informed regarding the risks they
wish to undertake.
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PREFACE
This doctoral dissertation is organized into eight chapters providing an overview of the
analysis of novel sources of food allergens using mass spectrometry and the application
of risk assessment methodologies to evaluate the risks posed to consumers.

Some of the content included in Chapter 1, section 1.7 is expected to be included in a
manuscript under the lead of Justin Marsh (J. T. Marsh, S. J. Koppelman, L. K. Palmer,
P. E. Johnson, “Determination of major allergen levels, isoforms, and hydroxyproline
modifications among peanut market types by mass spectrometry,” (in preparation for
submission to a refereed journal)).

Some of the content in included in Chapter 2 is expected to be included in a manuscript
under the lead of Lee Palmer (L. K. Palmer, B. Oppert, L. C. Perkin, M. Lorenzen, A. T.
Dossey, P. E. Johnson, “Predicted allergens and quantitative proteomics from life stages
of the house cricket, Acheta domesticus,” (in preparation for submission to a refereed
journal)).

Chapter 4 has been published in LWT (L. K. Palmer, J. T. Marsh, J. L. Baumert, P. E.
Johnson, LWT 132, 109903 (2020)).

The abstract of Chapter 5 has been submitted for publication in Allergy (L. K. Palmer, P.
E. Johnson, “Detection of Food Allergen-Derived Peptides from Extractive-Based ECigarette Liquids,” (submitted for publication in Allergy, January 2021)).
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Overall aims of the Dissertation Research
1. Explore novel foods, foods processed in novel ways, and novel means of exposure
as novel sources of food allergens;
2. Develop methodologies for incorporating mass spectrometry into allergen risk
assessment;
3. Evaluate how conventional risk assessment methodologies can be leveraged to
determine the qualitative and quantitative allergic risks posed by novel sources of
food allergens.

Structure of the dissertation
In Chapter 1, the literature regarding the relationship between food allergy and
novel foods is explored.
Chapters 2 and 3 introduce insects as a seldom consumed food in the Western
Hemisphere and explores Acheta domesticus, the house cricket, and Tenebrio molitor, the
yellow mealworm. Developmental stages of A. domesticus are evaluated for differences
in potential risk posed to consumers and a pair of genetically modified T. molitor are
compared with the wildtype to determine the effects of genetic modification on levels of
predicted allergens.
Chapter 4 explored extensively thermally processed peanuts to evaluate if any
remnants of proteins can persist and if they have the capacity to theoretically cause
reactions in peanut allergic consumers.
Chapter 5 evaluated the presence of food allergen residues in E-cigarette liquids
resulting in risk assessments in terms of both food allergens and respiratory allergens.

viii
Chapters 6 and 7 are literature-based risk assessments evaluating the use of
extensively thermally processed walnut hulls for water purification and the potential risks
associated with the use of tree nut wood to smoke foods.
Finally, Chapter 8 presents a discussion of the findings including limitations,
necessary assumptions, and future directions.
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CHAPTER 1: UNDERPINNING THE RELATIONSHIP BETWEEN FOOD
ALLERGIES AND NOVEL FOODS

1.1 Introduction
Technological advancement and globalization have led to the spread of food to
countries that do not have a history of safe consumption of that food, in other words
novel foods. As novel foods, novel techniques to process foods, and novel means to
consume foods continue to develop, so do the sources of potential food allergens. Food
allergies are becoming an increasingly important facet of public health around the world.
To protect the health of consumers a deeper understanding of both novel foods and the
risk posed is needed. The following will review food allergy and detection of food
allergens, novel foods and regulatory definitions, and the principles of food allergen risk
analysis with considerations to novel sources of food allergens.

1.2 Novel foods
1.2.1 The niche for novel foods
A novel food can be broadly defined as a food without a significant history of
consumption or produced by a method that had not been previously applied to food,
which is subjective at the level of the individual, culture, and governmental regulatory
agencies. For example, for many in the Western Hemisphere, insects are considered a
novel food but elsewhere, such as Thailand, they represent a common nutrient source.
Novel foods are diverse including examples such as cell-based meat [14], mycoprotein
[15], insects [16], microalgae [17], and valorization of waste or by-products [18] (Figure
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1.1).

Figure 1.1. Examples of novel foods and processes involving by-product or waste
valorization.
Novel processing technologies are also being researched and utilized such as cold
atmospheric plasma, oscillating magnetic fields, high-pressure processing, pulsed electric
fields, pulsed light, irradiation, and ultrasound, where much of the industry is focused on
maintaining sensory qualities but held back by costs and a current dearth of research into
the application of these technologies as applied to food [19]. Novel foods and ingredients
may also be produced through the application of traditional processing techniques to
foods that had not previously been processed in that manner, such as with protein
isolates. Genetic modification of crops and organisms can generate novel variants of
crops with improved nutritional quality as in golden rice engineered to produce βcarotene (provitamin A) and tackle vitamin A deficiencies, iron biofortified rice to
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increase the iron content and combat anemia, and quality protein maize to improve the
amino acid profile of corn via a higher production of essential amino acids [20].
The world population is projected as just under 10 billion people in 2050 [21],
and feeding the population requires adequate food and protein. Despite farmers producing
approximately 4600 kcal per person, or double what is needed, malnutrition remains a
persistent threat [22]. The global spread of the Western diet, characterized by a diet rich
in animal proteins, refined fats, sugars, and processed foods, has driven further animal
rearing and has been viewed as a significant confounder in a path toward sustainably
feeding the future population [23, 24]. Proponents suggest novel foods as a means to
alleviate unsustainable consumption of animal protein requiring profound inputs of land,
fresh water, and energy but also excessive environmental impacts such as generation of
greenhouse gasses, deforestation, loss of biodiversity, and degraded water supplies
through runoff of excess fertilizer and pesticides [23, 25]. Novel processing technologies
then can be implemented for improved efficiency of current food systems by reducing
food waste, where approximately one-third of food produced for human consumption is
lost or wasted throughout the supply chain [25].
Comparisons to conventional animal rearing have been performed using insects as
an alternative animal protein source. Insects broadly have a greater food conversion ratio,
require less land to rear, require minimal water, and produce fewer greenhouse emissions
than conventional livestock [26]. In terms of energy, mealworms have been investigated
in the Netherlands in a year-round climate-controlled facility and found to require less
energy than beef but equivalent to pork [27], but this could be improved by growing the
mealworms in a more suitable climate. Although insects have been touted for their ability
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to thrive on waste and by-products, crickets reared on an industrial scale do require at
least an organic side-stream of processed relatively high-quality feed to thrive and
preferably the current feed given to poultry [28]. Insects as a novel food demonstrate
considerable improvements in sustainability compared to conventional livestock but are
more appropriately understood as competition rather than wholly usurping the position of
conventional livestock.
As sustainable novel foods are but a competitor within the marketplace, ensuring
that novel foods are supported from both the consumer and producer sides is critical.
Producers need to be appropriately compensated for practicing sustainable farming
practices that support the environment [23]. Simultaneously, consumers need to be
appropriately guided to overcome neophobia through the persistence of the novel food in
the market but also labeling of food packages [29, 30]. Careful presentation of novel
foods is key, as evidenced by long-used processing technologies such as irradiation,
which is commonly regarded as a novel processing technology despite its use for
decades. Further, irradiated products when presented as ‘treated with ionization’ are
regarded less negatively as compared to ‘treated with irradiation’, likely through
associations of irradiation with inferior goods and nuclear power. Presentation of labels is
in part based on the producer’s interests but heavily driven by pertinent regulations
demanded by regulatory agencies.

1.2.2 Brief novel food regulations of selected countries and trade blocs
Although which foods are categorized as novel can vary by individual and
cultural standards, a key unifying factor is the guidance provided by regulatory agencies
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and government mandates. Regulations regarding what constitutes a novel food
commonly identifies a lack of a documented history of safe use within the purview of
each regulatory agency, with considerations given for safe use in other countries. Foods
deemed novel undergo risk assessments to determine if significant harm will come from
consumption of the novel food. Differences among regulations are often in the form of
differences of explicitly stated means that a food may be novel such as if a genetically
modified organism is also a novel food.

1.2.2.1 Australia and New Zealand
The statutory authority on food safety for both Australia and New Zealand is the
Food Standards Australia New Zealand (FSANZ) and is responsible for the development
and administration of the Australia New Zealand Food Standards Code [31]. As of 13
April, 2017, Standard 1.5.1 – Novel foods establishes that novel foods are non-traditional
and thereby require safety assessments specific to adverse effects, composition,
processing, source, consumption patterns [32]. Categories of non-traditional foods are
given as plants or animals and components thereof, plant or animal extracts, herbs and
extracts thereof, dietary macro-components, single chemical entities, microorganisms and
probiotics, and foods produced from new sources or by a process not previously applied
to food [32]. Further, the standard clarifies that a non-traditional food stipulates any of a
food, food-derived substance, other component of food, as well as any other substance
without a history of human consumption in Australia or New Zealand is non-traditional
and therefore a novel food.
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Retail sale of novel foods or foods with a novel ingredient may be sold if listed in
section S25-2 and stipulated conditions of use are complied with
(https://www.legislation.gov.au/Details/F2017C00413) [32]. Enquiries of the novelty of a
particular food or food ingredient are handled by the Advisory Committee on Novel
Foods and make recommendations to FSANZ pertaining to if it is a non-traditional food,
if an assessment of public health and safety should be required given intended levels and
use, and if the enquirer ought make an application to request the Food Standards Code be
amended by FSANZ to undertake an assessment of public health and safety [33]. FSANZ
also compilate a record of views formed on a larger body of foods and food ingredients to
clearly present a summary of if each were identified by FSANZ as a traditional food,
novel food, the justification of the view, and comments which may include safety
concerns, labeling requirements, and pertinent sections of the Food Standards that may
apply [32, 34].

1.2.2.2 Brazil
In Brazil, the statutory authority on food safety is the National Agency of Sanitary
Surveillance (ANVISA) whose purpose is to protect the health of the population via
sanitary control of food and pharmaceuticals [31]. Regulations for novel foods include
Resolution No. 16, of April 30, 1999 (Resolução nº 16, de 30 de abril de 1999) and
Resolution No. 17, of April 30, 1999 (Resolução nº 17, de 30 de abril de 1999) [35, 36],
which established the mandatory registration procedures for novel foods and ingredients
and the guidelines for safety assessments of novel foods and ingredients, respectively.
ANVISA has since released a guidance document the Food and Ingredient Safety
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Evidence Guide (Guia para Comprovação da Segurança de Alimentos e Ingredientes)
[37]. Novel foods were defined as foods or food ingredients for human consumption
without a history of consumption in Brazil or foods containing currently consumed
ingredients but at much greater levels than currently observed excluding food additives,
manufacturing aids, food provided as capsules, pills, tablets, or similar; and foods with
novel ingredients given an exemption [31, 37, 38]. The registrant must include
information pertaining to identity, scientific evaluations of safety, and comprehensive
literature regarding the food or ingredient. Novel foods then undergo a safety and risk
assessment on a case-by-case basis by the Techno-scientific Advisory Committee on
Functional Food and Novel Foods (CTCAF).
As of July 2020, regulatory discussion has identified that the current regulations
are highly subjective regarding what constitutes a safe history of use and clarity is
required into the legal definition of novel foods and ingredients as well as the
transparency into the safety assessments of novel foods and ingredients [38]. The
proposed definition of a novel food would include foods and ingredients from vegetables,
animals, minerals, microorganisms, fungi, algae, or synthetics without a history of safe
consumption in Brazil as food and further specifies that novel foods and ingredients
include but are not limited to: derivative products without a history of safe use, new or
intentionally modified molecules, cell cultures or tissues thereof, those produced with a
process not yet applied to food, products with an altered nutritional profile,
nanomaterials, nutrient sources, bioactive substances, and substances only authorized for
use in dietary substances if they were to be added to food.
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1.2.2.3 Canada
The regulatory authority regarding novel foods in Canada is the Food Directorate
of Health Canada and is responsible for assessments of novel food safety [31]. Novel
foods are regulated as described by Division 28 of Part B of the Food and Drug
Regulations [39], where B.28.001 stipulates that a novel food is a substance or
microorganism without a history of safe use as food, or manufactured by a process not
previously applied to that particular food and additionally causes the food to undergo a
major change (i.e. places the food outside the accepted limits of natural variations for that
food with regard to composition, structure, nutritional quality, physiological effects,
alters the manner of how it is metabolized, or affects the microbiological safety, chemical
safety, or safe use of the food), and lastly the food is derived from a plant, animal, or
microorganism that has been genetically modified resulting in new characteristics,
removed characteristics, or characteristics are outside of natural variation. The use of the
term “substance” is not defined, although a novelty determination may be requested to
clarify that a particular substance is either novel or non-novel
(https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modifiedfoods-other-novel-foods/requesting-novelty-determination.html).
Novel foods require pre-market authorization for either sale or advertisement
predicated on notification of Health Canada [31]. Petitioners provide pertinent
information regarding the safety of the novel food such as history of use, dietary
exposure, detail of production, and considerations of nutrition, toxicology, allergy,
chemistry, and microbiology. The Food Directorate encourages consultations during
development of novel foods to determine which data are necessary to demonstrate safety.
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The Food Directorate has released guidelines on the safety assessment of novel foods
[40], as well as a document providing transparency and insight into the Food
Directorate’s management process for novel foods [41]. The Food Directorate maintains
a list of approved novel foods and genetically modified organisms with completed safety
assessments and found to be safe for human consumption
(https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modifiedfoods-other-novel-foods/approved-products.html). Further, The Food Directorate also
maintains a list of non-novel determinations (https://www.canada.ca/en/healthcanada/services/food-nutrition/genetically-modified-foods-other-novel-foods/requestingnovelty-determination/list-non-novel-determinations.html).

1.2.2.4 China
The most current statutory authority overseeing inquiries on novel foods and
ingredients is the National Health Commission (NHC), which superseded the National
Health and Family Planning Commission (NHFPC) as of March 2018 [42]. The most
current novel food regulations are the Administrative Measure of Safety Evaluation of
Novel Food Ingredients as of 2013, which established that novel food ingredients are
those without a history of dietary use in China including animals, plants, microorganisms,
components from any of animals, plants, or microorganisms; components whose original
structure has been altered, and other newly developed foods. A history of dietary use was
established as more than 30 years. Novel food ingredients cannot be introduced to the
market without approval and safety evaluation from the NHC. Considerations are
provided to novel food ingredients that have substantial equivalence to foods or prior
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approved novel food ingredients not limited to genus, species, source, biological
characteristics, composition, edible parts, and level of use.
The NHC evaluates the safety of novel food ingredients and provides
recommendations with the assessment [42]. The assessment includes conclusions
pertaining to the safety, technical need, and social impact. If approved by the NHC, the
novel food ingredient may be used in general goods as well as health functional foods.
Notably, new genetically modified organisms, ingredients for the exclusive use for health
functional foods, or food additives are outside of the scope of the provisions of these
evaluations. Announcements and interpretations for novel food ingredients are posted on
the NHC website (http://www.nhc.gov.cn/sps/s2909/new_list.shtml).

1.2.2.5 Eurasian Customs Union (EACU)
The Eurasian Economic Union (EACU) formed as of 1 January 2015 and
currently comprises of Armenia, Belarus, Kazakhstan, Kyrgyzstan, and the Russian
Federation to represent a single market [43]. Across the EACU, the regulations for novel
foods are the Technical Regulations of the Customs Union TR CU 021/2011 [44]. Within
the EACU, novel foods are defined as food products including additives or flavorings
without a history of consumption by humans within the customs territory such as a new
or modified molecular structure, microorganisms or isolates thereof, microscopic fungi or
algae, plants, isolates of animals, genetically modified organisms, nanomaterials, or
nanotechnology products (Article 4). Classes specifically excluded from this definition
include food products obtained by traditional methods, are currently in circulation, and
are by virtue of experience safe. Food ingredients are not specifically identified as falling

11
within this regulation nor are new production processes unless they specifically modify
molecular structures [45].
Novel food products are subject to state registration as it is being produced within
the EACU or before importing into the EACU [43], where state registration is carried
about by a nationally authorized body dependent which nation the application is being
filed [43, 45]. Registration requires information regarding scientific procedures to
confirm the novel food product is safe for humans and information regarding its effects
on humans to establish no adverse effects. After successful registration, the novel product
is no longer novel and not subject to registration by other applicants, although each must
conform to the initial registration. Registered applications and documents are available to
the public (http://eec.eaeunion.org/).

1.2.2.6 European Union (EU)
The European Union (EU) comprises of 27 member states and with
Norway, Iceland, and Lichtenstein comprise the European Economic Area (EEA). The
European Commission (EC), the executive branch of the EU, acts as the regulatory
authority regarding novel foods with the European Food Safety Authority (EFSA) acting
as the advisory scientific body [31]. In 2015, the EC established the current definitions of
novel foods per Regulation (EU) 2015/2283 that applies across the EEA [46]. Using 15
May 1997 as a reference date, novel foods were defined as any food not used for
significant human consumption within the Union and is any of: a food with a new or
intentionally modified molecular structure, food consisting of or isolated from
microorganisms, fungi, algae, minerals, plants, animals, or nanomaterials; are from a
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production process not yet used for food production in the Union and resulting in
significant changes to the composition or structure of the food, nutritional value,
metabolism, or level of undesirable substances; vitamins, minerals or other substances
produced with a process not yet used for food production in the Union, or foods used
exclusively in food supplements with intent to use in foods other than supplements.
Novel foods were specifically segregated from genetically modified foods, enzymes,
additives, flavorings, or extraction solvents.
Novel foods require pre-market approval predicated on an evaluated lack of risk
to human health, its intended use is not misleading, and if substituted for current foods its
substitution would not be a detriment to human health [46]. Further, those producing
novel foods are compelled to verify the novelty of their food by consulting the country
where they plan to place the novel food. The administrative and scientific requirements
for novel food applications were established per Regulation (EU) 2017/2469 [47]. The
applicant provides a technical dossier including their own safety assessment data,
including biological or toxicological assessments, as well as their proposed conclusion
from their provided data to enable the EC to consult EFSA for an opinion on the overall
risk assessment of the novel food and highlighting uncertainties and limitations of the
evaluation. The EC catalogues lists of novelty determinations
(https://ec.europa.eu/food/safety/novel_food/catalogue/search/public/index.cfm#) as well
as lists of currently authorized novel foods
(https://ec.europa.eu/food/safety/novel_food/authorisations/union-list-novel-foods_en).

1.2.2.7 India
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Novel foods in India are under the supervision of the Food Safety and Standards
authority of India (FSSAI) [48]. Novel foods are currently regulated according to the
Food Safety and Standards Regulations, 2016 stipulating that a novel food may not have
a history of human consumption, may have any ingredient that may not have a history of
human consumption, or made from a new technology and process resulting in significant
changes in the structure to alter nutrition, metabolism, or undesirable substances [49].
Individual classes or types of novel foods are not specified within this regulation.
The pre-market approval process has been explained in the Food Safety and
Standards Regulations, 2017 [50]. As per guidance, novel foods may not be
manufactured or imported without prior approval, where the application includes
information on the source, function and intended use, scientific analyses, regulatory
status in other countries, and documents on risk and toxicological assessments.
Regulation, 2017 gives more insight into what constitutes a novel food, which includes
novel foods and ingredients, foods processed with novel technology, additives,
processing aids and enzymes, as well as foods consisting of or isolated from
microorganisms, bacteria, yeast, fungi, or algae.

1.2.2.8 Japan
In Japan, the primary statutory authority regarding food sanitation is the Ministry
of Health, Labor, and Welfare (MHLW) [31, 51]. Under the Food Sanitation Act, there is
no segregated definition of a novel food or ingredients nor delineated procedures for
approval (Article 4, Food Sanitation Act). Rather, the Food Sanitation Act has provisions
to prohibit sale of foods that have not been generally served for human consumption and
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have not demonstrated a lack of risk to human health, have been served for human
consumption but served in an extraordinarily manner, or where serious damage to human
health has been attributed (Article 7, Food Sanitation Act). In each case, the MHLW is
advised by the Pharmaceutical Affairs and Food Sanitation Council (PAFSC).
Genetically modified organisms are separately assessed by the Food Safety Commission
(FSC) but is also responsible for risk assessment of food hazards.

1.2.2.9 Saudi Arabia
As of the end of 2019, Saudi Arabia’s Saudi Food and Drug Authority (SFDA)
has proposed a set of draft requirements to regulate novel foods [52]. The draft
regulations pertain to microorganisms, fungi, algae, minerals, plants, animals, cell
cultures or tissues, and nanomaterials as well as foods with new or modified molecular
structures, foods derived from new production processes, and foods that are traditionally
consumed from other countries. The regulation would require pertinent information such
as the scientific basis for safety under intended use or in the case of traditional foods from
elsewhere would require information about history of safe use. The SFDA would take the
information provided into consideration as well as the similarity to foods that are
understood as safe.

1.2.2.10 Singapore
The Singapore Food Agency (SFA) is investigating a framework for novel foods
and had presented its proposed regulatory framework for comments [53]. The proposed
framework seeks to clearly define and gird the scope of novel foods, establish safety
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criteria, and application processes. The proposed definition is that a novel food is one not
used for human consumption in Singapore or outside of Singapore for more than 20 years
and is from an unconventional source or prepared by an unconventional process.
Examples provided include foods isolated from or produced from plants or animals or
their parts; isolated or produced from microorganisms, fungi, algae; food with new
chemical structures not previously found in food whether such food is synthesized from
raw materials or manufactured from a process not conventionally used in food
production; food derived from biologically synthesized substances such as genetically
modified organisms, tissue culture, cell culture, or cloning; foods consisting of
intentionally engineered nanomaterials. Therefore, foods with a history of safe use are not
novel foods, where the history is to be considered based on length of consumption and
use, extent of use, quantity used, purpose and context of use, evidence of lack of adverse
health effects. Delineated examples of novel foods include plant parts without a history of
safe use, insects without a history of safe use, animals without a history of safe use,
isolates from insects, refined extracts from animal products, newly identified
microorganisms without a history of safe use, substances synthesized using food-grade
raw materials (e.g. enzymatically modified ingredients), cell-based meat, engineered
nanomaterials (particle size < 100 nm).

1.2.2.11 United States of America (USA)
The regulatory authority overseeing food additives in the United States (USA) is
the United States Food and Drug Administration (USFDA) [31]. Under current law, there
is no delineated definition of novel foods or ingredients; however, any substance
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reasonably expected to become a component of food is a food additive and subject to premarket approval by the USFDA, unless that component is generally recognized as safe
(GRAS) or meets an exclusion from the definition of food additive according to section
201(s) of the Federal Food, Drug, and Cosmetic Act. Food additives approved either by
USFDA pre-market approval or GRAS is evaluated under the conditions of its intended
use and the use of a food additive above that which was approved would require
reevaluation [31, 54].
Substances that have not been documented as GRAS or USFDA approved, listed,
or excluded require USFDA pre-market approval using a food additive petition [54]. The
technical elements necessary include chemical composition, proposed use, levels of use,
data regarded intended effects, quantified detection levels, estimated exposure levels,
safety reports, proposed tolerances of production, and environmental impact information.
The USFDA provides various guidance documents for identifying pertinent regulations
as well as recommendations for chemical, toxicological, microbial, and environmental
testing, evaluations, and assessments (https://www.fda.gov/food/food-ingredientspackaging/food-additives-petitions).
An alternative to a food additive petition is GRAS status, which can be
determined either through demonstrated food use in the USA prior to 1958 or by
scientific procedures accompanied by a general recognition of safety based on the views
of qualified experts [54]. It is becoming more uncommon for food additives to be
approved by a history of use prior to 1958, and therefore GRAS by scientific procedures
is the principal means to attain GRAS. The data required for GRAS is like that of a food
additive petition such as technical safety evidence for intended use but also a
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demonstration of safety using evidence that is generally known (i.e. publicly available
information). A key difference is GRAS does not have to be filed with the USFDA and
providing a notification of GRAS is voluntary and so some companies convene a panel of
experts as a GRAS panel to evaluate a self-affirmation of GRAS while others document
the self-affirmation without a GRAS panel. Despite the voluntary notification scheme,
the USFDA is interested in GRAS notifications of foods that may pose a risk to the US
population. If the petitioner decides to notify the USFDA of its GRAS determination, the
USFDA responds to GRAS notifications either with acceptance without questions,
rejection for insufficient data or unclear safety, or stop by request of the inquirer. The
USFDA maintains lists of GRAS notifications
(https://www.cfsanappsexternal.fda.gov/scripts/fdcc/?set=GRASNotices), food additives
(https://www.fda.gov/food/food-additives-petitions/food-additive-status-list), and color
additives (https://www.fda.gov/industry/color-additive-inventories/color-additive-statuslist).

1.3 Food allergy
1.3.1 Overview
Allergic disease encompasses a broad spectrum of disorders characterized by
abnormal immune responses. Atopic diseases, in other words diseases with a genetic
predisposition toward development of allergic disease, encompass asthma, allergic
rhinitis, hay fever, atopic dermatitis, and food allergy, although the relationships between
these diseases and their immune response have not been fully clarified [55]. Those with
atopic diseases are commonly predisposed to greater production of immunoglobulin E
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(IgE) antibodies, but many people with elevated levels of total and allergen specific IgE
do not present with atopic disease. Some present with one specific atopic disease whereas
others co-express several. Atopic diseases are often categorized umbrella terms such as
asthma or allergic rhinitis but it is more appropriate that each be understood as a
collection of diseases merely grouped by the phenotype of the disease [56].
Causative agents in Immunoglobulin E (IgE)-mediated hypersensitivity reactions
that can first sensitize an individual to prime the immune system and secondly elicit a
reaction and develop symptoms are broad. Such agents include outdoor allergens (grass
and tree pollen) [57], indoor allergens (house dust mites, pets, cockroaches) [58], insects
stings and/or bites [59], as well as food [60], where the only difference among these is the
source of the allergen. Food allergy is an abnormal immunological response to foods or
their components [60], typically a naturally present protein and are differentiated into
antibody-mediated immediate hypersensitivity reactions, cell-mediated delayed
hypersensitivity reactions, and mixed antibody-cell mediated conditions. IgE-mediated
hypersensitivity reactions account for most food allergic reactions [61]. Other food
sensitivities and intolerances may not be immune mediated. Food intolerances are
metabolic food disorders that become evident upon consumption of certain foods (lactose
intolerance), and food sensitivities are idiosyncratic reactions to specific food
components occurring through unknown mechanisms (sulfite-induced asthma) [60].
Symptoms of IgE-mediated food allergy are diverse where symptoms include
pruritis (itching) and numbness and objective symptoms include hives, eczema, swelling,
wheezing, chest tightness, chest pain, nasal congestion, trouble breathing, abdominal
pain, diarrhea, nausea, vomiting, constriction of the airways, drops in blood pressure, and
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anaphylaxis (Table 1.1) [62]. Symptoms can be evident within minutes and can last for
several hours. In some cases, symptoms can appear hours after ingestion as in the case of
alpha-gal syndrome, a delayed syndrome related to red meat ingestion due to
sensitization through tick bites [60, 61]. The severity of reactions is understood to follow
a dose-response relationship [62], although this is complicated by factors such as the
allergen itself, individual host factors, and interventions to control the reaction [63].
Table 1.1 Symptoms by system associated with IgE-mediated reactions to food.
Adapted from [3].
System
Cutaneous
Ocular

Respiratory

Gastrointestinal

Cardiovascular

Neurologic

Symptoms
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Angioedema
Flushing
Conjunctival erythema
Periorbital edema
Chest tightness
Coughing
Dyspnea
Hoarseness
Laryngeal edema
Abdominal cramps
Angioedema of tongue,
lip, or pharynx
Bradycardia
Ventricular dysfunction
Dizziness
Dizziness
Sense of impending
doom

•
•
•
•
•
•
•
•

Pruritis
Urticaria
Pruritis
Tearing
Nasal congestion
Pruritis
Sneezing
Wheezing

•
•
•
•
•

Emesis
Nausea
Oral pruritus
Hypotension
Tachycardia

•

Syncope

A risk factor for development of food allergies was once thought to be early
exposure to the offending allergen, but early exposure was found to be a protective factor
rather than a risk factor according to the Learning Early about Peanut Allergy (LEAP)
trial [64]. Environmental factors also impact the development of allergies as protective
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effects have been ascribed to farm exposure, breastfeeding, and exposure to other
children; particularly older siblings, but risk factors include air pollution and pet
ownership [65]. Genetics are a major factor as studies on twins has shown significant
heritability of phenotypes of allergic disease, specifically a higher correlation of
heritability has been shown for monozygotic twins (sharing 100% of genes) than
dizygotic twins (sharing 50% of genes) [66]. A broad array of genes has been identified
where specific gene variants have been associated with greater susceptibility to various
allergic diseases. A key example is the gene for filaggrin (FLA), which has been
associated with asthma, atopic dermatitis, and food allergy as the product filaggrin is a
major component of the protein-lipid envelope of the epidermis and thereby important for
establishment and maintenance of the epidermal barrier. Meta-analysis has shown that
there is a strong dose-dependent association between atopic dermatitis, food sensitization,
and food allergy as well as evidence that atopic dermatitis precedes food sensitization and
food allergy [67].
There is currently no cure for food allergies. Therefore, management of food
allergies from a consumer perspective is often required and demands careful reading of
food package labels in addition to dietary choices [68]. Nonetheless, relying on package
labels can leave patients at risk of accidental exposure due to cross-contamination with
allergenic foods or incorrect labeling [62]. To reduce the burden of food allergies,
immunotherapies have been explored to increase the tolerance of allergic individuals
toward their offending allergens such as oral (direct consumption), sublingual (held under
the tongue), and epicutaneous (dermally applied patch) immunotherapies [69].
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1.3.2 Mechanisms of IgE-mediated hypersensitivity
During sensitization, the immune response is driven by differentiation of naïve T cells
into TH2 cells as well as class switching of naïve mature B cells from production of nonIgE antibodies to IgE production (Figure 1.2) [70].

Figure 1.2 Mechanism of cellular activation in response to allergenic insult and
subsequent recognition by IgE.
Adapted from [4].
Differentiation of T cells occurs as antigen presenting cells (including but not limited to
dendritic cells) present an antigen-derived peptide to the T cell along with appropriate costimulating molecules to result in activation. Upon activation, the T H2 cells secrete
cytokines [Interleukin (IL)-4, IL-13], which encourage continued TH2 differentiation,
proliferation, as well as B-cell IgE class switching and production. Activated CD4 T-cells
along with activated B-cells can result in B-cell differentiation into antibody-secreting
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plasma cells and memory cells, which persist and respond to future insults with IgE
production long after sensitization. Produced IgE can strongly bind to the surface of mast
cell and basophil FcɛRI to prime them for activation. During sensitization, there is no
active immune response and therefore no symptoms.
Subsequent antigenic insults result in antigens binding to IgE and subsequent
cross-linking of FcɛRI resulting in both activation and degranulation of mast cells and
basophils [70]. The granules release potent mediators to produce local, tissue, and
systemic responses, which are responsible for the symptoms associated with immediate
hypersensitivity reactions [60]. Released histamine from the granules can elicit
inflammation, pruritis, and vasoconstriction of blood vessels of the gastrointestinal and
respiratory tracts. Other released molecules include lipid mediators, leukotrienes, and
prostaglandins, where leukotrienes are related to symptoms that develop slowly as in latephase asthmatic reactions.
Exposure to food proteins do not typically result in the development of allergic
disease nor the formation of IgE antibodies. Even in atopic individuals exposure to food
proteins in the gastrointestinal tract promotes oral tolerance through the formation of
protein-specific IgG, IgM, and/or IgA antibodies [60]. Other mechanisms of tolerance
include clonal anergy, apoptosis of antigen specific T cells, active immune suppression,
and bystander suppression. Regulatory T cells (Tregs) are involved in controlling the
response of the immune system by inhibiting T cell proliferation and differentiation
through the cytokines IL-10 and TGF-β [70, 71], which act as a key component of oral
tolerance and maintain healthy immune responses to allergens [72].
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Other types of reactions are also meaningful as in IgG mediated hypersensitivity
reactions caused by IgG binding to cell surfaces resulting in cell death (penicillin
allergy), immune complex mediated reactions resulting from the formation and
deposition of antigen-antibody aggregates (serum sickness), and delayed hypersensitivity
reactions incorporating CD8 and TH1 cells and pathways (mosquito bites) [70]. Celiac
disease is a non-IgE mediated hypersensitivity triggered by gluten proteins in various
grains, predominantly wheat. Celiac is characterized by IgG and IgA responses to gluten
after the effects of endogenous transglutaminase has deamidated gluten and “produced”
the necessary antigen in the form a gluten-transglutaminase complexes. Resultant T cell
activation and subsequent proinflammatory response is coupled with an autoantibody
response causing damage to the small bowel and atrophy of the villi leading to long term
damage and nutrient uptake deficiencies [73].

1.3.3 Diagnosing food allergy
Diagnosis of food allergies begins with the clinical history of the patient.
Information such as the food consumed, how the food was prepared, symptoms
experienced, severity of symptoms, and the interval between consumption and onset of
symptoms are all incorporated to determine the likelihood of food allergy [74]. Further,
background regarding atopy, current food allergies, current medications (e.g.
antihistamines), and diet can refine the diagnosis and identify if any food sensitivities are
present, if the manifestation is a food allergy, and if offending foods can be singled-out
[75]. Clinical histories substantiating a possible food allergy are complimented with skinprick testing, serum IgE testing, and food challenges [76].
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Skin prick tests act as a relatively quick and cheap method to establish allergic
sensitization. The test is performed by puncturing the skin with food extract, puncturing
the suspect food and then the skin, or through intradermal injection and compared against
negative (e.g. saline solution) and positive (e.g. histamine) controls [77]. A positive
reaction is evaluated in terms of the resultant wheal and the size measured, where a wheal
diameter greater than 3 mm is considered positive. Skin prick results must be analyzed
carefully as wheal sizes vary according to age, site used for testing, skin prick technique
used, and the antigen used for the test whether fresh or commercial [78]. Skin prick tests
can have negative predictive values up to 95% but this varies greatly depending on the
food tested and the type of extract used as commercially produced plant extracts can
result in sensitivities of as low as 20% [74]. Positive skin prick tests only confirm the
presence of allergic sensitization as opposed to allergic disease, although positive results
coupled with a compelling clinical history are strongly incriminating [77].
Evaluation of allergen-specific IgE acts as an alternative and compliment to skin
prick testing, but is more costly, time-consuming, and similarly does not discriminate
allergic disease and allergic sensitization [74]. Methods to measure allergen-specific IgE
include fluorescent enzyme immunoassays such as ImmunoCAP and Immuno Solidphase Allergen Chip (ISAC). These tests are performed in a laboratory setting where
serum is applied to immobilized antigens and detected by anti-IgE antibodies with
fluorescent tags where greater fluorescence indicates more bound IgE. These tests are
semi-quantitative, and so are not perfectly comparable across different methodologies,
but are used to determine predictive values of allergic disease as increasing
concentrations of measured IgE are correlated with greater likelihood of allergic disease
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[79]. When measured specific-IgE are greater than or equal to 95% of the predictive
value then food allergy is likely, whereas if levels are less than or equal to 50% of the
predictive value then oral challenge may be carried out to exclude food allergy [78].
These tests can be further leveraged for component-resolved diagnostic testing to identify
individual proteins binding a patient’s serum IgE and establish patterns among foods with
homologous proteins.
When clinical history and diagnostic tests are unclear, food challenges can be
performed to assess clinical reactivity. Food challenges can be performed as a doubleblind placebo-controlled food challenge (DBPCFC) or open food challenge (OFC). Food
challenges can be expensive and necessitate a highly controlled environment and so are
not performed without careful consideration of alternative means of diagnosis. Open food
challenges are subject to observer bias and psychogenic factors resulting in a greater
false-positive rate but are more practical in clinical settings [74, 78]. Double-blind
challenges are the preferred diagnostic method, but the suspect allergen must be
appropriately masked in a vehicle food to be indistinguishable from a placebo, which can
be difficult in the case of easily detected allergenic foods such as apple or shrimp. In
either method, the food should be given in a tiered manner given timed intervals and
beginning with very low doses to determine the threshold dose resulting in symptoms.
The food challenge ends upon either completion of the challenge without symptoms or
discontinued upon development of symptoms and the patient treated immediately. In
some cases, food challenges can result in anaphylaxis, underscoring that food challenges
should be conducted by trained professionals in appropriate settings [79]. Negative
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results allow the patient to introduce the challenged food into their diet, but positive
results indicate that avoidance is necessary.

1.3.4 Prevalence and impact of food allergies
In 1995, the FAO-WHO Expert Consultation on Food Allergies of 1995 identified
eight major food and groups associated with over 90% of food allergies: gluten
containing grains, crustaceans, eggs, fish, peanuts, soybeans, milk, and tree nuts [80]. In
1999, the list was included in the Codex Alimentarius and later adopted by many
countries as the basis for their laws regarding labeling of allergenic foods. There are
differences in prevalence of individual food allergens as in celery allergy in Europe,
sesame allergy in Israel, and buckwheat allergy in Japan [60], which is commonly
reflected in differences among countries food allergen labeling laws.
Recent surveys have determined that the estimated total prevalence of convincing
food allergy in the U.S. is at least 10.8% given that of those surveyed 19% self-reported a
food allergy [81], which underscores the importance of clinical diagnosis and the proper
education of those at risk. However, the disparity among self-reported and clinically
confirmed food allergy identifies a problem that the true prevalence of food allergy is not
accurately known. Large epidemiologic studies incorporating studies of questionnaires
and surveys may not be accurate to the true prevalence of food allergy [56]. Considerable
heterogeneity is present among studies of food allergy prevalence due to differences
among how studies may incorporate likely, but unconfirmed, food allergy as opposed to
prevalence of clinically or objectively confirmed food allergy. Among well designed
studies, variability of questionnaires, IgE testing, skin prick testing material, and oral
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challenge material can cause the prevalence of food allergy to vary considerably across
studies [82].
Identifying those at risk is difficult as in the case of children born in East Asia or
Africa but raised in the West being at greater risk of developing food allergy compared to
Caucasian counterparts [83]. Many factors impact the prevalence of recorded food allergy
including geography, diet, age, race, and ethnicity [75]. The prevalence of food allergy is
generally regarded as increasing although uncertainty exists due mostly to lack of clinical
confirmation of food allergy (i.e. food challenges) in favor of skin prick tests, IgE-based
biomarkers, or a lack of any clinical evaluation [84].
Food allergies impose great social cost on those affected and while food allergy
has been historically understood as a pediatric disease a great and increasing proportion
of adults are affected [85]. The annual economic cost of food allergies has been estimated
at above $4,000 per child including costs of hospitalizations, clinician visits, and
medications. Those of lower socioeconomic status are most affected as they have a
greater propensity to spend more on hospitalizations and emergency room visits. In
addition to out-of-pocket costs, lost opportunity costs impose a great burden on those
with food allergy via lost wages to take themselves or others to the hospital as well as
potentially restricted career choices to take care of children with food allergies [86]. For
those self-reporting food allergies, some of these costs could also be undertaken and
thereby impose a burden even without the presence of disease.
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1.3.5 Properties and characteristics of allergenic food proteins
Formal nomenclature of allergens is performed by the International Union of
Immunological Societies (IUIS) as the IUIS Allergen Nomenclature Sub-Committee
under the purview of the World Health Organization (WHO) [87]. The nomenclature of
allergenic proteins is based on Linnaean binomial nomenclature identifying the genus and
species of all organisms. The base format includes the abbreviated genus name,
abbreviated species name, allergen number, and a four-digit number representing the
isoallergen and variant numbers (e.g. Ara h 10.0102; Arachis hypogaea 10th allergen,
isoallergen 1, variant 2). Allergen numbers were initially assigned in order of discovery
but has since been assigned to organize allergenic proteins by similarity for clarity.
Isoallergens are those from the same species representing similar function with a shared
sequence identity of >67% and variants are those with a shared sequence identity of
>90% [87].
Epitopes are specific chemical groups in an antigen that determine the specificity
of an antigen [88]. Epitopes are the basic structural unit of both B and T cell receptors
and antibodies and can be divided into either B or T cell epitopes according to which
cells they bind and divided further into linear or conformational epitopes. Linear epitopes
are made of sequentially contiguous amino acids as compared to conformational epitopes,
which are composed of amino acids representing a spatially close region formed due to
protein folding. Cross-linking of FcεRI requires two antibody molecules to bind to the
same allergen. Epitopes adhered to antibodies or either T cell or B cell receptors are held
by a binding pocket allowed by the receptor’s amino acid side chains and by noncovalent interactions with the epitope [70]. Although the receptors are highly specific for
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their antigen, binding is predominantly determined by anchor resides to determine the
principal specificity of the binding pocket.
Cross-reactivity is recognition of multiple antigens by antibodies with a single
specificity [89], in that antibodies produced against a specific protein may bind to related
sequences and structures of the same or similar organisms. Cross-reactivity permits
reactivity without initial exposure to the exact same epitopes, rather only highly similar
epitopes. Factors affecting cross-reactivity include common proteins, epitopes, and folds
[88]. In allergy, cross-reactivity results in a broader array of antigens that can result in
allergic reactions, and thereby is advantageous for protection against pathogens but not in
the case of dietary proteins [89]. Families of cross-reactive allergenic proteins have been
identified plants including profilins, prolamins, cupins, and Bet v 1-like proteins but also
animals including parvalbumins, tropomyosins, and arginine kinases [88, 90]. Crossreactivity also leads to some odd couplings and disparities when focusing on foods rather
than the cross-reactive allergens as those with cow’s milk allergy are highly likely to be
reactive to goat’s milk but seldom reactive to horse’s milk or another example of the
relatively common cross-reactivity of those with latex allergy reacting to any of kiwi,
banana, or avocado [91]. Cross-reactivity also bridges the gap between aero-allergens and
food allergens as in pollen-food syndromes between, for example birch-apple syndrome
through homology of birch Bet v 1 and apple Mal d 1 [92].
To determine if a particular protein has the capacity to elicit reactions, proteins
can be evaluated to determine the plausibility of their allergenicity. Decision trees and
weight-of-evidence approaches have been adapted from evaluations of proteins derived
from biotechnology to aid in the process of evaluating potentially allergenic proteins
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[93]. Individual proteins can be evaluated on the basis if there are other allergenic
proteins known from the organism, if the protein is homologous to other known
allergens, if sera with known reactivity have IgE that can bind the protein, enzyme
digestibility assays (e.g. pepsin, trypsin, chymotrypsin), and animal models (e.g. BALB/c
mice). Knowledge about the properties of the protein in question can also be informative
as allergens tend to have similar properties such as maintenance of protein folds (calcium
binding, lipid binding, and disulfide bonding leading to heat resistance), maintenance of
primary sequence (resistance to proteolysis), repeated epitopes (repeating primary
structures, multimeric quaternary structures), and unique motifs (glycosylation and
glycation sites) [94], where each of these properties results in a greater capacity to
distinguish the protein from self-proteins, allow for single epitopes to be bound multiple
times across a single antigen, as well as maintain the allergen for the immune system to
identify. Predictive tools aid in distinguishing plausible allergenic proteins, for example
AllergenOnline [95], AllerCatPro [96], and BepiPred [97], to predict allergenic proteins
on the basis of their sequence, structure, and B-cell epitopes. Guidelines on predicting the
allergenic potential of proteins based on sequence alone include CODEX guidelines of
greater than 35% identity over segments of 80 amino acids or 100% identity in 6 or 8
amino acids, but prediction based on greater than 50% identity over the full length has
been regarded as the most predictive [95].

1.3.6 Food processing and food allergens
For known allergenic proteins in commonly consumed foods the question is what
can be done about them. Various forms of food processing are common in preparation of
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food such as thermal, high pressure, enzymatic, and fermentative processing. Thermal
processing is one of the most common and preferable methods to prepare food for
desirable organoleptic properties [98]. Thermally processing allergenic proteins can result
in reduced IgE-binding for some proteins but can expose hidden epitopes for others. For
example, Bet v 1-like allergens tend to show greatly reduced IgE binding after heat
treatment but Ara h 1 shows similar IgE binding before and after baking. High-pressure
processing (HPP) is an emerging nonthermal technique often used for inhibition of
microbial growth. The underlying principle is that application of pressures above 200
MPa can affect higher order structures of protein without affecting covalent bonds, which
allows for nutritional value, flavors, and aromas to be unaffected. The efficacy of highpressure processing is still under investigation but shows promise as an alternative to
thermal processing for microbiological hazards.
Processing methods that directly impact the sequence of allergenic proteins tend
to have great effect in reducing their capacity to bind IgE. Enzymatic hydrolysis is a wellknown nonthermal processing technique commonly used for foods such as milk, lentils,
and peanuts, although this technique is heavily reliant on proteins that are susceptible to
the proteolytic cleavage for the end result to be a greatly diminished allergenic protein
[99]. Further, a major drawback of enzymatic hydrolysis are the negative impacts on
functional properties and emergent bitterness and astringency from resultant small
polypeptides [98]. Alternatively, fermentation is one of the oldest food preservation
methods. Utilizing microbes to produce enzymes and act upon the food results in changes
in texture, flavor, and functional properties [99]. Milk and wheat have consistently shown
that fermentation can result in reductions in IgE binding, although the range of foods
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where fermentation is applicable is limited as the fermented product is often greatly
different from the starting material in terms of both function and taste [98].

1.3.7 Novel sources of food allergens
Accompanying novel foods and processing comes food allergens that may be
themselves novel, processed to render a well-known allergen to be modified in a novel
manner, or a well-known allergen being consumed or ingested in an alternative manner.
Understanding a novel source of food allergens then demands insight into which proteins
are present, how they are affected by processing, as well as how to both detect and
quantify present proteins that may be hazardous to consumers. Accurate identification
and evaluation of the presence and quantity of food allergens is heavily dependent on the
methodology used.

1.4 Quantitative methodologies for the detection of food allergens
There are currently a wide variety of methodologies that can detect food
allergens, although a smaller subset has been widely accepted and utilized for
quantitative determinations. Methods for quantitative evaluation of food allergens include
polymerase chain reaction, enzyme-linked immunosorbent assay, and mass spectrometry
(Table 1.2).
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Table 1.2 Pros and cons of quantitative methodologies to detect food allergens.

Methodology
Polymerase chain
reaction

Enzyme Linked
Immunosorbent Assay

•
•
•
•
•
•
•

Pro
High throughput
Multiplex potential
Fast
DNA is tolerant of
robust extraction
High throughput
Industry standard
Fast

•
•
•
•
•
•

•
•
Mass spectrometry

•

Multiplex potential
Can be absolutely
quantitative
High sensitivity to all
present proteins

•
•
•
•

Con
Detects DNA rather
than protein
DNA may not
correlate to protein
presence
Requires antibodies
Antibodies can crossreact
Requires calibration
to reference materials
Extraction requires
antibody tolerance
High capital inputs
High levels of
expertise
Time consuming
Limited by data
analysis

1.4.1 Polymerase chain reaction
Polymerase chain reaction (PCR)-based methods allow for highly specific and
sensitive detection and quantification of DNA stretches, rather than protein, from
allergenic sources of interest beginning with extraction and purification of present DNA,
amplification of DNA, and subsequent detection of the DNA [100, 101]. PCR utilizes
thermal cycling and repeated cycles of both heating and cooling to denature DNA and
enzymatic replication with Taq polymerase [100]. Repeated cycles of denaturation,
annealing, and extension takes place until DNA of interest is sufficiently amplified. Key
factors in an effective PCR are the specificity of the stretch of DNA and the specificity of
the oligonucleotides chosen as primers for the reaction [100, 101].
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Real-time PCR is preferred for quantitative analysis of allergenic food- derived
DNA [100]. In real-time PCR, the reaction tube additionally contains a target specific
oligonucleotide probe and fluorescent reporter dye attached to a quencher. Detection of
fluorescence is prevented due to proximity of the dye and quencher but when the DNAhybridized probe is exposed to the 5’ exonuclease activity of Taq polymerase, the dye is
displaced into solution. As the reaction progresses, more dye is displaced into solution
and the reaction can be monitored and measured as fluorescence is proportional to the
amount of target DNA present.
In principle, PCR allows for a greater diversity of valid methods to be developed
per allergenic food compared to protein-based methods as three nucleotides represent
single codons as translated to amino acids where degenerate use of codons allows for
otherwise indistinguishable proteins to be distinguished by PCR in addition to
untranslated introns [101]. PCR methods only require the genetic code and so could be
utilized as open-source methods as compared to the limited and often proprietary
antibodies utilized by antibody-based methods. The time to run a PCR is comparable to
that of enzyme-linked immunosorbent assays (ELISA) and faster than mass spectrometry
(MS). In a well-designed PCR, simultaneous detection of several DNA stretches, i.e.
multiplex allergen detection, is possible.
DNA is generally more tolerant toward harsh extraction procedures than protein
and so PCR benefits; however, matrix impurities can impair detection more so than
protein-based methods such as polysaccharides, polyphenols, fats, minerals, and enzymes
[102]. PCR is not universally applicable to allergenic foods as both milk and egg are
poorly detected by PCR due to low levels of present DNA [100]. Use of PCR requires
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calibration curves to convert quantified allergenic food-derived DNA into total allergenic
food as quantities of DNA are not universal across foods [101]; further, as PCR does not
directly detect the proteins, their utility in assessment of the risk posed is limited [100].

1.4.2 Enzyme-link immunosorbent assays
Enzyme-linked immunosorbent assays (ELISA) are the most widely used tool by
the food industry for detection of specific allergenic proteins [100]. The antibodies used
for ELISA are typically IgG from animal sources, usually rabbits, goats, or sheep, which
allow for suitable quantities of antibody with minimal variability as compared to using
human serum IgE. Quantitative ELISAs come in either of sandwich or competitive
formats, each with their own benefits and drawbacks. Sandwich ELISAs are the most
common format for allergen detection where an IgG capture antibody is immobilized on
a solid phase, such as a 96-well plate, and the food is extracted and applied to the plate
and subjected to the immobilized IgG. After incubation and washing, a reporter IgG
labelled with an enzyme (e.g. horseradish peroxidase) is added to sandwich present
allergenic proteins. To quantify present allergenic protein a substrate is added, and the
enzyme labelled IgG develops a colored product that can be measured. Color is
proportional to the amount of present allergenic protein and is quantified by comparison
to a standard curve.
Alternatively, competitive ELISAs are available where allergenic proteins of
interest are immobilized on the solid phase and separately the sample extract is preincubated with allergen-specific IgG [100]. When the sample-IgG mixture is applied to
the wells, IgG that are unbound will bind to the plate. After washing, a reporter IgG is
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added, color developed, and colored product is measured. In competitive ELISA, the
color developed is inversely proportional to present allergenic protein.
Sandwich ELISAs require two IgG epitopes per target protein whereas
competitive ELISA only requires a single IgG epitope [100], which allows competitive
ELISA to have an advantage detecting fermented or hydrolyzed proteins where target
proteins may not be wholly intact for a sandwich ELISA to be wholly effective. ELISA
can be performed relatively simply with trained personnel and using inexpensive
equipment [101]. There are many commercially available ELISA kits that encompass
most food allergens, although different kits for the same allergenic food may not detect
the same protein fractions or allergens (e.g. the whey versus casein fractions of milk)
[100].
The performance of ELISA can vary among samples from different food sources
according to matrix effects and food processing effects [101]. Proteins may not be
effectively extracted due to protein aggregation, denaturation, or chemical modification,
which limits comparison to calibrants that may not be representative of the same matrix,
processing state of the allergenic protein in the food [101, 103]. Polyclonal IgG and the
calibration curves are subject to batch variation and may further vary across
manufacturers, producing different results across kits detecting the same allergenic
proteins [101].

1.4.3 Mass spectrometry
Mass spectrometry has historically been applied to the identification and
characterization of proteins, but only more recently has been applied to quantification of
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food allergens [100, 104]. The most applied quantitative workflow is called bottom-up,
where the measured targets are peptides derived from enzymatic digestion of allergenic
food-specific proteins [105]. A generalized quantitative workflow has four steps: 1)
protein extraction, 2) proteolytic digestion, 3) analysis of identified peptides for
evaluation, 4) iterative targeted evaluation of selected peptides. Extraction is often the
most important for sensitive detection of target peptides as the food matrix can contain
many non-target proteins and peptides as well as starches, fats, and other interfering
molecules that can be a detriment to accurate quantification [106]. After extraction, the
proteins can be prepared for mass spectrometry by reduction to break present disulfide
bonds, alkylation to prevent reintroduction of disulfide bonds, and proteolysis that
commonly features either trypsin or chymotrypsin to reproducibly cleave the proteins
into peptides [100].
To analyze the complex mixture of peptides, mass spectrometers are commonly
coupled with reverse phase high performance liquid chromatography (RP-HPLC) to
fractionate the peptides according to their hydrophobicity and feed the peptide fractions
into an electrospray ion source (ESI) [101]. Mass spectrometers can be any of an array of
different analyzers such as a quadrupole (Q), ion-trap, time-of-flight (ToF), OrbitrapTM,
or Fourier-transform ion cyclotron (FTICR) as well as used in tandem configurations,
such as a triple quadrupole (QqQ), to increase sensitivity, resolution, and accuracy [100].
The mass spectrometer measures ions according to their mass-to-charge ratio (m/z) and
so first measures the whole peptides and, for tandem mass spectrometry, fragment the
peptides to generate further information about the sequence of the peptide and generate
further actionable information about the peptide.
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An initial investigation proceeds without prior knowledge of present proteotypic
peptides representing the allergenic food to identify suitable candidates. Identification of
peptides is performed bioinformatically with software, such as Mascot or PEAKS, and
compared with databases of proteins representing the targeted allergenic foods and
background matrices [100]. Candidate peptides are screened on a wide array of criteria
not limited to uniqueness against the food matrix, conservation among varieties of the
allergenic food, high abundance, lack of modifications (i.e. Maillard reaction products,
oxidation sites, deamidation sites), efficient extraction and digestion, reproducible and
unique fragments, a predominant charge state, and of length between 6-12 amino acids
[105]. Optimal peptides from the allergenic food may be appropriate in some food
matrices but not others and therefore sub-optimal peptides may have to be used. Further,
it is a continuous challenge that the databases assessed for peptide identifications may be
incomplete for one or both of the allergenic food and matrix such that better peptides
could be present and not utilized. Once suitable candidate peptides are identified and
initial verification of their uniqueness and utility are established, chemically pure
peptides labelled with heavy isotopes (commonly C13 and N15) can be included with the
unlabeled target peptides to act as standards for quantification [101].
Mass spectrometry enables the detection of multiple proteins per allergenic food
and allergenic foods in a single analysis in addition to highly degraded proteins [101].
Mass spectrometry detects proteins from the allergenic food without the need for
immunochemistry, which can be affected by food processing [100]; however, the effects
of food processing must be evaluated with respect to mass spectrometry detection as
protein extraction can be greatly influenced by processing. Taking a sample through the
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entire process of mass spectrometry, data analysis, and quantification requires lengthy
periods of time, expensive equipment, and highly trained personnel. The use of mass
spectrometry is currently very well suited to confirmatory analysis, but as a young
technology can grow to distinguish itself.

1.5 Risk analysis and food allergens
Risk can be defined as a function incorporating both the probability and severity
of adverse health effects caused by a hazard, where a hazard is an agent that can cause
adverse health effects [107]. With respect to food allergens, the hazard is the food
allergen, and the risk is a function of an individual with allergy to that food allergen
consuming the allergen as well as the dose consumed. Risk analysis is a three-part
scientific process incorporating risk assessment, risk management, and risk
communication (Figure 1.3). By virtue of new developments or considerations, risk
analysis iteratively incorporates information, concerns of stakeholders, and feasibility to
gauge the level of risk posed relative to the level of risk permissible. Application of risk
analysis to food allergens can inform manufacturers’ use of non-mandatory precautionary
labeling.
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Figure 1.3 The constituent parts and sub-parts of an iteratively applied risk
analysis.
1.5.1 Risk assessment
Risk assessment incorporates four steps consisting of hazard identification, hazard
characterization, exposure assessment, and risk characterization [107]. For food
allergens, these steps can be summarized as identifying plausible allergens of concern,
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evaluation of the effects to allergic consumers, determination of likely consumption
patterns, and culminating in an estimation of the risk posed to allergic consumers.

1.5.1.1 Hazard identification
Hazard identification is the identification of agents capable of causing adverse
health effects [107], where for the hazard identification of a food allergen would be the
range of plausible food allergens that may be present in a given food. Identification of
relevant allergenic sources can be performed relative to data attributed to human
consumption, including clinical studies, provided that the allergenic source was attributed
correctly and judgment and/or guidance that the allergen is of significant concern to the
overall population [108]. For example, strawberries can cause severe reactions in those
with strawberry allergy; however, in the U.S. strawberries do not warrant delineation on
package labels as an allergen nor handling as an allergenic hazard. Such ingredients may
yet be judged as a hazard for a manufacturing plant or company if the packaged food
were to be sold specifically to those with food allergies.

1.5.1.2 Hazard characterization
Hazard characterization is the qualitative and/or quantitative evaluation of the
nature of the adverse health effects caused by agents [107]. If data is available, a doseresponse assessment should be included to determine the relationship between the
magnitude of exposure and the severity or frequency of adverse health effects. Nonallergen food safety (conventional) risk assessments may estimate the likelihood of the
presence of a hazard on a scale of 1-3 ranging from unlikely to very likely and similarly
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estimate the severity of the hazard from 1-3 ranging from minor injury to death and
further multiplying these to generate an overall risk score per hazard and thereby
determine a hierarchy of hazards to control [109]. Transposing such a scheme to allergens
does not adequately characterize present hazards as the severity of an allergen can be
further evaluated in terms of the physical nature of the allergen (liquid, powder,
granules), amount of allergenic protein present (concentration), processing applied to the
allergen, and clinical thresholds among allergic individuals [109]. As the severity of
allergic reactions are related to the exposure dose, consideration and discrimination
among allergen-containing ingredients provides a greater level of nuance. For example, a
soy protein isolate as compared to soy lecithin contains a far greater amount of protein
(allergens) as well as being a free-flowing powder rather than a viscous liquid where
without characterizing the nuances between the two would be regarded as equally
hazardous.
At the population level, allergic individuals begin to demonstrate symptoms at a
wide range of doses [110]. Individual minimum eliciting doses can be determined using
DBPCFC studies to determine the highest dose observed not to produce an adverse effect
(No Observed Adverse Effect Level (NOAEL)) and/or the lowest does that does produce
an adverse effect (Lowest Observed Adverse Effect Level (LOAEL)). Aggregation of
individual minimum eliciting doses by modelling can be used to determine eliciting doses
(ED) predicted to result in reactions in percentages of the population (i.e. 1% or 5% is
then ED01 and ED05, respectively). This approach has been applied in the Voluntary
Incidental Trace Allergen Labelling (VITAL) scheme for 14 allergens for manufacturers
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to use as reference doses for manufacturers and guide risk assessment and management
[7].

1.5.1.3 Exposure assessment
Exposure assessment is the qualitative and/or quantitative evaluation of the likely
intake of agents and other relevant sources [107]. Exposure can be quantitatively
determined by incorporating probabilities that allergic consumers purchase a product and
the amount of the food consumed in a single sitting. It has been demonstrated that food
allergic consumers do not differ in food intake as compared to non-allergic counterparts
[111], and so general data on food intake can be used to evaluate likely consumption and
exposure patterns allergic individuals will face. Country-wide dietary surveys can be used
to determine values for both purchasing and consumption. Examples include the U.S.
National Health and Nutrition Examination Survey (NHANES) and the Canadian Health
Measures Survey (CHMS). Exposure assessments can incorporate further variables such
as the propensity to heed specific wordings of precautionary allergen labeling as well as
proprietary marketing data to narrow the assessment to specific products or a single
company.

1.5.1.4 Risk characterization
Risk characterization is the qualitative and/or quantitative estimation including
uncertainties of the probability of occurrence and severity of potential adverse health
effects in a given population per hazard identification, hazard characterization, and
exposure assessment [107]. In order of increasing complexity and requirements for data
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quality, methods to characterize risk include safety assessments, benchmark dose [112],
and probabilistic modelling [113]. Evaluation in order of increasing complexity clarifies
if simpler methodologies are sufficient prior to application of more rigorous methods.
Briefly, a safety assessment is a classical toxicological approach where available
data is surveyed for the lowest NOAEL and/or LOAEL and further divided by an
uncertainty factor reflecting human variability to arrive at a dose that should be safe to
consume in a single sitting [108]. The benchmark dose method involves constructing a
dose-distribution curve from population data and determining a benchmark dose from the
lower confidence limit of a dose corresponding to a predetermined increase in reactions
(e.g. 1% or 10% or more) [108, 112]. Probabilistic modelling leverages distributions of
minimum eliciting doses, concentration of allergen present, and consumption amounts to
sample from using Monte Carlo simulations and calculate the likely number of expected
allergic reactions [108, 113]. Both safety assessment and benchmark dose methods
produce qualitative estimates of risk whereas probabilistic models are quantitative. Each
tend to produce estimates that are risk-adverse such as probabilistic models
overestimating the total number of reactions [108]. As the methodologies continue to
improve coupled with higher quality data, more accurate estimates of the true risk can be
produced.

1.5.2 Risk management
Risk management is weighing policies with respect to stakeholders and
considerations of risk assessment to select adequate prevention and control options [107].
In context of the risk assessment for a particular hazard, risk management seeks to
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actively control hazards considering all present hazards and heeding good manufacturing
practices. Managing allergens seeks to make food products such that allergic consumers
can make informed and safe choice [108]. Managing risk involves the entire supply chain
to the consumer. Examples of steps to control include the sourced ingredients, where
allergenic ingredients are stored in a facility, how manufacturing areas are cleaned and
validated, and ensuring packages are accurate and reflect the food therein.

1.5.3 Risk communication
Risk communication is the interactive exchange of information and opinions
throughout risk analysis including the explanation of risk assessment findings and the
basis of risk management decisions [107]. Much of the communication directly between
the manufacturer and consumer regarding the risk involved with foods is provided in the
form of labeling. Major allergenic sources are commonly mandated to be clearly
displayed such that concerned individuals can make safe choices. In the case of
unintentional allergens, precautionary labeling is voluntary but ought to be used to reflect
uncertainty where hazards cannot be controlled such that a preponderance of
precautionary labels are not used for foods that such a warning is not warranted [108].
Ensuring that allergic consumers are well-informed is important but precautionary
labeling should not be used in lieu of appropriate risk management as the result is undue
restrictions on the diets on those with allergy.
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1.6 Allergic risks of consuming insects
1.6.1 Background
There is increased interest and activity working toward production and use of
insects as food sources in industrialized countries. Certain insects (locusts, termites, and
other related arthropods such as scorpions) have been consumed for centuries in
Southeast Asia and elsewhere, usually as whole identifiable organisms. New food
products being developed now require processing of the insects into powders or
emulsions that are added to processed foods. Thus, regulatory authorities and developers
are interested in considering potential safety issues. The primary predictable risk is
potential IgE allergic reactions for those already allergic to crustacean shellfish (also
arthropods) or to other insects, who might react upon their first ingestion. This review is
intended to consider the prevalence and identity of proteins that might cause crossreactivity or de novo sensitization, but currently there is a lack of information on methods
for accurately predicting de novo sensitization.

1.6.2 Crickets
1.6.2.1 Food allergy to crickets
Allergic reactions to crickets can occur from either airway, contact or oral
exposure as discussed in a recent review [114]. Currently, there is little data regarding
food allergy to crickets, with only one reference to the possibility of reactions to cricket
as a food source [115]. There is little documentation of the use of insects as food sources
in the United States. However, it is not uncommon to find insects used as food in some
international cultures. Yet food allergy to crickets has been regarded as relatively rare in
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light of notable consumption of crickets around the globe [114]. Allergy to crickets,
locusts, and grasshoppers are often conflated, especially in light of the many species that
are classified in each of these categories and that healthcare professionals may have
difficulty in distinguishing them [114]. Published reports suggest that allergy to locusts or
grasshoppers is more severe and common than cricket allergy [114, 116, 117].
Consumption of edible insects has resulted in severe reactions in Thailand and China. A
Thai university hospital reported 24 cases of food-induced anaphylaxis over 6 years of
which a single instance was to unspecified fried insects [118]. Another study from a
tertiary care hospital found 36 food-induced anaphylaxis cases and 7 of those to fried
insects, predominantly grasshoppers and crickets, over 2 years [115]. A review of
Chinese allergy literature found that edible insects comprised the third leading cause of
food-borne anaphylaxis in China with 7.5%, 7.5%, and 1.4% of all cases attributed to
locusts, grasshoppers, and silkworm pupa respectively [119]. It should be noted that
anaphylaxis is defined differently by some clinicians and some studies do not define their
scoring system clearly. A common description is observable clinical signs involving at
least two organ systems, such as respiratory tract (asthma or rhinitis), skin (atopic
dermatitis or hives) or gastrointestinal involvement (pain, emesis, or diarrhea).

1.6.2.2 Non-food allergy to crickets
In adults, there are many reports that food allergic reactions can stem from crossreactivity with airway allergens [120, 121], where exposure to airway allergens can
sensitize individuals potentially leading to food allergy [122]. Inhalant allergies are more
associated with symptoms including asthma, rhinitis, and atopic dermatitis whereas food
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allergies may also include cutaneous symptoms and anaphylaxis [123]. Environmental
exposure can occur outside homes as in the case of field allergy which results from
exposure to swarms of insects or indoors such as exposure to cockroach matter such as
hair, scales, feces, and body parts that result in generalized dust [123, 124]. Individuals
with field allergy to grasshoppers and locusts have reported asthma and fatalities during
large outbreaks of insects can occur [124].
Immediate hypersensitivity to cricket has been detailed only once in the literature
where a teenager was using crickets as bait while fishing and exhibited lacrimation and
angioedema within 30 minutes and wheeze within 5 hours [114, 125]. Chronic
environmental exposure to Acheta domesticus in a cricket breeder resulted in a case of
hypersensitivity pneumonitis with arginine kinase as the implicated allergen [126]. A
case of occupational asthma with rhinoconjunctivitis due to occupational allergy to
Acheta campestris where monosensitization to cricket was demonstrated and several IgE
reactive proteins were described but not identified or characterized [127].
Cases of occupational allergy with grasshoppers and locusts have been reported in
the scientific literature as early as the 1950s [124]. A case study by Rauschenberg et al.
details a zookeeper with occupational allergy to locust (Locusta migratoria) with contact
urticaria occurring by direct cutaneous exposure to whole dead or live locusts [128]. The
patient was found to have specific IgE to locust without specific IgE to tropomyosin nor
other arthropods. Lopata et al. investigated ten subjects exposed to locusts (L.
migratoria) in a laboratory [129]. Six experienced symptoms of urticaria,
rhinoconjunctivitis, and asthma, seven had positive skin prick tests (SPT), and five had
specific IgE to L. migratoria. The authors suggested that a 35 kDa band identified from
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L. migratoria by immunoblot was likely tropomyosin according to similar weight of
reactive bands identified in cockroaches (Blattella germanica and Periplaneta
americana). Further, a 70 kDa immunoreactive protein was identified in locust wings.
Tee et al. investigated a research center breeding locusts (L. migratoria and Schistrocera
gergaria) and identified multiple IgE reactive bands of between 18 to 68 kDa by western
blot in extracts [130]. The source of the allergens was traced to the peritrophic membrane
in the gut where the allergens were aerosolized in the excreted feces.
Cross-reactivity is not complete across members of Orthoptera including
grasshoppers, locusts and crickets [114], but crickets have been suggested to be broadly
cross-reactive amongst crickets [131]. An early study of allergic asthmatic children found
that a significant proportion of children had IgE that bound to moth, cricket, grasshopper,
and housefly extracts as determined by radioallergosorbent tests (RAST) used to measure
specific IgE. Most were found to have cross-reactivity across the insects [132]. Crossreactivity of crickets and crustaceans has been explored as in a case study by Lineres et
al. which reported reactions upon exposure to crickets (Gryllus campestris, Gryllus
bimaculatus, and A. domesticus) in a farmworker that was related to occupational rhinitis
and asthma without cross-reactivity to prawns (Penaeus sp) or specific IgE to
tropomyosins [131]. However, Srinroch et al. tested IgE binding to field cricket (G.
bimaculatus) and giant freshwater prawns (Macrobrachium rosenbergii) with a pool of
16 prawn-allergic subjects’ sera and found IgE reactivity to both cricket and prawn
arginine kinases [133]. Additionally, hexamerin 1B was identified as a novel and minor
allergen of G. bimaculatus. Phiriyangkul et al. used shrimp allergic sera to probe the
effects of thermally processing Bombay locust (Patanga succincta) and identified
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hexamerin, enolase, and arginine kinase as allergens in raw locust and hexamerin,
pyruvate kinase, enolase, and glyceraldehyde-3-phosphate dehydrogenase as allergens in
fried locust [134]. These proteins are highly conserved in function and to a great degree
in amino acid sequence and structure across broad evolutionary taxa.

1.6.3 Mealworm
Mealworm (Tenebrio molitor) is an upcoming edible insect and currently has no
listed allergens by the WHO/IUIS, however studies have begun to illustrate the specific
associated risks. Verhoeckx et al. assayed mealworm protein fractions using sera with
inhalation or food allergy to house dust mites or crustacea [135]. IgE from some subjects
was found to cross-react with tropomyosin and arginine kinase and these proteins were
found to be moderately stable by pepsin stability assay. Broekman et al. investigated
thermal processing of mealworms and tested with shrimp allergic patients by SPT,
Basophil activation test (BAT), and immunoblot [136]. The authors found that arginine
kinase decreased in solubility upon heating whereas tropomyosin became soluble after
heating, but there were no significant differences noted in allergenicity of heated
compared to unheated samples despite changes in protein solubility. Further work by
Broekman et al. utilized double blinded placebo controlled food challenges (DBPCFC)
with 15 shrimp allergic patients using mealworm [137]. Confirmed oral mealworm
allergy was found in 13 patients with individual protein doses resulting in objective
symptoms ranging from 216 mg to 13 g with symptoms including oral allergy symptoms,
urticaria, nausea, abdominal cramps, and dyspnea. Four of the patients were also
challenged with shrimp and found to have similar eliciting does and severity even
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compared with dose threshold data for shrimp [137, 138]. The authors concluded that
mealworm allergy was not only likely in shrimp-allergic patients but also with severe
outcomes despite acknowledging the limited power of the study [137]. Exploring
potential cross-reactivity between primary airway and oral allergy to mealworm,
Broekman et al. used C3H/HeOuJ mice and 4 mealworm breeders, half of which reported
inhalant allergy and the other half reported food allergy to mealworm [139]. All four
were found to be sensitized to mealworm by ImmunoCAP, SPT, and BAT but were all
negative to oral challenge to shrimp. Only those with reported food allergy to mealworm
tested positive to mealworm by DBPCFC. Immunoblots using sensitized mice and
humans showed binding to tropomyosin, arginine kinase, and both myosin light and
heavy chain. Further, larval cuticle proteins were identified and suggested as a major
source of primary mealworm allergy, where larval cuticle proteins have been identified to
bind to chitin [139, 140].

1.6.4 Allergens of edible insects and related species
A review by Barre et al. identified 13 likely cross-reactive allergens of edible
insects: alpha-amylase, arginine kinase, chitinase, glutathione-S-transferase, triose
phosphate isomerase, trypsin, hemocyanin, hexamerin, actin, sarcoplasmic calcium
binding protein, myosin, tropomyosin, and troponin [141]. The list by Barre et al. was
formed according to their ability to cross-react IgE of patient sera allergic to shrimp and
dust mites. Arthropods with well-characterized allergens can be used as a measure to
assess the most likely and most dangerous risks associated with edible insects. Those

52
related to crickets, in order of increasing taxonomic distance, include cockroaches (order
Blattodea), mealworms (order Tenebrionidae), and crustaceans (subphylum Crustacea).

1.6.4.1 Cockroaches
Of Blattodea, P. americana (American cockroach) and B. germanica (German
cockroach) are the primary focus of allergy research [142], however Blatta orientalis
(Oriental cockroach) and Supella longipalpa (brown-banded cockroach) are also
important environmental pests [143]. Cockroach is an important indoor allergen
associated with severe asthma particularly in urban inner-cities where 40-60% of
asthmatics have IgE to cockroach antigens [144, 145]. Cockroach allergens from feces,
saliva, or bodily debris can persist in homes post-infestation and increase the risk of
developing asthma as well as asthma morbidity [146-148]. Wang et al. investigated the
correlations between IgE-medicated sensitization to shrimp, cockroach, and dust mite
related to exposure in inner-city children [149]. It was found that across 504 subject sera
a strong positive correlation was found between shrimp and cockroach IgE levels and
higher exposure to cockroach was significantly correlated with higher shrimp and
cockroach IgE.
Cockroach allergens have been well reviewed elsewhere [142, 150, 151] and a
brief summary is provided here. Cockroaches currently have twelve groups of allergens
listed by the by the World Health Organization/International Union of Immunological
Societies (WHO/IUIS online at www.allergen.org). Group 1 allergens (B. germanica 1,
Bla g 1; P. americana 1, Per a 1) are midgut and fecal proteins with a repeating tandem
structure and unique fold and a hydrophobic core understood to bind phospholipids. It is
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found as intertwined polymers resulting in varying molecular weights and has been
shown to have cross-reactivity with fruit flies as well as mosquitos. Group 2 allergens
(Bla g 2, Per a 2) are inactive aspartic proteases with a highly stable structure of 5
disulfide bonds as well as zinc binding domain and has also been found to cross-react
with mosquito and fungal allergens. Group 3 allergens (Bla g 3, Per a 3) are
hemocyanins, which are hexameric proteins similar to arylphorins and hexamerins and
are known to cross-react between arthropods. Group 4 allergens (Bla g 4) are lipocalins
and are calcium-binding proteins excreted or secreted and exclusively found in adult male
reproductive tracts, but as a class these are important inhalant allergens from dog, cats,
horses, and cows. Group 5 allergens (Bla g 5) are glutathione-S-transferases (GST) that
have been shown to have cross-reactivity with helminth but not dust mite due to low
surface similarity. Further, principal GSTs produced by B. germanica and P. americana
belong to separate subclasses of GST with low sequence identity and with low crossreactivity, but each cockroach does have homologs of each with high sequence identity.
Groups 6 (Bla g 6, Per a 6) and 8 (Bla g 8) are troponin C and myosin light chain, which
are EF-hand proteins associated with muscle contraction. Group 7 (Bla g 7, Per a 7) is
tropomyosin, which has been regarded as pan-allergen after shrimp tropomyosin was
found to have IgE cross-reactivity with crustaceans, mollusks, dust mites, and insects.
Group 9 (Bla g 9, Per a 9) are arginine kinases, which was identified to cross-react
between Indian meal moths and tiger shrimp, but also between shrimp and arthropods
more broadly. Group 10 (Per a 10) are serine proteases identified to be a major allergen
in India. Group 11 (Bla g 11, Per a 11) are alpha-amylases that were initially identified in
fecal extracts. With potential cross-reactivity to mite homologs, it has been suggested as a
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significant allergen in Korea. Group 12 (Per a 12) are chitinases with some identity to
mite homologs and more recently identified as a major allergen in China. Lastly, chitin is
known to be proinflammatory (promoting overall inflammation and Th1 responses) as
well as being able to induce Th2 cytokine responses in some cases [151].
Major allergens of cockroach are regarded as groups 1-5 while groups 1, 7, and 9
are regarded as cross-reactive, but the nature of the observed cross-reactivity among
cockroaches and other arthropods is not fully understood [150]. Groups 1, 2, and 10 are
released into the environment through feces, whereas the remaining are proteins found
within the insect bodies that can be released into the environment upon death [142]. In a
review focusing on the first ten groups of allergens in Taiwan, the most abundant P.
americana allergens in homes were groups 9, 10, and 2 [147]. Groups 6-8 are regarded as
minor allergens of cockroaches due to relatively low IgE sensitization [148], but the high
rate of sensitization to cockroaches makes relatively minor allergens potentially
significant. However, the prevalence of specific IgE to each of the allergens is known to
vary depending on regional exposure [150].

1.6.4.2 Crustaceans
Crustacean shellfish IgE cross-reactivity with insects has been well documented
[152-154]. Shellfish allergy is one of the most common food allergies with self-reported
rates of 1.9% in the United States [155], but also tends to persist through life [156].
Cross-reactivity is possible across airway and food allergens as in the IgE cross-reactivity
across house dust mites, shrimp, and cockroaches [153, 157]. Historically the source of
the cross-reactivity has been focused on tropomyosin. However other allergens have
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more recently been implicated in the cross-reactivity between insects and shellfish [152,
154]. The most relevant crustacean allergens are tropomyosin (Litopenaeus vannamei 1,
Lit v 1), Arginine kinase (Lit v 2), myosin light chain (Lit v 3), sarcoplasmic calcium
binding protein (Lit v 4), and hemocyanin [158]. Of shrimp allergens, tropomyosin,
sarcoplasmic calcium binding protein, and myosin light chain are suggested to be more
specific to shrimp, whereas arginine kinase and hemocyanin are cross-reactive among
arthropods [159]. Other allergens have been identified in crustaceans such as triose
phosphate isomerase (Crangon crangon 8, Cra c 8) and troponin I (Pontastacus
leptodactylus 7, Pon l 7). Consumption habits are important to consider for crustaceans
compared to insects. In the United States only the tail-muscle is consumed of shrimp and
lobster, while crab legs are the major tissues consumed. However, some people consume
the digestive glands and abdominal parts. In other cultures it is more common to eat most
of the soft-parts of these crustaceans. Insects such as crickets will be consumed whole.
Some insects (silkworm and meal worm) are immature larvae, and the body composition
can differ, which may alter the profile of proteins that consumers could become
sensitized to.

1.6.5 Allergen classes of concern
1.6.5.1 Arginine kinase
With respect to the composition and identified allergens of crickets, as well as
related species, the principal allergenic concerns are arginine kinase, tropomyosin,
hexamerin, and chitin. Arginine kinase been shown to be a cross-reactive allergen across
shrimp (M. rosenbergii) and crickets (G. bimaculatus) [133]. Arginine kinase from
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Indianmeal moth (Plodia interpunctella) has been demonstrated to be a cross-reactive
allergen across crustaceans and insects via serum IgE and SPT [160]. High levels of IgE
prevalence have been shown against arginine kinases from cockroaches (P. americana, B.
germanica) [142], and arginine kinase has been shown to be a major allergen among Thai
cockroach allergic patients [161]. Further, sensitization to arginine kinase without shrimp
allergy has been associated with allergy to house dust mite and/or cockroaches [159].
Cockroach (P. americana) arginine kinase is moderately thermostable and retains half of
enzymatic activity after heating for 10 minutes at 50 °C [162]. Crayfish (Procambarus
clakrii) arginine kinase shows low-level aggregation at above 44 °C and diminished IgE
binding after boiling [163]. However, mealworm (T. molitor) arginine kinase was only
found to decrease solubility when heated but not lose allergenicity despite lower
solubility [136]. The IgE reactivity of shrimp-allergic sera to arginine kinases of other
crustaceans has been shown to vary depending on denaturation [164]. Crayfish (P.
clarkii) and mealworm (T. molitor) arginine kinases have been shown to be stable by
pepsin stability assay [135, 163].

1.6.5.2 Tropomyosin
Tropomyosin has been identified as an inhalant allergen of cockroaches [165167], a food allergen of crustaceans [168, 169], as well as an occupational allergen in
crab processing workers [170, 171]. It has also been implicated as a cross-reactive
allergen across crustaceans, dust mites, and insects [154, 172, 173]. Investigations have
compared insects, dust mites, and crustaceans and shown tropomyosin has a very high
sequence similarity and therefore may also act as a cross-sensitizing allergen [174].
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Heating crustaceans and mollusks has been demonstrated to result in increased
tropomyosin reactivity post-heating according to a monoclonal tropomyosin antibody
[175]. However, heating in tandem with high pressure treatment was found to decrease
allergenicity of shrimp (L. vannamei) tropomyosin via pooled shrimp-allergic sera and
tropomyosin-sensitized BALB/c mice fed orally according to cytokines and IgE levels
[176]. Purified tropomyosin from Penaeus modon and Litopenaeus vannamei have been
shown to be resistant to pepsin digestion with Litopenaeus vannamei tropomyosin being
more resistant than Penaeus modon [177], but crab tropomyosin (S.paramamosain) has
been found to become more digestible after boiling and high pressure steam was found to
increase digestibility as well as decrease IgE binding [178].

1.6.5.3 Hexamerin
Hexamerins are multimeric proteins and belong to the same protein family as
hemocyanins and arylphorins, which have low sequence similarity but similar structure
[179, 180]. Hemocyanin has been suggested to be a clinically relevant crustacean allergen
due to the high prevalence of allergic individuals with IgE binding to the protein, but also
because a significant proportion of those have histories of anaphylactic reactions [181].
Again, Srinroch et al. has identified hexamerin 1B from cricket (G. bimaculatus) as a
novel and minor allergen [133]. Van Broekhoven et al. explored processing and in vitro
digestion across mealworm species and found that IgE from crustacean or dust mite
allergic patients were able to bind mealworm hexamerin 1B precursor without IgE crosslinking observed in heat processed fractions [182]. The observed hexamerin shared
approximately 40% sequence identity with the cockroach arylphorin Per a 3. Giant
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freshwater prawn (M. rosenbergii) hemocyanin was identified as heat-stable after it
bound IgE of shrimp-allergic patients after thermal treatment but Penaeus modon was
unable to inhibit M. rosenbergii reactivity using 13 shrimp-allergic sera [183]. However,
Ayuso et al. found that hemocyanin may be cross-reactive amongst crustaceans and
cockroach using 34 shrimp-allergic sera against recombinant hemocyanin and dot blot
assays demonstrated inhibition of hemocyanin by cockroach extract [184].

1.6.5.4 Chitin
Chitin is a thermostable polysaccharide comprising insect exoskeletons, but also
found in crustaceans [185-187]. Multiple studies have shown that chitin has
immunomodulatory effects. De Silva et al. used TLR2-2/TLR-4 null, MyD88-null, and
IL-17A null mice intraperitoneally injected with mixtures of chitin and ovalbumin or
alum and ovalbumin with subsequent challenge to aerosolized ovalbumin [186]. The
authors found that chitin induced adaptive immune responses and functioned as an
adjuvant similar to alum. Dubey et al. used crab chitin and C57BL/6 mice sensitized by
intraperitoneal injection of Aspergillus fumigatus culture filtrate or mixed with either
alum or chitin [188]. Compared to alum, chitin resulted in lower inflammatory responses,
depressed Th2 cytokines, enhanced Th1 cytokines, yet had similar total and specific IgE
and IgG1 levels. Bae et al. used C3H/HeJ mice sensitized by intraperitoneal injection of
ground whole peanut and challenged intragastrically where mice were given either αchitin, β-chitin, or β-chitosan in their food [189]. It was found that oral administration of
chitin and chitosan is protective against IgE-mediated anaphylaxis and inhibited Th2
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responses. Chitin has the potential to function as an adjuvant similar to alum and can
therefore contribute to de novo sensitization.
Oral, cutaneous, or inhalant exposure to chitin can result in sensitization to
proteins bound to the chitin or other protein antigens present [190]. Therefore, the chitin
content of insects could impact the potential allergenicity risk. By dry basis, crickets
(Gryllus testaceus) have been found to comprise of 8.7% chitin [191], three Blattodea
species (Blaptica dubia, Blaberus discoidalis and Blatta lateralis) had between 5.3 and
8.3% chitin [192], and seven grasshoppers of Orthoptera had chitin ranging from 5.3 to
8.9% [193]. The chitin content of these insects is similar and therefore risks associated
with chitin from cockroaches may be comparable to Orthoptera and crickets.

1.6.6 Allergen Carryover from Feed
Insects are commonly consumed whole, as a powder or paste, or as extracts; each
of which include gastrointestinal content of the insect [194]. Insects are commonly fasted
prior to freezing or may be fed a nutrient-rich diet prior to freezing, referred to as gut
loading. Fasting assists in mitigating the risks posed by allergens, otherwise the content
of the insect’s gastrointestinal tract could expose consumers to allergens from the feed
[195, 196]. For example, crickets raised on insect farms are often fed with high-quality
feed such as chicken feed or pet food [194, 197]. Chicken feed may contain a number of
allergenic ingredients including wheat, milk, soy, peanut, or fish in forms such as wheat
bran, dry whey, oilseed cake, and fishmeal [198]. A limited amount of research has been
done regarding identifying consumed proteins in insects including tomato defense
proteins in tobacco hornworm (Manduca sexta) and cabbage looper (Trichoplusia ni)
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[199] and wheat proteins in sunn pest (Eurygaster integriceps) [200]. Allergic reactions
to residual proteins from feed have yet to be attributed in the literature; however, the
insects’ diet may result in non-insect allergenic material passing to consumers to pose a
risk to allergenic consumers.

1.6.7 Summary
IgE binding and IgE cross-reactivity is not a measure of allergenicity. However, it
is clear that IgE binding to specific proteins is required to trigger immediate reactivity by
eliciting mediator release from mast cells and basophils. There are many studies that
demonstrate some IgE binding or low-levels of cross-reactivity that do not parallel
allergic reactions. The studies reviewed here rarely used food challenge, much less
double-blinded studies, to demonstrate clinical importance of the IgE binding. Few
studies used titrated inhibition to evaluate differences in affinity and epitope recognition,
however, this data is used by most for judging cross-reactivity. Some biological assays
such as skin prick test also over- or under-predict allergic reactivity. This review
demonstrates that there is shared IgE binding between a number of proteins that have
been reported to be important IgE binders, or in a few cases clearly proven allergens. The
level of risk for allergic consumers will vary by their specific sensitivities. Additional
steps are being taken to evaluate the likelihood of cross-reactivity between various
crustaceans and between crustaceans and insects. It is important to note that the sequence
identity of two proteins and overall structure influence likely cross-reactivity as does the
abundance of the protein in the source material that humans are exposed to. Some
proteins also denature and in foods that are highly processed or cooked, some proteins
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will aggregate and be difficult to extract and test. Others may unfold and if the IgE
binding epitopes are conformational, may be markedly reduced or lost following cooking.
It is important to consider those factors in judging potential cross-reactivity.

1.7 Peanut food allergy and the effects of thermal processing
1.7.1 Background
Peanuts (Arachis hypogaea) are a non-novel legume of the family Fabaceae
shared with other legumes such as soybeans, green peas, and chickpeas. Peanuts are
cultivated for a wide variety of products derived from the plants such as the peanuts
themselves as well as skins, hulls, oil, and press cake. As a food, peanuts are a relatively
protein rich food at approximately 25% protein per weight [201]. Four varieties are
peanuts are commonly produced in the US including Virginia, Spanish, Valencia, and
Runner [201]. The protein content, protein profiles, and IgE-binding profiles are largely
comparable among peanut varieties in terms of the major allergens with some variation
among minor allergens. The majority of U.S. peanut production is focused on either
Runner peanuts, commonly used for peanut butter, or Virginia, which is often a snack
peanut or for in-shell products. Peanuts are commonly processed to improve their flavor
and aroma such as by boiling, frying, or roasting. This review is intended to consider the
effects of thermal processing on peanut food allergy and allergens to explore how peanuts
may be extensively thermally processed into a novel source of food allergens.
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1.7.2 Peanut allergy
Peanuts are a known food allergen with a prevalence of 1.8% in U.S. adults and
2.2% of U.S. children and adolescents with increasing incidence [81, 202, 203]. In the
U.S., peanuts are a member of the eight classes of allergenic foods comprising 90% of
U.S. food allergies and use of peanuts must be signified on package labels [204]. Food
allergens are considered as a major allergen if recognized by IgE of >50% of the allergic
population, then minor allergens are recognized by <50% of the allergic population [1].
In peanut, the major allergens are Ara h 1, 2, 3 and 6 while the remainder are minor
allergens. On a weight basis, Ara h 3 is the most abundant allergen of peanuts followed
by Ara h 1, and then Ara h 2 and 6 [201]. Currently, a total of 16 peanut allergens have
been characterized (Table 1.3) [1, 2].
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Table 1.3 Major and minor allergens of peanut [1, 2]
Peanut allergens
Major allergens
Ara h 1
Ara h 2
Ara h 3
Ara h 6
Minor allergens
Ara h 5
Ara h 7
Ara h 8
Ara h 9
Ara h 10
Ara h 11
Ara h 12
Ara h 13
Ara h 14
Ara h 15
Ara h 16
Ara h 17

Biochemical name
Cupin
Prolamin
Cupin
Prolamin

Profilin
Prolamin
Pathogenesis related protein
family 10 protein (PR-10)
Non-specific lipid-transfer
protein (nsLTP)
Oleosin
Oleosin
Defensin
Defensin
Oleosin
Oleosin
nsLTP
nsLTP

A. hypogaea is an allotetraploid resulting from the genomic merger of the
ancestral species A. duranensis and A. ipaënsis resulting in both sets of chromosomes
being part of A. hypogaea [205]. Efforts have since mapped the genomes of the ancestral
species [206] and A. hypogaea [207].Progress in annotating the genome of A. hypogaea
has expanded the diversity of proteins known to be present, particularly novel isoforms of
known allergens but these have yet to be evaluated as allergens [208, 209].

1.7.2.1 Classification and superfamilies of seed storage proteins
Each of the major allergens of peanut are seed storage proteins, whose principal
function is as a storage reservoir for amino acids but may have other functions [210].
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Seed storage proteins are classified based on their sedimentation coefficient and
conditions of solubility. Solubility classifications include the water-soluble albumins,
dilute saline- soluble globulins, dilute alcohol-soluble prolamins, and dilute acid or
alkali-soluble glutelins. In peanut, the major storage proteins are albumins and globulins
[1].
2S albumins are a major group of seed storage proteins that are synthesized as a
single polypeptide and subject to proteolytic cleavage commonly at both the N- and Ctermini and trimming of linker peptides [210]. 2S albumins are compact globular proteins
with a conserved cysteine structure and disulfide bonds. The stability offered by the
compact and tightly bound structure offers 2S albumins a high degree of resistance to
gastrointestinal conditions; however, the flexible loops are solvent-exposed and
predominate known IgE epitopes [211]. Coinciding allergies to peanuts and various tree
nuts has been attributed in part to the homology and similar physiochemical properties
shared among 2S albumins [212].
The other major group of seed storage proteins in peanuts are the globulins as
either the 7S vicilin-type or 11S legumin-type [210]. In legumes, 11S legumins are the
major storge protein of legumes and consist of six pairs that interact noncovalently. Each
pair consists of a single polypeptide that is proteolytically cleaved after disulfide bond
formation to produce an acidic and basic subunit. 7S vicilins are often trimeric proteins
lacking significant cysteine residues and therefore disulfide bonds. The family of globulin
proteins have dissimilar sequences but share physiochemical properties and structures
where 7S globulins are trimers (3) and 11S globulins are either trimers (3) or dimertrimers (3, 3).
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1.7.2.2 Ara h 1 and Ara h 3
Ara h 1 and Ara h 3 are bicupin seed storage proteins belonging to the cupin
superfamily [2]. Ara h 1 is a 7S vicilin-type cupin and Ara h 3 is an 11S legumin-type
cupin. Ara h 1 has a β-barrel core domain and secondary domain predominantly made
from α-helices [213], which is conserved among other legume 7S vicilins such as lentil,
pea, and soy and has been leveraged to explain cross-reactive allergy among edible
legumes. While Ara h 1 can be observed naturally as the trimer, it can also be found in
oligomeric forms that are more resistant to enzymatic digestion [214]. Epitope mapping
studies have found that the IgE binding sites of Ara h 1 include the pepsin-resistant Nterminus [214], on connecting loop domains and coils in the core region [215], as well as
inside the β-barrel domain per monomer. Epitopes buried due to trimer formation have
been speculated to protect these regions from enzymatic digestion and preserve their
allergenicity [215, 216]
Ara h 3 is composed of multiple sub-units including an acidic and basic subunit
which are proteolytically processed prior to maturation and held together by disulfide
bonds [217]. Use of reducing conditions with Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) evidences a 42-45kDa acidic and 25 kDa basic subunit. Ara
h 3 is known to have trypsin inhibitory functionality and so contributes to the enzymatic
resistance of peanut [218]. It has been long understood that multiple Ara h 3 isoforms are
present in peanut as per the depreciated Ara h 4, which has since been understood as an
isoform of Ara h 3 [219].
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1.7.2.3 Ara h 2 and Ara h 6
Ara h 2 and 6 belong to the 2S albumin seed storage proteins and the prolamin
superfamily [2]. The structure of Ara h 2 consists of a five-helix bundle held together by
four disulfide bonds and noted to have a structure similar to trypsin inhibitors [220], and
has been confirmed as having trypsin inhibitory activity [221]. Ara h 2 contains multiple
hydroxyprolination motifs, DPYSPS [222], which have been shown to have profound
effects on IgE binding. Tscheppe et al. produced mutant Ara h 2 in insect cells to exclude
flexible loop regions, including hydroxyprolination motifs, and further unfolded through
reduction and alkylation demonstrate substantially decreased IgE binding and
anaphylactic potency [223]. Notably, comparison of the mutant to wildtype was marred
by lack of attention to the effects of hydroxyprolination, which may have made the
decreases more drastic.
Ara h 6 has a nearly identical structure to Ara h 2 in terms of both fold and
disulfide bonds [224], but does not contain the hydroxyprolination motifs of Ara h 2
[222]. Multiple forms of Ara h 6 have been characterized as both an intact polypeptide
and one posttranslationally cleaved in the core [225, 226]. The two forms of Ara h 6 do
not show differences in IgE binding or abundance [225]; however, the intact form is more
susceptible to thermal denaturation than the cleaved form [226].

1.7.2.4 Relationships between major allergens
Ara h 1, Ara h 2, and Ara h 3 do not share significant sequence or structural
similarities, but localized similarities have been implicated in IgE cross-reactivity among
these allergens [227]. Ara h 2 and Ara h 6 has been observed as cross-reactive due to
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shared homology [228]. Both Ara h 2 and Ara h 6 are resistant to pepsin digestion
whereas Ara h 1 and Ara h 3 are readily digested by pepsin [229]. Despite a higher
seroprevalence of Ara h 6 compared to Ara h 2, Ara h 6 has demonstrated weaker
biological activity via human basophils than Ara h 2 [230]. This has been corroborated
using rat basophil leukemia cells showing that Ara h 2 is a more potent allergen than Ara
h 6, but both are far more potent than either Ara h 1 or Ara h 3 [231]. A majority of the
allergenic activity attributable to crude peanut extracts have been attributed to Ara h 2,
Ara h 6, and their variants [232].
Ara h 2 coupled with Ara h 6 have been cited as the most accurate in diagnosing
peanut allergy as compared to other peanut allergens or specific peanut IgE [233, 234]. In
children, both Ara h 2 and Ara h 6 are the most frequently recognized major peanut
allergens and this pattern remains stable over time [235]. Further, co-sensitization to both
Ara h 2 and Ara h 6 is associated with severe allergic reactions as opposed to mild
reactions [236].

1.7.2.5 Minor peanut allergens
Profilins are one type of actin-binding proteins acting to regulate the organization
and function of the actin cytoskeleton [2]. Ara h 5 is a member of the profilin family and
related to other pollen allergens such as Hev b 8 (latex) and Bet v 2 (birch) [237]. The
structure of Ara h 5 is a seven stranded antiparallel β-sheet with two α-helices flanking
one side and another helix on the other side.
Ara h 7 is the third 2S albumin of peanut and has been found to be equally potent
compared to Ara h 2 and Ara h 6, but is far less abundant [238]. Multiple isoforms of Ara
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h 7 are known to exist but Ara h 7.0101 has not been demonstrated to exist as a protein
[238, 239]. In those with sensitivity to any of the peanut 2S albumins, sensitivity to each
of Ara h 2, Ara h 6, and Ara h 7 is most frequent.
Ara h 8 is a member of the family 10 of pathogenesis-related (PR-10) proteins and
related to the cross-reactive allergen Bet v 1 (birch) [240]. Members of PR-10 are
associated with sensitization to plant pollen and sensitization to food allergens [241].
Ara h 8 has a seven stranded antiparallel β-sheet with two short α-helices between the
first two strands of the β-sheets with a third α-helix at the C-terminus [242]. Ara h 8 has
similar structure and ligand binding to Bet v 1 including binding to various flavones
including quercetin, apigenin, and daidzein, and resveratrol [2, 240]. Reactions to Ara h 8
tend to be mild and likely mediated through individuals with cross-reactivity to Bet v 1
and other homologues. Monosensitization to Ara h 8 has been associated with tolerance
to peanuts rather than allergy [243].
Ara h 9 and 17 are regarded as type I non-specific lipid transfer proteins (nsLTP)
and Ara h 16 is a type II nsLTP [2]. The types of nsLTP are differentiated by their
molecular weight, primary sequence identity, and disulfide bond pattern where type I
nsLTP are approximately 9 kDa and type II are approximately 7 kDa [244]. Functionally,
nsLTPs can serve many purposes including membrane stabilization, cell wall
organization, signal transduction, and assist in growth and development [2]. nsLTPs have
been shown to be very stable to enzymatic digestion and thermal treatment due to a
structure of four α-helices stabilized by four disulfide bonds [245]. Associations have
been noted between peanut, peach and hazelnut allergies owing to homologies between
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Ara h 9, Pru p 3, and Cor a 8, respectively [240], specifically those with peanut allergies
for those in the Mediterranean area [245, 246].
Peanut oleosins (Ara h 10, Ara h 11, Ara h 14, and Ara h 15) function as
structural proteins of oil bodies to stabilize the oil body [247]. Allergies to oleosins is
relatively common but underestimated partially due to their underrepresentation in
aqueous extracts owing to their lipophilic nature [248]. Oleosins show resistance to both
temperature and enzymatic digestion. Peanut oleosins have been observed as multimers
on SDS-PAGE [249]. Sensitization to oleosins is associated with severe reactions,
although sensitization to peanut oleosins is highly associated with Ara h 2 sensitization
[247].
Defensins, such as the peanut defensins Ara h 12 and Ara h 13, are a large group
of small, cationic, and disulfide-rich proteins associated with the innate immune system
across animals, plants, and fungi [250]. Peanut defensins have demonstrated inhibitory
effects to some molds but without effects on bacteria [251]. Structurally both Ara h 12
and Ara h 13 are lipophilic proteins consisting of an alpha-beta fold and 4 disulfide
bonded structure [250, 251].

1.7.3 Effects of thermal processing on peanut allergenicity
Thermal processing of food proteins can lead to several modifications including
unfolding, aggregation, and chemical modifications [252]. Structural modifications can
further affect digestion stability as well as the manner that the allergens are presented to
the immune system. Through the Maillard reaction, chemical modifications of free
amines with free reducing sugars, proteins can be chemically modified not limited to
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cross-linking of proteins [1]. Through cross-linking, Ara h 1 and Ara h 2 can form higher
molecular weight aggregates that bind IgE more effectively than unmodified forms [252].
The type of thermal processing affects resultant advanced glycation end (AGE) products
as boiling generates approximately 10x fewer AGE than roasting. While peanut allergens
with AGE modifications are more frequently recognized by peanut allergic patients, there
is a level of bias given that consumers will typically consume peanuts that have been
thermally processed.
Thermal processing affects the proteins and their allergenicity by how the
processing was applied. Studies of thermally processed Ara h 1 and Ara h 3 are a
challenge as they tend to become insoluble, although in roasted peanuts IgE binding
shows minimal differences [252]. The trypsin inhibition activity of Ara h 2 increases after
roasting [221]. Both Ara h 2 and Ara h 6 retain similar IgE reactivity after roasting and
maintain their structure [253]. Ara h 8 increases IgE reactivity and resistance to
enzymatic digestion with roasting, which may be associated with binding to lipophilic
ligands [254]. Oleosins have also demonstrated a higher IgE binding capacity when
roasted in-shell [255]. The type of thermal processing does affect the structure of Ara h 1
as boiling causes the formation of rod-like aggregates with reduced IgE binding capacity,
whereas roasting causes the formation of globular aggregates with IgE reactivity similar
to non-thermally processed [256]. Boiling peanuts can decrease the IgE binding capacity
of Ara h 1, Ara h 2, and Ara h 3 compared to roasting, given that Ara h 2, Ara h 6, and
Ara h 7 tend to leech out of the peanuts into the water [2].
Extraction conditions can also result in differences in assessing relative
allergenicity. Assessments of Ara h 1 and Ara h 2 have shown that extraction procedures
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incorporating defatting and the buffer of choice can affect the protein yield and
sensitivity of subsequent immunoassays [257]. The extractability of peanut proteins is
also interconnected with the type of processing applied [258]. Further, the extraction
conditions itself can affect the protein structure and alter the evaluated allergenicity
[259].

1.7.4 Summary
As a staple food for many people around the world peanuts are a nutritionally and
economically valuable food, but for those with peanut allergies they are a significant
hazard and source of distress. To adequately inform stakeholders of the potential risks
associated with peanuts and their products, it is imperative to understand the breadth of
information known about the allergenic proteins of peanut. Thermal processing has wide
ranging effects on peanut proteins and assessment of the proteins can have similar effect
when attempting to evaluate the potential risk they pose to consumers.

1.8 Allergic risks of exposure to food allergens by inhalation
1.8.1 Background
The principal route of exposure for food allergens is through consumption of
foods that contain the allergen either as an intended ingredient or as a contaminant.
Similarly, inhalant allergens are principally encountered through inhalation; however,
these categories are not strict in that food allergens can be inhaled and result in elicitation
of allergic reactions and visa-versa. Cases of pancake syndrome also known as oral mite
anaphylaxis demonstrate that oral consumption of inhalation allergens can result in
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allergic reactions [260], whereas inhalation of food allergens is most detailed in terms of
occupational asthma due to handling or cooking of food and food allergens. This review
is intended to introduce how allergic individuals may be exposed to food allergens
through inhalation and result in novel sources of food allergens.

1.8.2 Defenses, barriers, and transport of allergens
1.8.2.1 Oral route
Consumption of food and exposure to food proteins begins in the mouth and has
been identified as both a means to effectively absorb proteins via sublingual and buccal
mucosa as well as a route for treatment of food allergies [261]. The oral cavity is
protected by mucosal associated lymphoid tissues. After swallowing, food proteins are
exposed to low pH via hydrochloric acid to assist protein denaturation as well as active
pepsin to begin proteolysis of proteins [262]. Passing the bolus to the small intestine
begins by partially neutralizing the pH and thereby allowing gastric proteases and
peptidases such as trypsin, chymotrypsin, elastase, and carboxypeptidases to continue
degradation the food proteins. The intestines include further defenses such as secretory
IgA, mucus, and microbes that can influence the rates of absorption of intact proteins as
well as provide extra time for proteolysis to occur [263]. Digestion of dietary proteins
ends with intestinal brush border cells uptake amino acids as well as di- and tripeptides
through various mechanisms [262].
Uptake or transport of partially digested or undigested proteins across the
intestinal tract can vary depending on the characteristics of the protein including size,
shape, and structure [263]. Transport routes for proteins include para-cellular and trans-
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cellular transport, where para-cellular transport refers to the movement of compounds
through the intercellular space between cells and is regulated by tight junctions, but the
maintained integrity of the tight junctions in healthy adults leaves this route of lesser
concern. Para-cellular transport is typically relegated to compounds that are far smaller
than allergic fragments capable of causing reactions, but some evidence suggests that
smaller intact proteins (insulin) may be able to pass [263, 264]. Allergic sensitization can
reduce the integrity of the tight junctions via presence of mast cells and increase the
permeability to intact proteins.
Several routes are possible for trans-cellular transport, but only endocytosis is
viable for non-degraded proteins [263]. Enterocytes are the most abundant cells in the
intestinal barrier and act as absorptive cells and endocytose soluble particles including
proteins that may include both degraded and intact protein. To assess if intact proteins
can be successfully transported across the intestine, Warshaw et al. assessed the
proportion of intact tritium labelled bovine serum albumin reaching the lymph and blood
circulation after duodenal infusion, finding that approximately 2% was able to be
identified [265]. Immune cells have also been suggested to take part in trans-cellular
transport including mast cells, dendritic cells, and macrophages [263].

1.8.2.2 Inhalation route
Compared to oral intake, inhalation has fewer strict barriers to restrict intact
protein. Upon taking a breath the first barrier to inhaling particles that may contain
protein is the particle size itself, where the inhalable range of proteins is less than 100 µm
[266]. Larger particles, greater than 8 µm, tend to deposit in the lung further up in the
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respiratory airway in a size-dependent manner from the nose to the larger bronchioles.
Smaller particles, up to 3 µm, tend to diffuse throughout the lung tissue including
deposition in the alveoli. Tidal breathing can also inhibit deposition of present particles
by removing the particles prior to deposition upon respiratory tissues. The epithelial
lining of the alveoli is principally responsible for resisting the transport of proteins across
the lung [267]. The alveolar surfaces of the lung are lined principally by thin, single-cell
thick, type I pneumocytes that are joined by tight junctions [267, 268].
Protein clearance from lung tissues often focus on pulmonary edema and
therefore endogenous proteins rather than exogenous but can be used to inform how the
mechanisms may apply to exogenous proteins. The rate of protein clearance in the
alveolar spaces of the lung is approximately 1-2% per hour for albumin [267], but
transport of albumin may be assisted through an albumin-specific receptor [269].
Depending on the amount of albumin present, mechanisms of transport proceed by
receptor-mediated endocytosis at lower concentrations but by para-cellular transport at
high concentrations. The rates that specific proteins are cleared from the lung depend on
molecular size and or weight as smaller proteins clear faster than larger proteins. Further,
insoluble proteins are degraded more slowly than soluble proteins. Degradation of
proteins is mediated by proteases and peptidases as well as alveolar macrophage
recruitment [269]. Proteases are first present to degrade proteins, but studies have not
demonstrated that this is a significant means to remove present proteins as repeated
studies have shown that greater than 95% of proteins remain intact and transport into the
blood [269]. In the long term (>24 hours), macrophages can be recruited to the alveoli
and significantly clear present proteins in a time scale from 2 to 6 days.
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1.8.3 Inhalation of food allergens
Exposure and inhalation of food allergens can occur during food preparation or
handling to generate aerosols and dust that can be inhaled by individuals and elicit
allergic reactions [270]. Case reports have implicated many foods including fish,
shellfish, seeds, soy, grains, eggs, and milk in causing allergic reactions due to inhalation
of a food allergen. Examples of specific proteins implicated in inhalation based allergic
reactions include shrimp tropomyosin [271] as well as hen’s egg lysozyme [272].
Baker’s asthma, an occupational allergic disease due to inhalation of cereal flours
such as wheat flour, provides insights into comparing inhalation and oral allergies [273].
Many of the same proteins that are associated with oral wheat allergy are also implicated
to some degree in inhalation allergy suggesting these proteins retain their allergenicity
through either route of exposure. Notably, the serodominance of each protein allergen
differs between oral and inhaled wheat allergy indicating that there are other key factors
to consider such as their relative stability after aerosolization compared to consumption
and capacity and ease to be aerosolized.

1.8.4 Insights into routes of exposure from biopharmaceuticals
The goal of a biopharmaceutical is to have an individual take an appropriate dose
resulting in positive effects. This is contrasted with allergens causing negative effects.
Studies of biopharmaceutical proteins and polypeptides can provide insight into how
different routes of administration impact the amount found systemically. To better
understand the differences among oral and inhalation the following examples of well
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characterized biopharmaceuticals are explored in terms of their contrasting
bioavailability.
Insulin is a 51 amino acid anabolic hormone with the mature form comprised of
two peptide chains and therapeutically used to assist individuals with either type 1 or 2
diabetes [274]. Reviews of the bioavailability, the systemic exposure, of inhaled insulin is
approximately 10% relative to injected [275], whereas the oral bioavailability has been
regarded as less than 1% [276]. Then the inhaled bioavailability of insulin is
approximately 10 times greater than when taken orally.
Human growth hormone is a 191 amino acid anabolic hormone comprised of a
single polypeptide prescribed in cases of deficiencies or stunted growth [277]. A study in
infants has measured the inhaled bioavailability of human growth hormone at
approximately 3.5% [278], compared to a study in rats estimating that the oral
bioavailability is 0.01% [279]. Each taken at face value, this results in a relative
bioavailability of 350 times greater when inhaled compared to oral.
Using these examples, we can infer how allergens may differ depending on their
route of exposure. If bioavailability limitations are due to the route of exposure, this
suggests that the impact upon sequence and structure is a key factor. As inhalation of a
protein does not have the same rigorous barriers to systemic entry as oral ingestion, the
protein structure can be expected to be less impacted and without the excess of
proteolytic enzymes similarly the primary sequence will also be kept intact. The risks of
either oral or inhaled intake are not clear as these studies of biopharmaceuticals indicate
that while the bioavailability is generally greater when inhaled it does not clarify typical
scenarios when an allergen may be alternatively inhaled as opposed to consumed in terms
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of dose. It is not realistic for an individual to inhale a similar dose that they may
otherwise consume orally; however, the doses required can be expected to be lesser if
they were to be inhaled as opposed to consumed orally.

1.8.5 Summary
While exposure to food allergens is predominantly through consumption,
inhalation of food allergens is also possible during handling, preparation, and cooking of
food and can similarly sensitize and elicit allergic reactions. The barriers and defenses
against intact proteins entering the body differ greatly between oral and inhalation and
may significantly impact consumers. Understating that those with a known food allergy
may be at risk when inhaling food proteins is critical to adequately protect individuals.

1.9 Concluding remarks
The principles of risk analysis are sufficiently broad to be readily applicable to
any hazard and keen understanding of allergens allows for specific considerations to be
applied to novel allergens. Methods to characterize the potential allergenicity of novel
foods is principally focused on cross-reactivity of proteins as evaluation of risk of de
novo sensitization is limited by the limitations of in vivo (animal) models [280]. Further
assessments of taxonomic relationships, homology of proteins to known allergens, and
analysis of sera with allergies to the novel food or taxonomically similar sources can be
utilized [281]. Given an intended use of the novel food, exposure may be estimated based
on similar products and uncertainty incorporated reflecting information gaps to allow for
characterization of the risk.
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Food allergy is a present and increasing threat to public health and adequate
controls are required to protect those with food allergies. Novel foods will continue to be
discovered and produced; therefore, novel sources of food allergens need to be carefully
scrutinized. The goal is not to unduly dissuade innovation but rather to inform consumers
and producers of the risks associated with novel foods. With pertinent and wide-spread
information stakeholders can more informed choices regarding novel foods and sources
of novel allergens.
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CHAPTER 2: PREDICTED ALLERGENS AND QUANTITATIVE
PROTEOMICS FROM LIFE STAGES OF THE HOUSE CRICKET, ACHETA
DOMESTICUS

2.1 Abstract
Background: Insects are increasingly important alternative food source to
conventionally grown animal sources of protein, but consumption of insects poses a risk
to those with shellfish allergy. A. domesticus (crickets) are commercially available in the
form of several life stages with unclear differences in the potential risks posed to
consumers. We evaluated life stages of crickets to determine the relative risks posed by
consumption of crickets.

Methods: Eight life stages of crickets were extracted and their proteins quantified by
mass spectrometry. Databases representing ab initio genomic predicted genes and
translated transcriptomic genes were applied and identified proteins annotated for
homology to known allergens. Predicted allergens with statistical differences among life
stages were evaluated to compare relative risks.

Results: Ten proteins were robustly identified among life stages with significant
differences among life stages and were predicted as allergens: a tropomyosin, arginine
kinase, alpha-tubulin, paramyosin, two myosin light chains, and four hexamerins.
Proportions of allergenic proteins to total proteins were equivalent excluding adult
females, which were significantly lower.
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Conclusions: Adult female A. domesticus were predicted to be of less risk to consumers
than other life stages. Segregating adult crickets may pose an undue burden on producers
posing a challenge to leverage the differences in predicted risk.

2.2 Introduction
Insects are an alternative protein source to conventional animal sources. While
consumption is increasing and perceptions are improving in Western countries,
entomophagy is still not widespread faces both neophobia and reports of allergic
reactions associated with shellfish allergy [282]. Food allergies affect approximately
10.8% of US adults and shellfish allergy affects approximately 2.9% [81]. Evaluation of
proteins present in Acheta domesticus crickets can help inform consumers as to the risks
associated with consumption and inform producers as to what can be done to manage
risks posed.
A. domesticus is a member of order Orthoptera and undergoes a hemimetabolous
life cycle, where upon hatching from an embryo the nymph resembles an adult but
without wings nor sexual organs and undergoes molts until finally reaching sexually
dimorphic adulthood [283]. Proteomic shifts are expected to accompany the development
of A. domesticus that may similarly result in possibly allergenic proteins changing in
abundance. The phylum Arthropoda contains numerous allergens that demonstrate crossreactivity among species including both the panallergens tropomyosin and arginine
kinase [284]. The related two-spotted cricket, Gryllus bimaculatus, has demonstrated
reactivity to hexamerin [133]. Allergens specific to A. domesticus are yet unknown and

81
so insight into potentially cross-reactive proteins can permit an evaluation of the risks
present.
This study addresses the potential relative risk posed to consumers by various life
stages of A. domesticus crickets. The potential risk is evaluated utilizing protein
quantification supplied by mass spectrometry. Annotation of quantified proteins in terms
of identity and associations with known allergens clarifies which proteins are of
importance. We evaluated the quantifications and annotations of proteins to describe how
the life stages differ and how that translates into allergenic risk to consumers. The aim
was to evaluate if there are life stages of crickets that may pose relatively less risk to
consumers.

2.3 Methods and Materials
2.3.1 Chemicals and samples
Tris, iodoacetamide (IAA), and rabbit glycogen phosphorylase B (GP; P6635;
Uniprot P00489.3) were obtained from Sigma (St. Louis, MO, USA). Trypsin (Pierce,
MS grade) was obtained from Thermo Scientific (Waltham, MA, USA). Dithiothreitol
(DTT) was obtained from Arcos Organics (Geel, Belgium). Ammonium bicarbonate
(ABIC) was obtained from Honeywell Fluka (Charlotte, NC, USA). Acetone, methanol,
hexanes, acetic acid, acetonitrile (ACN), and formic acid were obtained from Fisher
(Hampton, NH, USA). Precision plus ProteinTM Dual Xtra standards and Coomassie
R250 were obtained from Biorad (Hercules, CA, USA). NuPage LDS sample buffer,
Nupage MES SDS running buffer (20x), and 4-12% NuPage Bis-Tris gels were obtained
from Invitrogen (Carlsbad, CA, USA).
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Crickets (Acheta domesticus) were purchased from a cricket farm representing 7
developmental stages: pinhead, 1 week, 1/3 grown, 2 weeks, 1/2 grown, 2/3 grown, and
adults; adults were segregated as males and females for a total of 8 samples (Appendix A
Figure 2.1.1). Triplicate samples were taken per stage (n=24) to an approximate 200 mg
(wet basis) of material per sample and ground by mortar and pestle under liquid nitrogen.
Samples were stored -80 °C until use.

2.3.2 Extraction and SDS-PAGE
Samples were individually prepared for defatting in 2 mL Eppendorf tubes by
adding 0.5 mL of acetone and vortexed to saturate the material. Defatting was performed
by adding an additional 1 mL of acetone (>1:5 w/v) followed by vortexing, shaking for
10 minutes, and centrifugation (10 minutes, 17 k x g). The supernatant was discarded and
acetone defatting repeated three additional times. The material was then defatted by
substituting the acetone for hexanes and repeated as before four times. Pellets were dried
in a fume hood overnight and were then stored at -80 °C.
Defatted samples (n=24) were extracted 1:20 (w/v) using a zwitterionic
chaotropic buffer (50 mM Tris pH 8.8, 5 M urea, 2 M thiourea, 2% CHAPS, 67 mM
DTT) in a heated sonicating water bath (60 °C, 30 minutes) and centrifuged (10 minutes,
17 k x g). Per extraction, half of the extraction buffer was removed as supernatant and
fresh buffer added to maintain volume. Each pellet was extracted a total of three times
and the three supernatants per defatted sample were pooled (n=24). Samples underwent
protein quantification via 2D-Quant kit (GE healthcare, Chicago, IL, USA).
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Samples were prepared for SDS-PAGE by adding sample buffer with 50 mM
DTT. An equivalent of 500 µg of tissue per sample was fractionated. Gels were fixed
with a solution of 50% methanol and 10% acetic acid for 1 hour and visualized with
Coomassie R250. Gels were imaged using a UVP Biospectrum 815 Imaging System
(Analytik Jena US LLC, Upland, CA, USA) with VisionWorks software (Version 8.20,
Analytik Jena US LLC).

2.3.3 Mass Spectrometry
2.3.3.1 In-solution digestion
Sample volumes equivalent 250 µg of tissue were diluted 1:10 in zwitterionic
chaotropic buffer and 4 volumes of chilled acetone added for an acetone precipitation (80 °C, overnight). The samples were then centrifuged (4 °C, 30 minutes), decanted, and
the pellet washed with 200 µL of 80% acetone and the centrifugation repeated. The pellet
was then allowed to dry in a fume hood and stored at -80 °C until use.
In-solution digestion of acetone precipitated pellets was preformed according to
Palmer et al. [285]. Briefly, proteins were reduced with DTT for 5 minutes at 95 °C,
alkylated with IAA for 20 minutes in the dark, and digested twice with trypsin first for 3
hours at 37 °C and secondly overnight at 30 °C.

2.3.3.2 Preparation for mass spectrometry and running parameters
Digested peptides were cleaned, and MS preformed as previously described with
modifications [285]. In brief, digests were cleaned using Pierce C-18 Spin columns
(Thermo scientific), the eluate dried, and peptides resolubilized in 30 µL of 0.1% (v/v)
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formic acid with 5% (v/v) ACN. Samples were aliquoted into vials with 12 µL of
peptides and 2 µL of 200 fmol µL-1 GP. A 3.5 µL injection is equivalent to 25 µg of
tissue and 100 fmol GP. Samples were injected into the MS in triplicate (N=72).
One-dimensional microscale liquid chromatography separation of tryptic peptides
was performed with an UltiMate 3000RSL® liquid chromatography system (Thermo
Scientific), equipped with a Hypersil Gold C18 1.9 μm, 100 x 1 mm analytical reversed
phase column (Thermo Scientific). Mobile phase A consisted of 99.9% (v/v) water
containing 0.1% (v/v) formic acid and mobile phase B was 99.9% (v/v) ACN containing
0.1% (v/v) formic acid. 3.5 µL of the sample was injected on-column and peptides were
eluted from the analytical column and separated using a gradient of 2-40 % mobile phase
B over 60 minutes at a flow rate of 60 µL/min. The analytical column temperature was
maintained at 35 ⁰C.
Mass spectrometric analysis utilized a Q Exactive PlusTM Hybrid QuadrupoleOrbitrapTM MS (Thermo Scientific) in the data-independent mode with survey scans and
fragment ion spectra acquired at a resolution of 70,000 at m/z 400. Up to the top 20 most
abundant isotope patterns with charge 2 to 4 from the survey scan were selected with an
isolation window of 2 m/z with a window offset of -0.4 m/z and fragmented by higher
energy collisional dissociation with normalized collision energies of 27. The maximum
ion injection times for the survey scan and the MS/MS scans were 100 and 240 ms,
respectively, and the ion target value for scan modes were set to 3E6 and 1E5,
respectively. Repeat sequencing of peptides was minimized by dynamic exclusion of the
sequenced peptides for 20 s.
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Injection quality was assessed via consistency of GP quantification using PEAKS
8.5 (Bioinformatics Solutions Inc., Waterloo, ON, Canada) [286]. against a Polyneoptera
database (Uniprot, accessed 190403) and including GP. PEAKS search parameters were
5 ppm mass error tolerance, 0.05 da fragment mass error tolerance, no missed cleavages,
and fixed carbamidomethyl cysteine. Data representing individual injections were
handled independently and assessed together in PEAKS. GP was quantified via Top3
excluding peptides that were identified within the Polyneoptera database. Quantifications
were tested for normality via Shapiro-Wilk Test using GraphPad Prism version 4.03 for
Windows (GraphPad Software, La Jolla California USA) at a significance level of 0.05
both including and excluding outliers. Injections indicated as outliers from normality
were regarded as injection failures. In this case, the injection was freshly prepared again
and reinjected to replace the data from the injection failure.

2.3.4 Data Analysis
2.3.4.1 Protein identifications
Protein databases for MS analysis included ab initio genes predicted from the
genome by Dovetail Genomics (Santa cruz, CA, USA) and an A. domesticus
transcriptome (GenBank GHUU00000000.1) [287], translated in 6-frames by EMBOSS
transeq [288]. Both databases were appended with 348 sequences representing GP and
347 decoy sequences identified from Uniprot from a search for “glycogen
phosphorylase” within Insecta (obtained 18/09/2020). Data was analyzed using PEAKS
8.5 with search parameters including tryptic peptides, maximum of 3 missed cleavages, 5
ppm parent mass error tolerance, 0.05 fragment mass error tolerance, carbamidomethyl
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cysteine as a fixed modification, and a contaminant database (www.thegpm.org/crap;
version 3/3/19). Searches including post-translational modifications (PTM) were
preformed using the default 313 modifications included by PEAKS. Data was analyzed
using the multi-round search feature in four rounds in the order of ab initio predicted
genes, the A. domesticus transcriptome, PTMs of ab initio predicted genes, and lastly
PTMs of the A. domesticus transcriptome where de novo only spectra remaining from
each prior search were passed to the following search.
Each search was quantified using the label-free quant feature with a 6-minute
retention time shift tolerance and data adhering to a peptide-spectrum match FDR < 0.1%
and at least 1 unique peptide per protein was exported for analysis. Data was aggregated
from each analysis and searches without PTMs was used for quantification. PTMs were
assessed relative to their unmodified forms. Proteins were evaluated for robust presence
requiring that each protein be present in at least 2 technical replicates of a single
biological replicate and 2 biological replicates of a single sample.

2.3.4.2 Protein quantification
Peptides were normalized to GP and converted to fmol. Proteins robustly
identified within developmental stages were quantified by averaging across valid
technical replicates and quantified by average of the top 3 most abundant unique peptides
per protein, if possible. Data was handled in Microsoft Excel 365 and Graphpad Prism
(version 9.0.0; GraphPad Software, San Diego, CA, USA). For statistical analyses,
missing values were imputed with zeroes. Heatmaps are presented as log 2(fmol) without
imputation. Life stages and proteins were analyzed by two-way ANOVA at a significance
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level of 0.05 with multiple comparisons tested by two-stage step-up method of
Benjamini, Krieger, and Yekutieli at a significance level of 0.01.

2.3.4.3 Protein annotation
Proteins were queried against AllergenOnline by sliding 80mer windows with
matches of greater than 35% (Version 20, Accessed 201027) [95]. Proteins with a full
length E-value below 1E-7 and > 50% shared identity were regarded as predicted
allergens [289]. Hits were not excluded based on taxonomy. Hexamerins identified by
Oppert et al. were included as predicted allergens regardless of their evaluation by
AllergenOnline [287]. The originating species of matched proteins were phylogenetically
visualized by IcyTree [290].
Proteins identified by MS were compared with the non-redundant protein
sequences database from NCBI using BLASTp-fast limited to Hexapoda (taxid: 6960)
with a default E-value of 1E-3 [291]. Proteins were mapped and annotated in Blast2GO
v5.2.5 (BioBam, Valencia, Spain) [292]. Sequences were also annotated by InterPro
within Blast2GO with default settings and the annotations merged [293]. Gene ontology
enrichment analyses were performed using Blast2GO using Fisher’s exact test. Proteins
representing the top 10% of proteins by quantification per life stage were submitted as the
test set compared to the reference set of the remaining proteins (FDR < 0.05). Enriched
terms were reduced to the most specific terms (FDR < 0.05).
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2.4 Results
2.4.1 Characteristics of samples and cricket life stages
Crickets were handled to ensure at least 200 mg of sample was used during
sample processing resulting in an increasing number of individuals used for earlier stages
of development compared to later stages (Appendix A Table 2.1.1). There were no
significant differences in protein content among life stages. Fractionation by SDS-PAGE
evidenced more shifts in protein composition in adults than in earlier stages as a 35 kDa
band in adult males and a band above 100 kDa in adult females but otherwise differences
were indistinguishable from differences in total protein applied per lane (Appendix
Figure A 2.1.2)

2.4.2 Proteomic shifts across life stages
Use of the multi-round search methodology resulted in most (97.5%) of all
acquired spectra assigned to one of the databases (Appendix A Table 2.1.2). After labelfree quantification requiring at least one unique peptide, the total number of valid
proteins dropped to 675 encompassing 3977 peptides without and 81 peptides with noncarbamidomethyl post-translational modifications. Among life stages, there were no
statistical differences in the mean peptides, mean proteins, or summed quantification of
all proteins (Table 2.1). There were significant differences in the quantification of the top
10% most abundant proteins per stage and the proportion these proteins encompassed
particularly in adult females.
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Table 2.1 Life stage quantification characteristics

Mean
peptides
Identified
(CV%)
Mean
proteins
identified
(CV%)
Summed
fmol
quantified
(CV%)
Sum fmol
of top 10%
of proteins
(CV%)
%fmol
represented
by top
10% of
proteins
(CV%)

Pinhead

1
Week

1/3
Grown

2
Weeks

1/2
Grown

2/3
Grown

Adult
Male

Adult
Female

3132.7a
(2.04%)

3176.0a
(1.92%)

3264.3a
(0.88%)

3178.7a
(7.45%)

3213.3a
(3.5%)

2685.3a
(13.5%)

2567.7a
(17.9%)

2501.3a
(25.3%)

579.0a
(1.79%)

593.3a
(1.02%)

601.3a
(1.58%)

598.7a
(2.56%)

588.3a
(1.82%)

537.7a
(7.77%)

519.7a
(9.96%)

479.3a
(15.3%)

2635.1a
(27.5%)

2668.4a
(10.4%)

3150.9a
(4.4%)

4344.0a
(17.0%)

3958.9a
(23.9%)

2935.1a
(22.9%)

3232.2a
(26.1%)

4637.7a
(19.6%)

1394.2a
(30.0%)

1406.4a
(9.8%)

1784.3a
(4.8%)

2623.4ab
(18.8%)

2310.6ab
(27.0%)

1767.8a
(21.0%)

2065.5a
(27.2%)

3433.9b
(15.4%)

52.6%a
(2.9%)

52.7%a
(2.8%)

56.6%ab
(0.8%)

60.3%bc
(3.0%)

58.1%b
(3.5%)

60.4%bc
(2.2%)

63.8%c
(2.2%)

74.5%d
(6.1%)

Values that do not share common letters are significantly different by one-way
ANOVA (p < 0.05) and two-stage linear step-up procedure of Benjamini, Krieger, and
Yekutieli (FDR < 0.01).

Comparison of quantifiable proteins across life stages resulted in most being
similar with correlation coefficients between 0.45-0.99 comparing all proteins (Figure
2.1). Focusing only on proteins that were robustly identified in at least 7 of 8 life stages
(74.5% of all proteins), comparison of the quantifiable proteins demonstrated correlation
coefficients between. 0.84-0.99. Adult females were less correlated due to several highly
abundant proteins that were uniquely identified in adult females.
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Data were further assessed for biologically derived posttranslational modifications
to match as much of the data possible to the databases used. A total of six modifications
were identified in the form of N-terminal acetylation, acetylation of lysine, and
methylation but only one, [YPIEHGIITNWDDMEK]3+, was also identified as
unmodified, which was observed almost exclusively as the modified form in later stages
(85.1% in pinheads, 96.3% in adult females; Appendix A Figure 2.1.3 and Appendix A
Table 2.1.3). Each peptide was observed in at least 66 injections (91.6%) with spectra
that substantiated the position of the modification.
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Figure 2.1 Heatmaps and Pearson correlation matrices of all proteins and robust
proteins
Heatmaps (A and C) and Pearson correlation matrices (B and D) of all quantified
proteins (A and B) and proteins robustly identified across at least 7 of 8 life stages (C
and D). Data are presented from the Log2 (fmol) per protein without imputation.
2.4.3 Proteome annotation and gene ontology enrichment
Of quantified proteins, 85.5% were successfully annotated, 9.5% identified
without gene ontology (GO) terms, and the remaining 5% did not have significant
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BLAST search results (Appendix B). A total of 64 proteins (9.5%) were predicted to be
allergens, most of which (75%) had their best allergenic match to members of Arthropoda
(Appendix A Figure 2.1.4). For allergen hits that were well described, most closely
matched the descriptions assigned via BLAST; however, proteins that did not meet the
cutoff criteria for predicted allergens had more mismatches between BLAST and
Allergenonline searches.
GO enrichment was applied to evaluate the primary functional focus during each
life stage (Figure 2.2, Appendix A Table 2.1.4). Life stages were similar in a focus on
higher representation of proteins associated with motor activity, actin filament binding,
and myosin complex terms. Prior to 2 weeks of development, terms including purine
ribonucleotide and triosephosphate binding were enriched. Between 2 weeks and 2/3
grown, enriched terms indicate an increasing focus on cuticular structure and
monophenol oxidase activity with relatively less focus on metabolism. The shift into
monophenol oxidase activity is associated with proteins annotated as hexamerins that are
highly abundant in 2 weeks and 1/2 grown crickets. Adult males and females continued
with a lesser focus on metabolism while females greatly increased proteins associated
with lipid transport. These lipid transport proteins were predominantly annotated as
vitellogenins, which were almost exclusively identified in adult females.
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Figure 2.2 GO enrichment of life stages
Summary of GO enrichment results of top 10% of proteins per life stage of A.
domesticus. GO terms significantly enriched (FDR<0.05) and reduced to most specific
terms (FDR<0.05). Cell color represents log10 (p-value) from a floor of p=0.01 and
numbers per cell represent number of proteins with enriched term. MF: Molecular
function, BP: Biological process, CC: Cellular component, +: Overrepresented term, -:
Underrepresented term.

2.4.4 Predicted allergens across life stages
The quantitative distribution of predicted allergens showed no pattern and was not
significantly different compared to the remaining non-predicted allergens for any of the
life stages (Figure 2.3).
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Figure 2.3 S-curves of quantifiable proteins and predicted allergens per life stage
Quantifiable proteins per life stage differentiated by predicted allergens (red) and nonpredicted allergens (black). The x-axis is arbitrary and scaled. No differences were
found in average quantity of predicted allergens and non-predicted allergens in any
life stage by two-way ANOVA (p < 0.05) and two-stage linear step-up procedure of
Benjamini, Krieger, and Yekutieli (FDR < 0.01).
Most proteins identified (73.0%) were robustly identified in 7 of the 8 life stages
(Figure 2.4). Only a small subset of 10 proteins were robustly identified, predicted as
allergens, and statistically differed among the life stages. Predicted allergens that were
robustly identified comprised a vast majority of the quantifiable protein (97.3%)
compared to proteins not robustly identified across life stages and therefore were the
primary focus.
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Figure 2.4 Venn diagram of protein assignments and annotations
(A) 182 proteins identified by mass spectrometry were not robustly identified across at
least 7 of 8 life stages with 64 proteins predicted as allergens and 11 not robustly
identified and predicted as allergens. (B) Within 493 robustly identified proteins, 65
were significantly different among life stages by two-way ANOVA (p < 0.05) and
two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli (FDR <
0.01). 10 proteins were robustly identified, predicted as allergens, and significantly
different among life stages.
Of predicted allergens that were robustly identified but found to be significantly
different among life stages, four hexamerins were identified and demonstrated far greater
amounts in crickets at 2 weeks, 1/2 grown, and to a lesser degree adult females (Figure
2.5 A). The remaining six predicted allergens either were variable from stage to stage or
broadly increasing over development. Evaluation of the variable predicted allergens to all
predicted allergens evidenced a significant and increasing trend toward a greater
proportion of the allergens being encompassed by these variable predicted allergens
(Figure 2.5 B). Comparison between all predicted allergens and all remaining proteins
only was significant for adult females, which had significantly less predicted allergenic
content compared to other life stages.
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Figure 2.5 Robust and variable predicted allergen heatmap and characteristics of
predicted allergens across life stages
(A) Heatmap of predicted allergens robustly identified across at least 7 of 8 life stages
with significant differences across life stages presented as Log2 of the sum of each
group per life stage. (B) Proportions of quantified variable predicted allergens
compared to all predicted allergens and the proportion of predicted allergens to all
proteins. Values per protein or data point that do not share common letters are
significantly different by two-way ANOVA (p < 0.05) and two-stage linear step-up
procedure of Benjamini, Krieger, and Yekutieli (FDR < 0.01).
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2.5 Discussion
This study was devised to follow the development of A. domesticus crickets from
a proteomic perspective, evaluate the identity of present proteins, predict plausible
allergenic proteins, and examine the protein-level differences among life stages. We
sought to explain what various A. domesticus life stages are doing at the protein level as
well as if there were any differences among life stages that could be leveraged to
decrease the risk posed to consumers.
Comparison of the GO enrichment performed here based on protein abundance to
that of Oppert et al. based on transcript abundance shows little correlation via the terms
shared by similar life stages [287]. Far fewer proteins were identified here to serve as a
test set for GO enrichment as opposed to highly abundant transcripts resulting in a less
rich comparison of life stages at the protein level. Terms enriched at the protein level for
all stages related to muscle development and similar terms can be seen sparingly in the
transcriptome in the form of myosin complex, troponin complex, and calcium ion binding
(e.g. tropomyosin and myosin light chain); however, terms enriched among highly
abundant transcripts such as cytochrome-c oxidase activity or related to DNA were not
enriched in abundant proteins. Notably, terms related to lipid transport that were enriched
among highly abundant proteins were absent in adult female transcripts. The model
insect, Drosophila melanogaster, has also evidenced a poor correlation between mRNA
and protein [294]. Factors explaining the discrepancy includes protein stability as related
to protein turnover as highly stable proteins do not require high levels of transcription to
become abundant as well as post-transcriptional controls that maintain protein levels
[295].
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Protein annotation identified homologues to many known allergens of
cockroaches, shellfish, and house dust mites and were predicted as allergens in A.
domesticus. As many of the predicted allergens were identified as robust and stable
among the life stages, focus was given to predicted allergens that showed variation
among life stages. Given the cumulative stability in overall predicted allergen abundance
it is likely that the variability observed reflects both the choice to normalize samples on a
tissue basis rather than protein as well as the naturally greater noise observed in the
quantity of highly abundant proteins [296]. Of the focused upon predicted allergens, both
tropomyosin and arginine kinase are known as panallergens among arthropods [160,
297]. Myosin light chain is known as an allergen in cockroaches (Bla g 8), shrimp (Pen m
3), and house dust mites (Der p 26) and cross-reactivity has been speculated among
invertebrates but not clearly established [92, 298]. Both alpha-tubulin (Der p 33) and
paramyosin (Der p 11) are known as allergens in house dust mites. Alpha-tublin of
Tenebrio molitor, the yellow mealworm, was identified using immunoprecipitation using
sera of patients with known shellfish allergy and regarded as a putative allergen [299].
Paramyosin has been described as potentially cross-reactive among house dust mites and
mollusks [92], but paramyosin from the mollusk Halitosis discus discus, the disc abalone,
has been demonstrated to have cross-reactivity with tropomyosin [300].
Hexamerin has been identified as a novel allergen in Gryllus bimaculatus [133],
the two-spotted cricket, although the evidence provided was limited to possible IgEbinding and 2 peptides matched to Tribolium castaneum Hexamerin 1B precursor but
without reporting the identity of the peptide sequences matched. Hexamerins are a
member of the greater hemocyanin superfamily, which comprises many similar proteins
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with diverse function, and care was taken to ensure that the proteins identified were
attributable to the appropriate storage hexamerins as opposed to phenoloxidases,
hormone binding proteins, or hemocyanins [301]. Ten members of the superfamily were
identified in part with allergen hits to either Per a 3 or Fenneropenaeus merguiensis
hemocyanin, of these three (ANN16672.RA, ANN17126.RA, GHUU01045934.1.4) were
annotated as phenoloxidases rather than storage hexamerins by Oppert et al. [287], and
another two (ANN20571.RA, ANN20572.RA) were evaluated as juvenile hormone
binding proteins via matching peptides and N-terminal sequencing according to the work
of Tawfik et al. on G. bimaculatus [302]. The remaining five (ANN12312.RA,
ANN12313.RA, ANN12314.RA, ANN12315.RA, GHUU01039257.1.1) were identified
using contigs from Oppert et al. [287]. Members of the hemocyanin superfamily have
been demonstrated as allergens across Arthropoda, but cross-reactivity is less clear but
may be achieved through cross-reactive carbohydrate determinants [303].
Among the surveyed life stages, predicted allergenic content was relatively stable
saving the exception of adult females, which had significantly less predicted allergenic
content. However, adult females were highly rich in vitellogenins. Various vitellogenins
are known allergens such as Api m 12 and Ves v 6, which are injection allergens and
cross-reactive despite low shared identity (40%) [304]. Cockroach vitellogenins have also
been demonstrated to bind IgE at relatively higher rates than other cockroach allergens
[305]. Cockroach vitellogenin is distantly identical to other known allergenic
vitellogenins such as Der p 14, although fragments of Der p 14 has been shown to be
highly IgE reactive and speculated to act as an adjuvant to enhance IgE responses to itself
and other potential allergens [306]. It is not clear if the distances in identity would result
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in vitellogenins of A. domesticus sharing characteristics of other known allergenic
vitellogenins but should be a consideration if IgE binding is identified in the future.
Many of the allergens identified are principally known as airway allergens, which
suggests that farming operations should be aware of the risks posed during cricket
rearing. For consumers, the risks are yet unclear. A. domesticus poses risks at each life
stage surveyed and while current data suggests adult females may pose lesser risk the
need to segregate male and female crickets to leverage this difference may pose undue
burden on producers. We suggest that consumers be adequately informed of the risks they
are undertaking and that crickets be cautiously consumed by those with current allergies
to arthropods.
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CHAPTER 3: PROTEOMIC EVALUATION OF YELLOW MEALWORM,
TENEBRIO MOLITOR, WITH EXPERIMENTAL GENETIC MODIFICATIONS

3.1 Abstract
Background: T. molitor (yellow mealworm) larvae are an important alternative food and
protein source to conventionally grown animal protein but retain risks to those with
crustacean shellfish allergy. Genetic modification can result in unintended effects to the
presence and quantity of other proteins present, including potential allergens. We
evaluated wildtype and proprietary genetically modified variants of T. molitor to assess
the allergenic risks posed as well as the effects of the modifications on the proteome.

Methods: Three mealworm samples including one wildtype and two genetically
modified variants were extracted and proteins investigated by mass spectrometry.
Databases representing ab initio genomic predicted genes and publicly available protein
sequences were used and identified proteins annotated for homology to known allergens.
Predicted allergenic proteins with statistical differences among samples were used to
assess the relative risks posed.

Results: A total of 655 proteins were identified among samples with 531 identified
robustly in each sample. 45 proteins were predicted as allergens representing many
known allergens of Arthropods, but 2 proteins, arginine kinase and a myosin light chain,
were predicted as allergens and significantly elevated in one of the genetic variants.
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Conclusions: Compared to wildtype T. molitor one of the genetically modified samples
posed no greater allergenic risk but the other posed an elevated risk. Wildtype T. molitor
poses risks to consumers particularly those with allergies to crustacean shellfish,
cockroaches, or house dust mites.

3.2 Introduction
Food allergies affect approximately 10.8% of U.S. adults with shellfish allergy
affecting 2.9% [81]. Symptoms of a food allergic reaction varies but can include rash,
hives, shock, and anaphylaxis. Tenebrio molitor has been assessed by the European Food
Safety Authority (EFSA) as a safe novel food with respect to whole insects and as a
powder at a maximum level of 100% in the form of snack foods [307]. The scientific
opinion notes that T. molitor as a food contains risks of both de novo sensitization as well
as cross-reactions with those with allergies to either crustaceans or dust mites.
Safety assessment of genetically modified organisms relies on establishing
substantial equivalence relative to the unmodified organism and can be performed at the
level of the metabolome, transcriptome, or proteome [308]. Proteomic evaluations rely on
evaluating the effects on protein levels due to the genetic modification and so the natural
variability observed in accepted unmodified organisms plays a key role in assessing
genetically modified organisms. Food allergens are predominantly proteins and therefore
assessment of the effects of genetic modification on allergen levels is important.
Allergens of interest in mealworms include the panallergens tropomyosin and arginine
kinase as well as other proteins known to be allergenic in other Arthropods such as
crustaceans, cockroaches, and house dust mites [309, 310].
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This study evaluated the risk posed by wildtype T. molitor as well as two
genetically modified variants. The risk was assessed by protein quantification using mass
spectrometry. Annotation of quantifiable proteins clarified what proteins were identified
and searches against allergen databases predicted which proteins were of relevance. We
evaluated both the quantification and annotations of proteins to evaluate the relative
allergenic risks of T. molitor samples as well as the effects of genetic modification.

3.3 Methods and Materials
3.3.1 Samples and Chemicals
Tris, iodoacetamide (IAA), 3-[(3-Cholamidopropyl)dimethylammonio]-1Propanesulfonate (CHAPS), and rabbit glycogen phosphorylase B (GP; P6635; Uniprot
P00489.3) were obtained from Sigma (St. Louis, MO, USA). Trypsin (Pierce, MS grade)
was obtained from Thermo Scientific (Waltham, MA, USA). Dithiothreitol (DTT) and
Thiourea were obtained from Arcos Organics (Geel, Belgium). Ammonium bicarbonate
(ABIC) was obtained from Honeywell Fluka (Charlotte, NC, USA). Acetone, acetonitrile
(ACN), hexanes, LC/MS grade water, and formic acid were obtained from Fisher
(Hampton, NH, USA). Urea was obtained from Biorad (Hercules, CA, USA).
Yellow mealworm larvae (Tenebrio molitor) were obtained from the Dossey
laboratory including wildtype mealworms and two genetically modified variants denoted
as WT, GM1, and GM2, respectively. Information regarding the genetic modifications
was proprietary.
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3.3.2 Sample preparation and protein extraction
For each type of mealworm (N=3), individual mealworms were ground by mortar
and pestle under liquid nitrogen in triplicate (N=9). Ground samples were stored at -80
°C until use. Samples were individually prepared for defatting in 1.5 mL Eppendorf tubes
by adding 0.5 mL of acetone and vortexed to saturate the material. Defatting was
performed by adding an additional 1 mL of acetone (>1:5 w/v) followed by vortexing,
shaking for 10 minutes, and centrifugation (10 minutes, 17 k x g). The supernatant was
discarded and acetone defatting repeated three additional times. The material was then
defatted by substituting the acetone for hexanes and repeated as before four times and the
pellets dried in a fume hood overnight.
Defatted samples (N=9) were extracted 1:20 (w/v) using a zwitterionic chaotropic
buffer (50 mM Tris pH 8.8, 5 M urea, 2 M thiourea, 2% CHAPS, 67 mM DTT) in a
heated sonicating water bath (60 °C, 30 minutes) and centrifuged (10 minutes, 17 k x g).
Per extraction, half of the extraction buffer was removed as supernatant and fresh buffer
added to maintain volume. Each pellet was extracted a total of three times and the three
supernatants per defatted sample were pooled (N=9).

3.3.3 Mass Spectrometry
3.3.3.1 Sample preparation for mass spectrometry
Per sample, 10 µL of each extract was diluted 1:10 in zwitterionic chaotropic
buffer and to 10 µL of the diluted extract (equivalent to 1 µL undiluted) 4 volumes of
chilled acetone added for an acetone precipitation (-80 °C, overnight). The samples were
then centrifuged (4 °C, 30 minutes), decanted, and the pellet washed with 200 µL of 80%
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acetone and the centrifugation repeated. The pellet was then allowed to dry in a fume
hood and stored at -80 °C until use.
Pellets were reduced by adding 45 µL of 50 mM ABIC, 4.5 µL of 100 mM DTT,
26.7 µL of water, and 4.8 µL of 100% ACN and incubating at 95 ⁰C for 5 minutes. The
samples were alkylated by adding 9 µL of 100 mM of IAA and incubating at room
temperature in the dark for 20 minutes. The samples were digested by adding 3 µL of 100
ng µL-1 trypsin (Pierce, MS grade) and incubating at 37 ⁰C for 3 hours. A further 3 µL of
100 ng µL-1 trypsin was added and incubated at 30 ⁰C for overnight. The reaction was
quenched by freezing.
Pierce C-18 Spin columns (Thermo Scientific) were used according to
manufacturer’s instructions excluding the final elution, which was performed using 50%
ACN. Eluted samples were dried by centrifugal vacuum evaporation (RC1010, Jouan,
Saint-herblain, Pays de la Loire, France). Dried samples were resolublized in 27 µL of
0.1% (v/v) formic acid and 5% (v/v) ACN. Samples were aliquoted into vials with 9 µL
of resolublized peptides and 1.5 µL of 200 fmol µL-1 rabbit glycogen phosphorylase B
(GP; Uniprot sequence P00489.3; Sigma-Aldrich #P6635) where a 3.5 µL injection
would be equivalent to 100 fmol of GP. Samples were injected in triplicate (N=27).

3.3.3.2 Running parameters for mass spectrometry
One-dimensional microscale liquid chromatography separation of tryptic peptides
was performed with an UltiMate 3000RSL® liquid chromatography system (Thermo
Scientific), equipped with a Hypersil Gold C18 1.9 μm, 100 x 1 mm analytical reversed
phase column (Thermo Scientific). Mobile phase A consisted of 99.9% (v/v) water
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containing 0.1% (v/v) formic acid and mobile phase B was 99.9% (v/v) ACN containing
0.1% (v/v) formic acid. Two µL of the sample was injected on-column and peptides were
eluted from the analytical column and separated using a gradient of 2-40 % mobile phase
B over 60 minutes at a flow rate of 60 µL/min. The analytical column temperature was
maintained at 35 ⁰C.
Mass spectrometric analysis utilized a Q Exactive PlusTM Hybrid QuadrupoleOrbitrapTM MS (Thermo Scientific) in the data-independent mode with survey scans and
fragment ion spectra acquired at a resolution of 70,000 at m/z 400. Up to the top 20 most
abundant isotope patterns with charge 2 to 4 from the survey scan were selected with an
isolation window of 2 m/z with a window offset of -0.4 m/z and fragmented by higher
energy collisional dissociation with normalized collision energies of 27. The maximum
ion injection times for the survey scan and the MS/MS scans were 100 and 240 ms,
respectively, and the ion target value for scan modes were set to 3E6 and 1E5,
respectively. Repeat sequencing of peptides was minimized by dynamic exclusion of the
sequenced peptides for 20 s.

3.3.4 Data Analysis
3.3.4.1 Protein identification
Protein databases for mass spectrometry data analysis were constructed using
translated genes predicted using Augustus (v 3.4.0) against a T. molitor genome acquired
from NCBI (WGS Project JABDTM01) [311, 312]. Parameters for Augustus included
softmasking, the species set to tribolium2012, alternatives from evidence set to true, and
a hints file generated using Peptimprove with default settings and utilizing the prior
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genome along with raw mass spectrometric data generated from wildtype T. molitor
[313]. A total of 26806 translated genes were predicted using Augustus. The database
appended with 348 sequences representing GP and 347 decoy sequences identified from
Uniprot from a search for “glycogen phosphorylase” within Insecta (obtained
18/09/2020) as well as 13 tropomyosin sequences of T. molitor manually curated by
comparison of genomic contigs to the tropomyosin-2 gene structure of Tribolium
castaneum (NCBI LOC656914; Appendix C Table 3.1.1 and Appendix C Table 3.1.2).
Translated genes representing tropomyosin-1 and arginine kinase were also compared
with T. castaneum gene structures (NCBI LOC656904 tropomyosin-1 and LOC660479
arginine kinase) but predictions were of sufficient quality and were not altered (Appendix
C Figure 3.1.1). A second database of 626 T. molitor proteins was acquired from Uniprot
(Obtained 10/01/2021).
Data was analyzed using PEAKS 8.5 with search parameters including tryptic
peptides, maximum of 1 missed cleavage, carbaminomethyl cysteine as a fixed
modification and a contaminant database (www.thegpm.org/crap; version 03/03/2019).
Searches including post-translational modifications (PTM) were preformed using the
default 313 modifications included by PEAKS. Data was analyzed using the multi-round
search feature in four rounds in the order of the concatenated Augustus predicted gene
database, Uniprot database, PTMs of the concatenated Augustus database, and lastly
PTMs of the Uniprot database where de novo only spectra remaining from each prior
search were passed to each following search.
Each search was quantified using the label-free quant feature with a 6-minute
retention time shift tolerance and data adhering to a peptide-spectrum match FDR < 0.1%
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and at least 1 unique peptide per protein was exported for analysis. Data was aggregated
from each analysis and searches without PTMS used for quantification. PTMs were
assessed relative to any unmodified forms. Proteins were evaluated for robust presence
requiring that each protein be present in at least 2 technical replicates of a single
biological replicate and 2 biological replicates of a single sample.

3.4.4.2 Protein quantification
Peptides were normalized to GP and converted to fmol. Proteins robustly
identified within samples were quantified by averaging across valid technical replicates
and quantified by average of the top 3 most abundant unique peptides per protein, if
possible. Data was handled in Microsoft Excel 365 and Graphpad prism (version 9.0.0;
GraphPad Software, San Diego, CA, USA). For statistical analyses, missing values with
imputed with zeroes. Heatmaps are presented as log2(frmol) without imputation. Samples
and proteins were analyzed by two-way ANOVA at a significant level of 0.05 with
multiple comparisons tested by two-stage step-up method of Benjamini, Krieger, and
Yekutieli at a significance level of 0.01.

3.4.4.3 Protein annotation
Proteins were queried against Allergenonline by Full Fasta 36 with an E-value
cutoff of 1 and 20 max alignments shown (Version 20, accessed 13/01/2021) [95].
Proteins with a full length E-value below 1E-7 and > 50% shared identity were regarded
as predicted allergens and the top hit retained for annotation [289]. Hits were not
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excluded based on taxonomy. The originating species of matched proteins were
phylogenetically visualized by IceTree [290].
Proteins identified by mass spectrometry were compared with the non-redundant
protein sequences database from NCBI using BLASTp-fast limited to Hexapoda (taxid:
6960) with a default E-value of 1E-3 [291]. Proteins were mapped and annotated in
Blast2GO v5.2.5 (BioBam, Valencia, Spain) [292]. Sequences were also annotated by
InterPro within Blast2GO with default settings and the annotations merged [293]. Gene
ontology enrichment analyses were performed using Blast2GO using Fisher’s exact test.
Proteins representing the top 10% of proteins by quantification per life stage were
submitted as the test set compared to the reference set of the remaining proteins (FDR <
0.05). Enriched terms were reduced to the most specific terms (FDR< 0.05).

3.4 Results
3.4.1 Proteomics of T. molitor samples
The multi-round search methodology allowed for most (93.8%) of acquired
spectra assigned to any of the four databases (Appendix C Table 3.1.3). After filtering the
label-free quantification results by requiring at least one unique peptide, the pool of valid
proteins decreased to 655 encompassing 4154 peptides without and 129 peptides with
non-carbamidomethyl post-translational modifications. There were no statistical
differences identified among mealworm samples regarding quantification metadata such
as the mean number of peptides, proteins, or quantification of proteins (Table 3.1).

Robustly
identified
proteins

All identified
proteins
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Table 3.1 Sample quantification characteristics
WT
GM 1
3637.67
3819.67
Mean peptides identified (CV%)
(4.54%) (2.11%)
576.67
594.33
Mean proteins identified (CV%)
(2.08%) (0.54%)
7112.26 7721.74
Summed fmol quantified (CV%)
(18.11%) (7.66%)
5135.38 5493.03
Summed fmol of top 10% (CV%)
(17.54%) (8.19%)
%fmol represented by top 10%
72.2%
71.1%
(CV%)
(1.12%) (2.30%)
6960.38 7501.65
Summed fmol quantified (CV%)
(17.99%) (7.44%)
4987.32 5265.57
Summed fmol of top 10% (CV%)
(17.22%) (8.11%)
%fmol represented by top 10%
71.7%
70.2%
(CV%)
(0.94%) (2.30%)
Proportion of fmol from robustly
97.9%
97.2%
identified proteins to all identified
(0.79%) (0.45%)
proteins (CV%)

GM 2
3789.33
(2.57%)
600.33
(1.93%)
8120.95
(7.16%)
5870.05
(7.26%)
72.3%
(2.66%)
7966.67
(6.87%)
5682.36
(7.15%)
71.3%
(2.87%)
98.1%
(0.39%)

Values per category were assessed by one-way ANOVA (p < 0.05) and none were
significantly different. Robustly identified proteins were those identified as present in
each of the three samples as opposed to all proteins that were found in a single sample
independent of other samples. WT: Wildtype Tenebrio molitor, GM: genetically
modified Tenebrio molitor.

Assessing quantifiable proteins among mealworm samples evidenced minimal
differences assessing either all proteins or only proteins quantified in each of the three
samples (Figure 3.1). Each of the samples were highly comparable regardless of the set of
proteins used as Pearson correlation coefficients were each above 0.97. Proteins that were
robustly identified across samples were of principal focus as they embodied most proteins
identified (79.5%) and encompassed most all the quantifiable protein (Table 3.1).
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Figure 3.1 Heatmaps of all proteins and robustly identified proteins
Heatmaps of all quantified proteins (A) and proteins robustly identified across each of
the three mealworm samples (B). Pearson correlation coefficients were greater than
0.97 for each comparison per data set (p < 0.001). Data are presented from the
log2(fmol) per protein without imputation. WT: Wildtype Tenebrio molitor, GM:
genetically modified Tenebrio molitor.

Data were evaluated for biologically derived posttranslational modifications to
make the most of the data. A total of four modifications were identified as N-terminal
acetylation and methylation of serine and histidine. Only one of these peptides,
[NLLISASSQYTK]2+ was also identified as unmodified, although only in WT (Appendix
C Figure 3.1.2 and Appendix C Table 3.1.4). Excluding the unmodified
[NLLISASSQYTK]2+, each of the modified peptides were observed in at least 22
injections (81.5%) with spectra substantiating the position and identity of the
modifications.
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3.4.2 Proteome annotation and gene ontology enrichment
Among quantified proteins, 90.0% were annotated or assigned gene ontology
(GO) terms, 8.6% were not assigned GO terms, and the remaining 1.4% had no
significant BLAST results (Appendix D). Proteins predicted to be allergens encompassed
45 proteins (6.9%) with most (73.3%) having their best allergenic match to members of
Arthropoda (Appendix C Figure 3.1.3). Matches to allergenic proteins closely resembled
assigned annotations.
GO enrichment was utilized to evaluate differences in functionality among T.
molitor samples in terms of either all proteins or only proteins robustly identified among
each sample (Figure 3.2, Appendix C Table 3.1.5 and Appendix C Table 3.1.6). GO
enrichment did not show large differences through assessment of all proteins as opposed
to robust proteins indicating that the cutoff of the top 10% of quantified proteins was a
contributor to differences among samples. WT mealworms evidenced an enrichment of
proteins associated with the structure of the cuticle among highly abundant proteins as
well as a lack of representation of terms associated with metabolism. Both GM
mealworms showed similar trends compared to WT mealworms with some differences in
the particular underrepresentation of terms associated with biological processes.
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Figure 3.2 GO enrichment of samples against all proteins or robustly identified
proteins
Summary of GO enrichment results of top 10% of proteins of wildtype and genetically
modified T. molitor using (A) all quantifiable proteins or (B) all proteins robustly
quantifiable across samples as a reference set. GO terms significantly enriched
(FDR<0.05) and reduced to most specific terms (FDR<0.05). Cell color represents
log10 (p-value) from a floor of p=0.01 and numbers per cell represent number of
proteins with enriched term. MF: Molecular function, BP: Biological process, CC:
Cellular component, +: Overrepresented term, -: Underrepresented term. WT:
Wildtype Tenebrio molitor, GM: genetically modified Tenebrio molitor.
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3.4.3 Predicted allergens of T. molitor
Quantitative distributions of predicted allergens did not differ compared to
remaining non-predicted allergens of any of the samples (Figure 3.3); however, on
average proteins predicted as allergens were significantly more abundant than nonpredicted allergens for each of the three samples without significant differences across
samples.
A majority of proteins identified were robustly identified among mealworm
samples (81.1%; Figure 3.4). Every predicted allergen was robustly identified among
mealworm samples but only two also statistically differed among samples: g5623t1 –
arginine kinase and g4621t1 – myosin light chain alkali (Figure 3.5 A). These variable
predicted allergens were exclusively significantly different in GM 2 with WT and GM 1
being not significantly different from each other. This significant difference transferred to
the proportion of these two variable predicted allergens compared to the remaining 43
predicted allergens (Figure 3.5 B). With respect to the proportion of predicted allergens
to non-predicted allergens there were no significant differences identified among
samples.
Evaluation of the tropomyosins present found that the sequence present in
AllergenOnline for T. molitor (g11661t1) is less identical to other known allergenic
Arthropod tropomyosins than the sequence manually curated (ManualTM1.2.n; Appendix
C Figure 3.1.4 and Appendix C Figure 3.1.5). While both sequences were relatively
highly abundant, ManualTM1.2.n was approximately twice as abundant than g11661t1.
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Figure 3.3 S-curves of quantifiable proteins
Quantifiable proteins per sample differentiated by predicted allergens (red) and nonpredicted allergens (black). The x-axis is arbitrary and scaled. On average, predicted
allergens were significantly more abundant than non-predicted allergens for each oof
the three T. molitor samples by two-way ANOVA (p < 0.05) and two-stage linear
step-up procedure of Benjamini, Krieger, and Yekutieli (FDR < 0.01). WT: Wildtype
Tenebrio molitor, GM: genetically modified Tenebrio molitor.
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Figure 3.4 Venn diagram of protein assignments and annotations
(A) 124 proteins identified by mass spectrometry were not robustly identified across
T. molitor samples with 45 proteins predicted as allergens and 0 not robustly identified
and predicted as allergens. (B) Within 513 robustly identified proteins, 28 were
significantly different among samples by two-way ANOVA (p < 0.05) and two-stage
linear step-up procedure of Benjamini, Krieger, and Yekutieli (FDR < 0.01). 2
proteins were robustly identified, predicted as allergens, and significantly different
among samples.
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Figure 3.5 Selected predicted allergen heatmap and characteristics of predicted
allergens across life stages
(A) Heatmap of predicted allergens arginine kinase (g5623t1) and myosin light chain
(g4621t1) that were robustly identified in all T. molitor samples with significant
differences among samples presented as Log2 of the sum of each protein. (B)
Proportions of quantified variable predicted allergens compared to all predicted
allergens and the proportion of predicted allergens to all proteins. Values per protein
or data point that do not share common letters are significantly different by two-way
ANOVA (p < 0.05) and two-stage linear step-up procedure of Benjamini, Krieger, and
Yekutieli (FDR < 0.01).
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3.5 Discussion
This study was designed to examine the proteome of T. molitor yellow mealworm
larvae, annotate proteins, predict the allergenicity of present proteins, and lastly evaluate
the effects of genetic modification on two proprietary samples of mealworms. In effect,
this study first evaluated T. molitor and the various proteins present to then compare
wildtype and genetically modified variants to frame both what typical proteins and
possible allergens are present to then judge if these genetically modified variants could
pose a modified level of risk to consumer relative to the wildtype.
The use of Augustus for ab initio prediction was to both compare with the
predictions by Eriksson et al. as well as incorporate further data into the prediction [311].
Predictions here was preformed including alternative predictions according to evidence
provided as the wildtype mealworm raw data and partial gene models allowed as opposed
to Eriksson et al. only incorporating partial gene models. An additional 32% of complete
and incomplete gene models were predicted here compared to Eriksson et al. despite
using the same prediction software and reference gene database; however, a newer
version of Augustus was used here. Augustus is highly accurate compared to other ab
initio gene prediction tools, although such tools are not yet perfect and still have
difficulty with correctly identifying coding regions for proteins [314]. Notably, the
sequence for tropomyosin-2 was predicted with numerous errors and inconsistent with
that of T. castaneum and manually added.
Homologues to many known Arthropod allergens were identified particularly
among shellfish, house dust mites, and cockroaches and were predicted as allergens in T.
molitor. Barre et al. identified a number of T. molitor proteins that bound IgE of shrimp-
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allergic patients including heat shock protein 70, α-amylase, arginine kinase,
tropomyosin, apolipophorin-III, larval cuticle protein, and a 12 kDa hemolymph protein
[309], where many of these proteins were predicted here as allergens excluding
apolipophorin-III, larval cuticle protein, and the 12 kDa hemolymph protein. Both
apolipophorin-III and the 12 kDa hemolymph protein were identified in part as g19557t1
and g5735t1, respectively; however, many proteins were identified and annotated as
larval cuticle proteins and so it is unclear which protein was identified with IgE binding.
Further, the total number of proteins identified by Barre et al. was just 106 whereas 655
were identified here with stringent sample-wise filtration requiring repeated
identifications for acceptance, which makes it unclear if the proteins identified as IgE
binding were in fact the only proteins present. They did similarly note the presence of
both a tropomyosin-1 and a tropomyosin-2 as was identified here. Tropomyosins are
known pan-allergens of Arthropoda [297], and have been implicated in cross-reactivity
between mealworms and shellfish [310]. With respect to multiple tropomyosins present,
it may be speculated that these are important for reactivity and cross-reactivity.
Functional annotation of T. molitor unigenes by Liu et al. provides insights into
the GO enrichment based on protein abundance performed here [315]. Many T. molitor
genes have been annotated principally with terms including binding, cellular process, and
metabolic process, which were found to be underrepresented in the highly abundant
proteins as opposed to extracellular matrix, which was only assigned to approximately
1% of genes by Liu et al. but was overrepresented in the highly abundant proteins. These
exhibit an inverse relationship suggesting that a greater diversity of proteins are needed
for binding, cellular processes, and metabolic processes that may discourage any
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particular proteins from becoming highly abundant. These proteins may also have
significant differences in protein stability and therefore protein turnover as highly stable
proteins do not require high levels of transcription to become abundant [295].
Some differences were observed among wildtype and genetically modified
variants. The observed differences in GO enrichment were likely associated with the
limited number of samples and the arbitrary cutoff of the top 10% most abundant
proteins. The relatively higher content of arginine kinase and myosin light chain content
identified in GM2 would indicate that these pose a potentially higher risk to individuals
with clinical reactivity to these proteins. GM1 did not show any significant differences in
abundance compared to WT and therefore from this assessment would not be of greater
risk to consumers. Both arginine kinase and myosin light chain are recognized as food
and airway allergens depending on the source and therefore care should be observed
either with respect to production or use of any of these mealworms.
Risk is present regardless of the trait effect of genetic modification and allergenic
proteins were predicted to be present in all samples assessed, including wildtype T.
molitor. The risk posed may be higher in GM2 mealworms, but a greater number of
samples would assist in clarifying the magnitude of the difference in risk. We suggest
that stakeholders be informed of the mealworms they are handling or using to allow for
individuals to make informed choices as to the risks they are willing to face.
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CHAPTER 4: PERSISTENCE OF PEANUT ALLERGEN-DERIVED PEPTIDES
THROUGHOUT EXCESSIVE DRY THERMAL PROCESSING

4.1 Abstract
Scope: Commercial dry roasting of peanuts can result in accumulation of extensively
heated peanut residue in ovens. These residues could pose a potential allergenic risk if
residues are transferred to food products subsequently processed in the oven. Peanut
residues can be detected in food products using antibody-based methods, but detection is
greatly affected by thermal processing. We investigated the detectability of peanut
allergens after excessive thermal processing using mass spectrometry (MS).
Methods and results: Peanut kernel halves were roasted in a muffle furnace, ground,
robustly extracted, and probed by immunoblot with sera from patients with peanut allergy
(anti-peanut IgE) and anti-peanut IgG. Extracts were further analyzed by MS. After 8
hours at 176 °C, detectable allergenic protein content, by MS, decreased 54.6-fold, with
surviving contiguous regions sufficient to bind IgE to Ara h 3.
Conclusions: Failure to detect peanut residues with antibody-based methods should not
be regarded as an indication of the absence of peanut residues as robust extractions
coupled with MS were able to identify peanut from some of these processed samples.
Peanut residues should be physically removed prior to thermal processing as reliable
existing antibody-based methods are inadequate to detect peanut residues after extensive
heating of products.
Keywords: Food allergen, Mass spectrometry, Peanut, Thermal processing
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4.2 Introduction
Food allergies affect approximately 10.8% of US adults and peanut allergy affects
approximately 1.8% [81]. Symptoms of food allergies range from rashes, hives, and
anaphylaxis where harmful doses of allergenic protein can be as low as sub milligram
quantities [316]. Representative quantification of present allergenic residues is required
to support allergen management, which is required to adequately inform allergic
consumers of the potential risk via labeling.
Residues of commercially dry roasted peanuts may accumulate in ovens, possibly
resulting in harmful levels of exposure to peanut-allergic consumers. Thermal processing
can hinder or even negate the detection of peanut residues when using enzyme-linked
immunosorbent assays (ELISA) [209, 317]. Peanuts are commonly oven roasted at 160180 °C, but higher temperatures are used for cleaning. Detection of peanut residues in
thermally processed material may be compromised by decreased solubility of peanut
protein especially given that extraction buffers must be compatible with antibody
binding. Thermal processing may also result in aggregation of, and chemical or structural
modifications to, proteins that can further complicate accurate detection and
quantification [318]. Thermal processing affects both the detectability of allergens and
their allergenicity to variable extents dependent upon the type of thermal processing
[319]. Inaccurate assessment of allergenic residues following thermal processing presents
a challenge to industry and could pose a risk to peanut-allergic consumers.
This study addresses the identification of peanut allergens persisting after up to 8
hours of dry thermal processing. The quantity of allergen present at each stage represents
the potential risk and is addressed with antibody binding and quantitative mass
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spectrometry (MS). The use of MS allows for the detection of many targets (peptides and
modifications thereof) derived from peanut allergens. This contrasts to ELISA methods
where only one measure of peanut presence is determined. We further describe the effects
of thermal processing by examining the survival of potentially contiguous regions of
allergens using MS. The aim was to determine if peanut residues with the capability to
bind to peanut-specific antibodies would remain after excessive dry thermal processing.

4.3 Materials and methods
4.3.1 Chemicals
Acetone, hexane, methanol, sodium chloride, disodium phosphate,
monopotassium phosphate, formic acid, water, ACN were obtained from Fisher
(Hampton, NH, USA). Mass spectrometry solvents were Optima grade. Thiourea,
CHAPS, Tris, and Iodoacetamide were obtained from Sigma Aldrich (St. Louis, MO,
USA). DTT was obtained from Acros (Geel, Belgium). BSA and PVDF were obtained
from Millipore (Burlington, MA, USA). Nupage 4-12% Bis-Tris SDS-PAGE gels,
NuPage MES SDS running buffer, and LDS sample buffer were obtained from Invitrogen
(Carlsbad, CA, USA). Urea, Tween 20, Coomassie Blue R-250, Precision Plus ProteinTM
Dual Xtra standards, and 10x Tris Glycine buffer were obtained from Biorad (Hercules,
CA, USA). Potassium chloride was obtained from Labchem (Zelienople, PA, USA).
Pierce C18 spin columns, Pierce MS grade Trypsin, and SuperSignal West Dura
Extended Release Substrate were obtained from Thermo Scientific (Waltham, MA,
USA). MassPREP Phosphorylase b Standard was obtained from Waters (Milford, MA,
USA). Milli-Q purified water (18.2 MΩ cm) was used throughout this study.
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4.3.2 Thermal Processing
Raw, blanched (deskinned) peanuts were obtained from the Golden Peanut
Company (Alpharetta, GA, USA) and stored at 4 °C until use. Groups of 10 peanut
kernel halves were placed into foil-lined crucibles. Crucibles were heated inside a
Thermolyne muffle furnace (Model F30420C, Thermo Scientific, Waltham, MA, USA)
preheated to either 176 °C or 260 °C. Crucibles were removed at 15, 30, 60, 120, 240,
and 480 minutes. Non-heated controls were also prepared and appear as time=0 in results.
Five replicates per time point and temperature combination were prepared.

4.3.3 Protein Extraction
Per replicate, pairs of peanut kernel halves were placed into a 2 mL microfuge
tube and manually homogenized by metal spatula and glass rod in the presence of 500 µL
of acetone. An additional 1 mL of acetone was added, samples vortexed, rocked for 15
minutes, centrifuged at 17,000g for 15 minutes, and decanted. This was repeated three
more times. The samples were then defatted with 1 mL of hexane, a total of four times as
described for the acetone procedure. Samples were dried overnight at room temperature,
vortexed to produce a homogenous powder, and then stored at -20 °C.
Samples were extracted as modified from [285, 320]. In brief, 50 mg of each
defatted sample was extracted in 1 mL of zwitterionic chaotropic buffer (50 mmol/L Tris,
pH 8.8 containing 50 mmol/L 1,4-Dithio-D-threitol (DTT), 5 mol/L urea, 2 mol/L
thiourea, and 32.5 mmol/L 3-[(3-Cholamidopropyl)dimethylammonio]-1Propanesulfonate (CHAPS)). Suspensions were vortexed, incubated in a heated
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sonicating water bath (60 °C, 20 min), and extracts were clarified by centrifugation
(17,000g, 20 min). The supernatants (500 µL) were taken and an equal amount of
extraction buffer replaced. Each sample was sequentially extracted three times and
pooled as a single replicate. Extracts were stored at -20 °C until further analysis.

4.3.4 Mass Spectrometry and data analysis
MS was performed as previously described [285] with modifications. Briefly, 1
µL of extracts were precipitated with excess acetone and the pellet was reduced,
alkylated, digested using trypsin, cleaned via C18 Spin columns, vacuum evaporated, and
resolubilized with 28 µL of 0.96 mol/L acetonitrile (ACN), 26.5 mmol/L formic acid.
Prior to injection, 1.5 µL of 200 fmol/µL rabbit glycogen phosphorylase B was added to
9 µL of each sample and 3.5 µL were injected into Thermo Q Exactive Plus™ Hybrid
Quadrupole-Orbitrap™MS coupled to UltiMate 3000RSL® liquid chromatography
(UPLC) system (Thermo Scientific™). Each sample was injected twice as technical
replicates.
Data was analyzed using PEAKS 8.5 (Bioinformatics Solutions Inc., Waterloo,
ON, Canada) using a peanut allergen database was generated by Marsh et al. including
rabbit glycogen phosphorylase b (Uniprot.org P00489.3) and the common Repository of
Adventitious Proteins contaminant database (thegpm.org/crap; obtained 190121) [209,
286]. PEAKS search parameters were 5 ppm (mg/kg) mass error tolerance and 0.05 Da
fragment mass error tolerance with no modifications of amino acids. Secondary PEAKS
PTM search was performed with 3 missed cleavages per peptide and performed with
fixed carbamidomethyl cysteine and 3 variable modifications against a base list of 313
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modifications with 31 additional Maillard reaction and lipid peroxidation modifications
representing 46 different potential modifications as well as a modification reflecting
acetone aldol condensation (Appendix E Table 4.1.1) [321-324]. The base list was
curated to remove overlap with the added modifications for a total of 337 modifications.
Peptides identifications with both <1% FDR, and each PTM identified per peptide had an
ambiguity score of 20 or greater (p< 0.01) were accepted. Peptides with potentially
artefactual modifications, not limited to ion substitutions, carbamylation, or in-source
decay, were disregarded from analysis.
For peptide level data, peptides were filtered by requiring presence in both
technical replicates of at least two biological replicates within a single time point. For
peptide persistence, allergen-derived peptides were also filtered to only evaluate peptides
that met requirements for inclusion for two time points. Contiguous peptides were
evaluated per allergenic sequence and reported as the maximum contiguous length per
allergenic family (e.g. Ara h 1) across all replicates. The longest contiguous peptide was
determined using three methods: 1) only observed peptides, 2) extending observed
peptides by the first contiguous tryptic peptide under 6 amino acids, 3) extending
observed peptides by all contiguous tryptic peptides under 6 amino acids. PTMs of
interest were curated relative to robust parent unmodified peptides. Peptides including a
missed tryptic cleavage were included as unmodified. PTMs of interest included
deamidation, pyroglutamate, and Maillard products. Peptides were grouped according to
modification of interest and evaluated for trends.
Protein quantification evaluated two lists of peptides with either a focus on
robustness in raw peanuts or robustness to dry thermal processing (Appendix E Table
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4.1.2). Only Ara h 1, 2, 3, and 6 were investigated as the remaining allergens were not
robust through dry thermal processing, were not highly abundant in raw samples, and/or
prohibitively diverse. Proteins were regarded as present if both technical replicates had
two peptides observed, quantified by averaging up to the top 3 peptides, and the
quantities were averaged across replicates.
Data were normalized via the top three predominantly present and abundant
peptides from rabbit glycogen phosphorylase. Statistical analyses were performed using
GraphPad Prism version 8.3.0 for Windows (GraphPad Software, La Jolla California
USA) via two-way ANOVA with significant p-values at 0.05 and multiple comparisons
via two-stage linear step-up method of Benjamini, Krieger, and Yekutieli with an FDR
set at 0.05. Non-detect values were treated as zeroes.

4.3.5 SDS-PAGE, sera, and immunoblotting
Protein contents of raw peanut extracts were determined using a 2D Quant-KitTM
per manufacturer’s instructions (GE Healthcare Life Sciences, Chicago, IL, USA).
Volumetric aliquots of samples equivalent to 30 µg of raw peanut protein were separated
by SDS-PAGE and visualized with Coomassie staining.
Immunoblotting was performed as described elsewhere with the immunoblot
transfer performed at 100 V for 60 minutes and dot blots were produced by applying
extracts to activated polyvinylidene difluoride (PVDF) membrane and dried prior to
treating them similarly [325]. Enzyme conjugated secondary anti-peanut antibody was
obtained from a Morinaga Peanut ELISA Kit (Cat# M2104, Yokohama, Japan). Pooled
sera from six peanut-allergic individuals were used. All individuals have positive skin
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prick tests to peanut and compelling histories of allergic reactions upon peanut ingestion
including laryngeal edema, angioedema of face/eyes, urticaria, vomiting, diarrhea,
hypotension, and respiratory symptoms. All individuals had positive Immunocap scores
ranging from 3.13-85.5 kIU L-1. Each individual provided informed consent as stipulated
by The University of Nebraska-Lincoln IRB Approval 200305289FB, Project ID 6029.
Dot blots included positive control Morinaga enzyme conjugated antibody and negative
control bovine serum albumin that had been heated for 480 minutes at 260 °C (Extracted
as in 4.3.3). A solution of 1 g of non-fat dry milk in 40 mL phosphate buffered saline,
450 µM tween 20 (PBST) was used to dilute Morinaga antibody (1:20), human sera
(1:10), and secondary mouse anti-human IgE Fc-HRP (1:1,000; Southern Biotech,
Birmingham, AL, USA). Immunoblots were visualized by chemiluminescence using
SuperSignal West Dura Extended Release Substrate and detected using a UVP
Biospectrum 815 Imaging System (Analytik Jena US LLC, Upland, CA, USA) with
VisionWorks software (Version 8.20, Analytik Jena US LLC). Maximum exposure time
was 5 minutes and images taken were inverted with intensity range set to auto.

4.4 Results
4.4.1 Observable Properties of Thermally Processed Peanuts
Peanuts roasted at 176 °C developed off-odors and were visibly darkened after 60
minutes (Appendix E Figure 4.1.1). At 120 minutes and beyond, the peanuts were
blackened and smelled burnt. Peanuts roasted at 260 °C for 15 minutes had the same
blackened appearance as peanuts roasted at 176 °C for 2-8 hours; however, the burnt odor
was noxious. After 30 minutes, the peanuts were smoking and produced an oily resin.
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Defatted powders prepared from the roasted peanut halves had colors matching the
peanut halves (Appendix E Figure 4.1.2). Extracts of the peanuts roasted at 176 °C
reflected the same color progression as the powders but extracts of the peanuts roasted at
260 °C darkened through 120 minutes before lightening for the 240 and 480-minute time
points (Appendix E Figure 4.1.3).

4.4.2 Mass Spectrometry
4.4.2.1 Quantification of Peanut Allergens over Time
Peanut allergens were quantified in extracts from peanuts roasted for the 176 °C
time series but not for the 260 °C time series as data was insufficient to be quantified.
Quantification of the major peanut allergens (Ara h 1, 2, 3, and 6) after roasting at 176 °C
is shown in Table 4.1. The variation observed reflects differences among peanuts and the
effects of the entire workflow. The most abundant allergens present in the extracts was
Ara h 3, followed by Ara h 1, 2, and 6. Significant decreases in the detected quantity of
all allergens were observed during roasting at 176oC. Ara h 1 and 6 decreased
consistently, whereas Ara h 2 and 3 showed a small, statistically significant, increase at
15 minutes followed by consistent decrease. After 120 minutes, further decreases in
detectable allergen content were not statistically significant, excluding Ara h 1. Ara h 3
detection was least susceptible to heating, followed by Ara h 2, 6 then 1. The relative
composition of detectable proteins therefore changes over time, with Ara h 3 accounting
for 59% of quantified allergens at 0 min, and 87% of quantified allergens at 480 minutes
(Appendix E Figure 4.1.4).
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Table 4.1 MS quantification and summary of peanut allergens after roasting at
176 °C

Ara h 1
Ara h 2
Ara h 3
Ara h 6
Sum of
1, 2, 3, 6

Time (min)
0
15
1775.4
2061.0
(54.2)a
(52.5)a
2065.0
2523.7
(37.4)ab (35.1)a
8550.1
10859.9
(36.1)ab (41.3)a
2081.6
2063.5
(9.2)a
(58.6)ab
14472.0 17508.0
(32.9)ab (40.0)a

30
1572.0
(39.8)a
1891.5
(35.8)b
8295.9
(24.6)ab
1329.4
(52.7)ab
13088.8
(27.0)ab

60
359.6
(57.7)b
1167.2
(48.0)b
5842.6
(36.8)b
903.2
(30.4)b
8272.6
(36.4)b

120
38.5
(118.3)cd
214.3
(110.5)c
980.2
(82.3)c
103.5
(135.3)c
1336.6
(91.3)c

240
11.7
(65.7)c
56.4
(122.2)c
516.5
(65.1)c
32.0
(123.0)c
616.6
(71.3)c

480
4.4
(97.6)d
19.9
(148.8)c
232.7
(71.5)c
8.1
(150.9)c
265.1
(68.9)c

Fold Loss
0 vs 480
405.49
103.69
36.74
258.31
54.60

Allergen quantifications are reported in fmol as mean (CV%) of five biological
replicates with different superscript letters denoting significantly different individual
allergen quantities over time via two-way ANOVA (p<0.05) and two-stage linear
step-up method of Benjamini, Krieger, and Yekutieli (FDR<0.05).

4.4.2.2 Identification of Thermally Induced PTMs and Processing Biomarkers
We examined the presence of PTMs in all time points of peanuts heated at both
temperatures using label-free quantitation to evaluate chemical changes in peptides as a
result of thermal processing (see Appendix F complete peptide list). At the peptide level
per allergen, unmodified and modified peptides followed similar decreasing trends with a
large range of values per time (Appendix E Figure 4.1.5). Focused assessment of PTMs
used exemplar, robust peptides with high-quality identification of unmodified peptide as
well as deamidation, pyroglutamate and Maillard products to assess prevalence of these
modifications during heating (Figure 4.1). Heating at 176 °C dataset utilized the peptides
[QQPEENACQFQR], [IESEGGYIETWNPNNQEFQCAGVALSR], and
[FNLAGNHEQEFLR], all derived from Ara h 3. No equivalent, robust peptides were
found for other allergenic proteins. Deamidation was observed in raw samples with
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further increases occurring with roasting until 120 minutes when a plateau was reached.
Pyroglutamate products were also present prior to processing with a large increase
occurring after 60 minutes of roasting and increasing thereafter. Maillard products were
not observed in raw peanuts and showed gradual increases before peaking at 120 minutes
of roasting but then decreased afterward. Interestingly a deamidated Ara h 3 peptide
[FNLAGN(+0.98)HEQEFLR] was found to be abundant, robust toward heating, and
present in all samples (including unheated peanut) (data not shown). Further, BLAST
search of the peptide with substituted Asn (N) to Asp (D) yielded no hits, indicating that
the deamidation is the likely source of the peptide. Heating at 260 °C data set resulted in
only one peptide detection. The pyroglutamate modified, non-tryptic peptide
[E(-18.01)LQEGHVLVVPQ] was only detected at 15 minutes. It is possible that this
peptide resulted from β-elimination induced by heating, which did not occur after
roasting at 176oC.

Figure 4.1 Trends of selected post-translational modifications in peanuts heated
at 176 °C.
Quantity of deamidation, pyroglutamate, and Maillard adduct (sum of the abundance
of all modified peptides to the abundance of unmodified peptide) for selected peptides
(n=5).
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4.4.2.3 Evaluation of Maximally Contiguous Peanut Peptides
The maximum length of contiguous peanut peptides from extracts of peanuts
roasted at 176 °C was assessed based on three scenarios to account for bias in the MS
data (Table 4.2). Across the three scenarios, decreasing maximum peptide lengths were
noted over time predominantly occurring at 120 minutes and later. Ara h 2 and 6 were
both consistently present and decreased at 120 minutes whereas Ara h 1 and 3 had a more
gradual decrease over time.
Table 4.2 Maximum length of contiguous peptides of peanut allergens after
roasting for 176 °C

Ara h 6

Ara h 3

Ara h 2

Ara h 1

Contiguous Peptide Time (min)
Strategy
0
15 30

60

147 146 85

120 240 480

1

87

61

26

25

2

247 269 179 179 98

44

49

3

314 360 288 253 103 49

49

1

41

70

57

70

68

9

9

2

70

70

69

70

68

12

16

3

70

70

70

70

69

15

17

1

138 155 155 155 138 99

69

2

188 253 215 209 163 108 108

3

509 509 506 509 319 113 113

1

67

67

67

67

34

29

14

2

67

67

67

67

34

53

28

3

67

67

67

67

67

67

28

The maximum contiguous length of peptides (number of residues) was calculated
using three methodologies: 1) only observed peptides, 2) extending observed
peptides by the first contiguous tryptic peptide under 6 amino acids, 3) extending
observed peptides by all contiguous tryptic peptides under 6 amino acids.
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4.4.3 Antibody Binding to Thermally Processed Peanut
As shown in Figure 4.2, proteins in extracts of peanuts roasted at 176 °C showed
evidence of aggregation after 15-60 minutes of roasting. The aggregated proteins were
able to bind both IgE and IgG antibodies, with a gradual decrease in band intensity across
the time points resulting in very little visible protein by 120 minutes. Extracts of peanuts
roasted at 260 °C had no clear protein bands present in SDS-PAGE or immunoblotting,
excluding smearing of lanes. Dot blotting of extracts of peanuts roasted at 176 °C showed
antibody binding of the anti-peanut IgG through 60 minutes and allergic sera IgE through
120 minutes (Figure 4.3). No non-specific binding was observed to peanut proteins on
negative control blots (Appendix E Figure 4.1.6).
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Figure 4.2 SDS-PAGE and immunoblots
SDS-PAGE (left), Morinaga anti-peanut IgG (center), and pooled peanut allergic sera
IgE (right) separated according to the 176 °C (top) and the 260 °C (bottom) roasting
times. Lanes were loaded volumetrically relative to 30 µg of raw peanut
(approximately 1.7 µL). Molecular weight of protein standards (kDa) indicated to left
of each panel.
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Figure 4.3 Dot blots
Dot blots probed with either Morinaga anti-peanut IgG (left) or pooled peanut
allergic sera IgE (right). Dot blots were prepared by applying either 0.5 or 0.25 µL
of extracts of peanuts heated at 176 or 260 °C. Negative control was bovine serum
albumin heated at 260 °C for 8 hours and extracted while positive control was
directly applied Morinaga anti-peanut IgG.

4.5 Discussion
This study was designed to assess the persistence of peanut allergens after
excessive dry thermal processing, evaluate the fate of the individual major peanut
allergens, and examine the possibility for detection of peanut after extensive heating.
From a practical perspective, would peanut allergens survive in dry baking ovens for
extended time periods? And could peanut allergens potentially be removed by using high
oven burnout temperatures over extended time periods?
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Clear differences were observed in identifiable proteins present after roasting at
176 °C and 260 °C. Work by Fu et al. using commercial ELISA kits found that assays of
thermally processed peanut flours were hindered by decreased solubility and
immunoreactivity of target proteins [317]. A key difference between this study and that
of Fu et al. is that here we used a more robust, sequential extraction incorporating
zwitterionic chaotropic buffer while the previous study was limited to an ELISAcompatible heated PBS extraction. Even with more complete extraction, and multianalyte detection of proteins (with MS), quantitative detection of extensively heated
peanut allergens was not possible.
IgE binding of extracted peanut allergens was observed extending to 120 minutes
for peanuts roasted at 176 °C. Regardless of which bioinformatics method is used to
assess the presence of contiguous peptides, Ara h 1, 2, 3 and 6 peptides of sufficient
length to elicit IgE reactivity likely survive. Although estimates of minimum required
peptide length to elicit IgE reactivity vary, Huby et al. estimated that 30 residues were
sufficient for cross-linking [326]. After 120 minutes, IgE binding was not apparent.
Interestingly, this decrease corresponds with a conspicuous decrease in longest
contiguous peptide length, particularly with respect to Ara h 2. The ability to demonstrate
detectable peptide length after proteolysis may be a useful predictor of potential IgE
binding. It should be noted that IgE binding is not a biological measure of allergen
reactivity. Much additional work would be required to establish the existence of a useful
correlation between detectable contiguous peptides and clinically relevant reactivity in
different scenarios.
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Quantification of present residues demonstrated that robustly occurring peptides
were present in extracts of peanuts roasted at 176 °C, but not in extracts of peanuts
roasted at 260 °C. These peptides represented each of the major peanut allergens
including Ara h 1 and 3, which are regarded as becoming relatively less detectable after
thermal processing due to their tendency to denature and aggregate [327]. However, even
with chaotropic extraction conditions, Ara h 1 detection was most sensitive to thermal
processing, as has been observed previously [209]. The robust extraction method used
here likely contributes to detectable peptides leading to Ara h 3 acting as an abundant and
robust target. Further, in contrast to previous studies, we find that Ara h 1, 2, and 6
followed similar decreasing trends over time [328]. Continuous thermal processing can
break disulfide bonds and denature tightly packed albumins [329, 330]. In effect, this
may cause these allergens to extract similarly. Therefore, Ara h 3 represents an increasing
proportion of detectable protein after thermal processing.
IgE binding and peptide identifications decrease with increasing thermal
processing times and temperatures, but it is unclear what happens to the proteins and
peptides as they undergo thermal processing. Modifications are a potential reason for loss
of identifiable allergen peptides. Deamidation and pyroglutamate modifications may
function as processing biomarkers for evaluating the degree of processing [331]. Other
potential modifications including crosslinking, Maillard, and peroxidative adducts make
detection of residues more difficult as these products progressively react, degrade, and
differentiate. Nonenzymatic cleavage was observed in conjunction with pyroglutamatecontaining peptides commonly following Gln, Glu, Asn, and Asp residues, which are
known to cleave C-terminally [332, 333]. The only robust peptide identified from extracts
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of peanuts roasted at 260 °C was doubly non-tryptic flanked by Glu and Gln and this
peptide was not observed in extracts of peanuts roasted at 176 °C.
Allergenic peanut proteins clearly persist, even after extended heating, at typical
roasting (176 °C) conditions. Interestingly, even short periods of higher temperature (260
°C) are dramatically more effective at diminishing detectable allergen-derived peptides.
The robust, chaotropic, repeated extractions used in this study, combined with the
inherent capability of MS to detect many, diverse analytes, represents likely the most
comprehensive method for detection of peanut allergens in heated samples. However, the
failure of detection should not be regarded as absence of allergenic risk. We suggest that
biological or clinical models may be used to assess the reactivity of heavily thermally
processed allergens.
Current (e.g. ELISA) or even specifically designed MS detection methods are not
capable of reliably detecting heavily heated peanut residues. This is unlikely to change
using currently available technology. Care should therefore be taken in interpreting
allergen analysis after the possible introduction of heavily heated peanut material. We
suggest that the risk of product contamination by oven residue be controlled by cleaning,
as high temperature heating may be insufficient.
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CHAPTER 5: DETECTION OF FOOD ALLERGEN-DERIVED PEPTIDES
FROM EXTRACTIVE-BASED E-CIGARETTE LIQUIDS

5.1 Abstract
Background: E-cigarette liquids may be flavored using either synthetic flavors, or those
derived from plant material by extraction. Plant materials used for flavoring include
many known and potent allergens. Although proteins are not significant flavor
contributors to these liquids, the use of plant-derived flavors raises the possibility of
presence of protein allergens in the resultant flavors and therefore in the inhaled vapors.
The presence of such allergens may pose a risk of de novo sensitization or eliciting
existing allergies.
We investigated the possible presence of proteins in flavored vape fluids using SDSPAGE and protein mass spectrometry. Further, we estimate the risk that inhalation of the
observed levels of allergenic protein may pose to consumers.

Methods: Extractive-based E-liquids were purchased from online vendors based on
potential presence of plant-derived flavors. We selected apple, cherry, peach, almond,
coconut, hazelnut, pecan, and peanut brittle flavored liquids. Protein from E-liquids were
dialyzed, precipitated, and analyzed by SDS-PAGE with subsequent in-gel digestion and
LC-MS/MS, and by in-solution digestion and LC-MS/MS. Proteins were identified by
comparison to relevant sequence databases, and relative quantitation performed using
label-free quantitation.
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Results: SDS-PAGE analysis showed the presence of a single protein in almond, peach,
and coconut E-liquids. This protein was identified by LC-MS/MS as the basic subunit of
11S globulin (Pru du 6 in almond) in each case. Comparison of the observed allergen
concentration with VITAL®3.0 reference dose for almond of 0.1 mg of almond protein
(based on the reference dose established for hazelnut), and using conservative but
reasonable assumptions on dosing, suggests little risk in an ingestion scenario. However,
estimation of inhalation risk is more difficult. We describe potential routes for estimating
risk of inhalation of food allergens. Based on these assessments it is likely that some Eliquids pose a credible risk to food allergic individuals.

Conclusions: Some plant extract-based E-liquids likely pose a risk to allergic
individuals. We emphasize the difficulty in estimating this risk due to the different route
of exposure. We suggest that inhalation of proteins in E-liquids may also play a role in
sensitization. We suggest that such liquids should be clearly labelled to mitigate risk
posed to sensitized individuals.

5.2 Introduction
Electronic nicotine delivery systems (ENDS) are a common alternative to
cigarettes with an increasing proportion of young adults in the U.S. using ENDS with
rates between 6-9% [334], and of these a positive association between use of non-tobacco
and non-menthol flavors has been found with higher frequency and amounts consumed
[335]. A mixture of nicotine, propylene glycol, vegetable glycerin, flavorings, and other
ingredients, herein referred to as an E-liquid, are loaded into ENDS to be aerosolized and
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inhaled. Flavorings included in E-liquids can be synthetic or extractives, where
extractive-based E-liquids may include extracts of allergenic foods.
Food allergies affect approximately 10.8% of U.S. adults with symptoms ranging
from rhinitis to anaphylaxis [81]. The doses of protein required to elicit allergic reactions
can be as low as sub-milligram quantities [316]. Allergenic sources vary greatly in the
amounts of inhaled allergens to result in allergic disease [336], but inhaled allergic
responses tend to be less severe than responses to ingested allergens [337]. However,
aerosolized proteins pose a risk of sensitization through inhalation [338]. As yet there are
no cases in the literature reporting allergic reactions associated with ENDS use attributed
to proteinaceous material in E-liquid [339]. Allergic consumers of extractive-based Eliquids may be at risk for eliciting allergic reactions and both allergic and non-allergic
consumers may be at risk of de novo sensitization.
This study addresses the identification of food allergens present in extractivebased E-liquids. The quantity of allergenic proteins represents the potential risk and is
examined using quantitative mass spectrometry (MS). Use of MS allows for broad
identification of allergen-derived peptides without the need for specific antibodies that
may not be specific to the proteins present in the extractive-based E-liquids. The aim was
to determine if allergenic protein residues were present in extractive-based E-liquids and
evaluate the risks posed to allergic and non-allergic consumers.
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5.3 Methods and Materials
5.3.1 Samples and Chemicals
Tris, iodoacetamide (IAA), and rabbit glycogen phosphorylase B (GP; P6635;
Uniprot P00489.3) were obtained from Sigma (St. Louis, MO, USA). Trypsin (Pierce,
MS grade), 3.5 kDa molecular weight cut-off dialysis tubing (Snakeskin), and tris(2carboxyethyl)phosphine were obtained from Thermo Scientific (Waltham, MA, USA).
Dithiothreitol (DTT) was obtained from Arcos Organics (Geel, Belgium). Ammonium
bicarbonate (ABIC) was obtained from Honeywell Fluka (Charlotte, NC, USA). Acetone,
methanol, acetic acid, acetonitrile (ACN), and formic acid were obtained from Fisher
(Hampton, NH, USA). Precision plus ProteinTM Dual Xtra standards and Coomassie
R250 were obtained from Biorad (Hercules, CA, USA). NuPage LDS sample buffer,
Nupage MES SDS running buffer (20x), and 4-12% NuPage Bis-Tris gels were obtained
from Invitrogen (Carlsbad, CA, USA).
E-liquids were obtained based on either “may contains” labeling or marketed as
an extractive of an allergenic food and purchased without nicotine or propylene glycol to
simplify sample processing. The E-liquid flavors were labeled as green apple (apple),
cherry, peach, sweet almond (almond), coconut, hazelnut, pecan, and peanut brittle
(peanut). Of the E-liquids, peanut brittle was purchased from Vape Organics (Riverside,
CA, USA) and the remainder were purchased from Velvet Vapors (Tucson, AZ, USA).
The density of each liquid was measured three times and the mean reported.
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5.3.2 Sample preparation
For each E-liquid, 2 mL were dialyzed against 1 L of 50 mM Tris, pH 8 with
three changes of buffer. Dialyzed E-liquids were divided in half and up to 3 mL per
sample were used for acetone precipitation. Samples were precipitated by adding 4
volumes of acetone chilled at -20 °C and precipitated at -80 °C overnight. Samples were
centrifuged at 17,000 x g for 30 minutes at 4 °C and the pellet washed with 80% acetone
twice.

5.3.3 SDS-PAGE
Dried precipitated samples were prepared with 40 µL of SDS-PAGE sample
buffer with 50 mM DTT and 20 µL of each sample was fractionated. SDS-PAGE gels
were fixed with a solution of 50% methanol and 10% acetic acid for 1 hour and
visualized with Coomassie R250. Images were taken using a Kodak Gel Logic 440 Image
station (Kodak, Rochester, NY).

5.3.4 Mass Spectrometry
5.3.4.1 In-gel digestion
Protein bands were removed from the SDS-PAGE gel using a clean razor and
slices were fixed with a solution of 50% methanol and 10% acetic acid for 2 hours. The
gel slices were destained with 200 µL of destaining solution (50% ACN, 25 mM ABIC)
and incubated at 37 °C for 30 minutes while shaking, the destain removed, and the wash
repeated. Proteins were reduced with 30 µL of 50 mM tris(2-carboxyethyl)phosphine in
25 mM ABIC and incubating at 60 °C for 10 minutes. Proteins were alkylated with 30 µL
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of 100 mM IAA in 25 mM ABIC for 1 hour in the dark. Gel slices were destained twice
before shrinking with 50 µL of 100% ACN for 15 minutes and air drying for 10 minutes.
Proteins were digested by adding 10 µL of 10 ng µL-1 trypsin in 25 mM ABIC and 15
minutes later adding 25 µL of 25 mM ABIC before incubating at 37 °C overnight. The
slices were votexed, 30 µL of supernatant removed, and 1.6 µL of 100% ACN added.

5.3.4.2 In-solution digestion
In-solution digestion of acetone precipitated pellets was preformed according to
Palmer et al. [285]. Briefly, pelleted proteins were reduced with DTT for 5 minutes at 95
°C, alkylated with IAA for 20 minutes in the dark, and digested twice with trypsin first
for 3 hours at 37 °C and then overnight at 30 °C.

5.3.4.3 Preparation for mass spectrometry and running parameters
Digested peptides were cleaned, and MS was performed as previously described
with modifications [285]. Briefly, digests were cleaned using Pierce C-18 Spin columns
(Thermo Scientific), the eluate dried, and dried in-solution digests and in-gel digests
resolubilized in 20 and 30 µL, respectively, of 5% ACN and 0.1 % formic acid. Prior to
injection, 1 µL of 500 fmol µL-1 GP was added to 9 µL of each sample and 2 µL were
injected into a Thermo Q Exactive Plus™ Hybrid Quadrupole-Orbitrap™MS coupled to
UltiMate 3000RSL® liquid chromatography (UPLC) system (Thermo Scientific™).

5.3.4.4 Data Analysis
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Data was analyzed using PEAKS 8.5 (Bioinformatics Solutions Inc., Waterloo,
ON, Canada) against a concatenated database including Arachis hypogaea, Carya
illinoinensis, Cocos nucifera, Corylus americana, Prunus avium, Prunus dulcis, Prunus
persica, Malus domestica, and GP (Uniprot, 225786 sequences, accessed 08/11/2020)
with a contaminant database (thegpm.org, accessed 08/11/2020, version last modified
03/03/2019) [286]. PEAKS search parameters were 5 ppm mass error tolerance, 0.05
fragment mass error tolerance, fixed carbamidomethylation of cysteines, and the protease
set to no enzyme or trypsin with up to 3 missed cleavages. PEAKS searches were further
analyzed with a post-translational modification (PTM) search including up to 3 variable
modification per peptide from a curated list of 336 possible modifications including a
base list of 312 PTMs provided by peaks [340]. Peptide false discovery rate (FDR) was
set at 0.1% and protein identifications required a -10lgP score of ≥30, at least two
peptides identified, and at least 1 unique peptide. Identified peptides underwent BLAST
searches (Uniprot.org) to verify their species of origin. For quantitation, data were
normalized via the top three GP peptides and proteins were quantified according to the
top three peptides if possible.

5.3.5 Risk assessment
Protein identifications and quantifications were compared with literature values
and utilized assumptions to evaluate the allergic risk to consumers.

5.3.5.1 Food allergen risk assessment
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Assumptions and literature values used for food allergen risk assessment are
presented in Table 5.1. Exposure doses were calculated from the concentration of
proteins identified, the hourly rate of E-liquid consumption, a maximum time limit to
accumulate the dose, and a safety factor. Per allergenic source, exposure dose was
compared to reference doses to determine if the risk of eliciting an allergic reaction was
present.

5.3.5.2 Respiratory allergen risk assessment
Assumptions and literature values used for respiratory allergen risk assessment
are presented in Table 5.2. A framework and associated experiments from Costigan et al.
was utilized incorporating a generalized derived minimum-effect level established for
enzyme protein respiratory allergens and a safety factor but without adjustment for
enzyme content instead substituting total quantified protein content [5].

5.4. Results
5.4.1 Visualization of present proteins
Coomassie staining was performed to evaluate the presence of proteins in Eliquids. Samples were dialyzed and precipitated with the relationship of used volumes to
original volumes as seen in Table 5.3. Visualization of samples via SDS-PAGE (Figure
5.1) demonstrates the presence of proteinaceous matter in the almond, coconut, and peach
E-liquids as a band between 20 and 25 kDa, which was of identical among the three
samples. The bands were excised for later in-gel digestion and analysis by MS.
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Table 5.1 Literature values and assumptions used in food allergen risk
assessment of E-liquids
Literature values

Associated
value(s)

Reference(s)

Reference dose of
ingested almond
protein

0.1 mg total
almond protein

[6, 7]

Prunin fraction of total
almond protein

Total almond
protein is 70%
prunins

[9, 10]

High end of published
E-liquid consumption

30 mL day-1

[11, 12]

High end of published
ENDS aerosol
collection efficiency

91%

[13]

Assumptions

Associated
value(s)

Rationale

Maximum duration of
dose accumulation

2 hours

Excessive time to have
inhalation rates correspond to
elicitation via ingestion

Perfect transfer of
dose from E-liquid

100%

Limitations of literature on
transfer of protein through
ENDS systems

Average waking day
for an adult to
consume E-liquid

16 hours day-1

8 hours of sleep per night

Total safety factor

100

Limitations of study and
uncertainty of relationship of
eliciting dose via inhalation
compared with ingestion
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Table 5.2 Literature values and assumptions used in respiratory allergen risk
assessment of E-liquids
Literature values

Associated
value(s)

Reference(s)

Transfer ratio of cocoa shell
extract proteins from Eliquid to filter pads

1 / 12,500,000

[5]

Proposed highest tolerable
derived no effect level for
enzyme respiratory allergens

15 ng m-3

[8]

Prunin fraction of total
almond protein

Total almond
protein is 70%
prunins

[9, 10]

Safety factor for efficient
lung delivery

10

[5]

Assumptions

Associated
value(s)

Rationale

Cocoa proteins aerosolize
from E-liquid equivalently to
almond proteins

Required to substitute
quantified protein values

Total protein reported as
ppm - mg protein per liter Eliquid

Conservative assumption to
maximize theoretical
aerosolized allergenic dose

E-liquids assessed in
Costigan et al. 2017 are
equivalent to those assessed
here

Required to substitute
quantified protein values

Silver stained SDS-PAGE
and standard BSA accurately
reflect transferred protein

Required to substitute
quantified protein values
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Table 5.3 E-liquid properties and volumes analyzed by SDS-PAGE and Mass
Spectrometry

#
1

Sample
Green
apple

Postdialysis
volume
(mL)

% acetone
precipitated

Equivalent
mL digested
for MS

Equivalent
mL on SDSPAGE

Density
(g mL-1)

4

100

1

0.5

1.1995

2

Cherry

3

100

1

0.5

1.1692

3

Peach

7

83

0.83

0.415

1.1905

5.5

100

1

0.5

1.1914

6.5

89

0.89

0.445

1.2027

4
5

Sweet
almond
Peanut
brittle

6

Coconut

6

100

1

0.5

1.1521

7

Hazelnut

7.5

83

0.83

0.415

1.1246

8

Pecan

7.5

83

0.83

0.415

1.1502
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Figure 5.1 SDS-PAGE gel of E-liquids

Dialyzed and acetone precipitated E-liquids visualized using SDS-PAGE and
Coomassie stain with lanes as follows: (L) molecular weight standards, (1) green
apple , (2) cherry, (3) peach, (4) sweet almond, (5) peanut brittle, (6) coconut, (7)
hazelnut, and (8) pecan.
5.4.2 Assessment of Data Sets and Peptide Assignments
To identify proteins present in the E-cigarette liquids, the samples were
proteolytically digested and analyzed by MS. Data was initially assessed with protease
set to no enzyme or trypsin both with secondary PTM searches, but initial assessment
found that compared to the tryptic search without additional PTM search that the
remainder had inferior peptide or protein identifications without significant
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improvements in the breadth of data added and so only the base tryptic search was
utilized. Identified peptides were scrutinized by individual BLAST searches on Uniprot
to verify their origin. Peptides identified in almond E-liquid were attributable to P. dulcis
and peptides identified in peach and coconut E-liquids were attributable to either P.
dulcis or P. persica. Other species hits per peptide did not reach an alternative consensus
species of origin.
Of the samples, only almond, coconut, and peach had at least 2 peptide matches to
a single protein within a single MS injection and so the remaining samples were
disregarded from further analysis. Coconut did not meet peptide identification criteria via
in-solution digest but did meet criteria via in-gel digest and so was included for analysis.
Among the remaining samples, a total of 14 peptides were identified (Appendix G Table
5.1) and quantified (Appendix G Table 5.2)
Peptide spectra matched across injections for peptides that were identified in
multiple injections (Appendix G Figure 5.1). Overall, two peptides identified from
almond were identified both in-solution and in-gel, but only one peptide from peach
overlapped between in-gel and in-solution digests, and further no peptides overlapped
between digests from coconut. Of specific peptides that matched across injections,
[GNLDFVQPPR] was identified in both the in-solution digests of almond and peach but
in neither in-gel digest. [TEENAFINTLAGR] was identified in each of the in-solution
digests of almond, coconut, and peach as well as the in-gel digest of peach but was not
identified in the in-gel digest of almond or coconut. Both [ADIFSPR] and
[QETIALSSSQQR] were identified in each of the three in-gel digests of almond,
coconut, and peach as well as the in-solution digest of almond. Only
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[ALPDEVLANAYQISR] was not likewise identified in the in-solution almond digest;
however, this peptide identified in the in-gel peach digest without identified in the insolution digest.

5.4.3 Identification of proteins present in E-cigarette liquids
Proteins identified among all samples were attributable to two protein groups
headed by Q43607 and A0A5E4FK23 (Appendix G Table 5.3), which both are
themselves or contain proteins with descriptions regarding the almond allergen Pru du 6.
Only the almond in-solution digest identified the protein group A0A5E4FK23, whereas
all remaining samples identified Q43607. Peptide matches from in-solution digests of
almond and peach spanned the length of Pru du 6 whereas in-gel digests from almond,
coconut, and peach exclusively had peptides representing the basic chain of Pru du 6
proteins

5.4.4 Quantification of proteins and evaluation of the risk of eliciting allergic
reactions
Quantified protein groups are presented in Table 5.4. For use in risk assessment,
protein quantifications from in-gel digests were not used due to lack of identifications
from both basic and acidic chains of Pru du 6 proteins. For protein group Q43607, the
annotated signal peptide was ignored, and the molecular weight of the mature protein
used to determine a concentration of 2.30 and 136.56 ng mL-1 present in peach and
almond E-liquids, respectively. For protein group A0A5E4FK23, the signal peptide was
not well annotated for any proteins within the group and so Q43608 was used with the
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end of the signal peptide inferred from identity to Q43607 to determine a concentration of
4.40 ng mL-1 present in almond E-liquid and a summed protein concentration of 140.96
ng mL-1 prunins or 201.37 ng mL-1 total almond protein. The peach E-liquid protein
quantification was not similarly converted due to unclear protein origin. According to
food allergen risk assessment, the exposure doses were calculated as 687.17 ng and 7.84
ng for almond and peach E-liquids, respectively, and both were under the safety factor
adjusted reference dose for almond of 1 µg. For respiratory allergen risk assessment, the
exposure doses were calculated as 16.110 ng m-3 and 0.184 ng m-3 for almond and peach
E-liquids, respectively. Compared to the safety factor-adjusted reference dose of 1.5 ng
m-3, almond E-liquid exceeded the reference whereas peach did not.

Table 5.4 Protein quantification using mass spectrometry

In-solution digest
In-gel digest
(fmol)
(fmol)
Accession
Almond Coconut Peach Almond Coconut Peach
Q43607
201.89
0.00
2.82
28.33
19.53
19.56
A0A5E4FK23
7.09
0.00
0.00
0.00
0.00
0.00

Mature
molecular
mass
(Da)
60874.45
55890.21

5.5 Discussion
This study sought to assess the presence of proteins present in a variety of
extractive-based E-liquids, possible biological activity, evaluate their quantity, and
examine the risk posed. In other words, are allergenic proteins present in extractive based
E-liquids? And do these proteins pose a risk to allergic consumers?
Peptides representing Pru du 6 or a nearly identical homologue were identified in
almond, peach, and coconut E-liquids. In decreasing order of both evidence and quantity
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were almond, peach, and coconut. Both digests of almond confirmed the presence of
almond peptides, peach identified either almond or peach peptides but was confirmed by
both digests, but coconut only identified either almond or peach peptides by SDS-PAGE
and corresponding digestion. The peptides identified in peach digests may have
originated from peach, but this is unclear as seed storage proteins of genus Prunus are
highly identical [341]; however, protein databases for species other than P. dulcis or P.
persica are relatively small and are not similarly representative. The source of the almond
peptides present in the coconut E-liquid is less clear, but we speculate that either the
almond flavoring was mixed with coconut in preparation of the E-liquid or cross-contact
of the flavoring itself or during mixing.
Each of the sequences identified are potentially allergenic as they have been either
been themselves regarded as an allergen or nearly identical (>96%) to a known allergen.
SDS-PAGE and its associated digestion of each of almond, peach, and coconut identified
the presence of the basic subunit of Pru du 6 without accompanying acidic subunit [342];
however, in-solution digests of almond and peach did simultaneously identify both
subunits. Linear epitopes have been identified across both subunits of Pru du 6 isoforms
[343], as well as conformational epitopes to recombinantly produced whole or either
independently produced subunit [344]. Peptides were identified for almond and peach
that in-part encompassed epitopes and so the protein, if present in part or whole, may
have the capacity to elicit allergic responses.
Inhalation of almond proteins, as opposed to ingestion, is atypical and not well
documented in literature; therefore, risk was evaluated through both food allergen and
respiratory risk assessments. As food allergens, assumptions were made such as
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excessive E-liquid consumption as observed in a subset of ENDS users using heating
coils rated to less than 1 Ohm of resistance [345], which can produce greater amounts of
aerosol compared to conventional ENDS. These assumptions in factor of gross
accumulation of allergenic protein did not permit a determination of risk of elicitation in
allergic consumers. Alternatively, as respiratory allergens the primary assumptions were
to allow substitution of observed total protein values to produce total aerosolized protein
and therefore dose, which were weighed against the choice of threshold. Use of the
highest proposed derived no effect level was still low enough to identify almond E-liquid
as a sensitization risk, but not the peach E-liquid; however, Basketter et al. also reported
levels for safe use of other respiratory sensitizers as low as 0.01 ng m-3 (1500x less than
the generalized threshold used) [8], therefore the peach E-liquid may still pose a risk of
de novo sensitization to consumers.
Food allergen aerosols have been assessed for egg [346], fish [347], and peanut
[348], as well as wheat in the form of bakery dust [336]. Parallels can be drawn between
extractive-based E-liquids and wheat allergies as those with oral wheat allergy commonly
also have reactions to inhaled wheat [349], whereas those with inhaled wheat allergy are
commonly observed to be tolerant to ingested wheat [350]. This divergence has been
speculated to be due to differences in the epitopes where inhaled allergy to raw flour
would utilize epitopes, likely conformational, that are not well represented in cooked
wheat-based foods [349]; however, many of the same allergenic proteins implicated in
oral wheat allergy have also been implicated in inhaled wheat allergy [351]. As the Eliquids are directly inhaled it is likely that any proteins present in the E-liquid would pose
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a risk of sensitization although the sensitization is likely specific to the inhaled
aerosolized proteins as opposed to ingested food.
Beyond proteins, the ENDS itself may also be involved in allergic sensitization.
The size of particulate matter influences the immune response, where fine particulate
matter (0.1 – 2.5 µm) tends to encourage Th2 responses [352], and most of the aerosol
produced by ENDS fall within this range [353]. Large proportions of the vapor produced
by ENDS are of the size to penetrate the tracheobronchial and bronchoalveolar regions of
the lung [354], and such particulate matter has been associated with the development of
asthma, particularly those with atopy [355]. Aerosolized E-liquid itself has been found to
be proinflammatory [356], which constitutes an impaired barrier for allergic sensitization
[357]. Use of extractive-based E-liquids is likely to encourage allergic sensitization to
proteins present from the extract.
This work was designed as an initial investigation and therefore individual
techniques were not well replicated, but rather used in tandem to identify proteins present
in E-liquids. Inclusion of further extractive-based E-liquids, controls per allergenic food
source, as well as replication is required to further establish the risk posed. Further
controls regarding ENDS in terms of design, aerosolization temperatures, power, and a
standardized protein-containing E-liquid are required to correlate allergen presence in Eliquids to dose inhaled. Lastly, biological testing is needed to establish the effects of
inhaling these allergenic proteins on de novo sensitization as well as elicitation of current
allergies.
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CHAPTER 6: LITERATURE-BASED RISK ASSESSMENT OF ACTIVATED
CARBON MADE FROM WALNUT HULLS FOR USE IN WATER
PURIFICATION SYSTEMS

6.1 Summary
Activated carbon (AC) is a common material in water purification, which can be
made from various materials including walnut hulls. Unprocessed walnut hulls contain
several hazards including food allergens, naphthoquinones, and ellagitannins. When
properly processed, the present hazards are expected to be rendered inert to make the
resultant AC not a significant risk to consumers.

6.2 Background
AC is a porous material with a high surface area with multiple uses including the
purification of drinking water and is often used in sequence with several other materials,
where AC is included for its ability to adsorb organic compounds [358-360]. Production
of AC proceeds though dehydration, pyrolysis, and carbonization using high heat and is
subsequently activated by using hot steam, acid, base, or salt [360, 361]. AC is made
from carbonaceous materials such as walnut shells, coconut husks, wood, or coal [358,
362, 363]. Walnut hulls are a byproduct of walnut shelling and can be used as a potential
value-added source material for the production of AC. Walnut hulls form the outer husk
around the shells and kernels and do not have a principal use beyond production of
animal feed, applications as a dye, or as an herbal medicine [364-367]. In the U.S. there
are two walnut species of economic importance: Juglans nigra, the Eastern black walnut,
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and Juglans regia, the English walnut [368]. Walnuts contain a number of hazards such
as food allergens and toxins, which may contaminate walnut hulls and may persist
through processing [369, 370].

6.3 Activated Carbon Processing
Production of AC uses heat to cause dehydration, pyrolysis, graphene nucleation,
and carbonization via heating at or above 600 °C under an inert atmosphere to increase
the solid carbon content to more than 90% [361]. During carbonization solid, liquid, and
gaseous byproducts are formed and can be separated to leave only carbonized biochar
[371, 372]. Afterwards, the biochar is activated either by chemical means by adding
inorganic acids, bases, or salts and heated for hours above 300 °C or alternatively by
physical means using oxidizing gasses such as steam above 800 °C [360, 361, 373-375].
Diffusion of oxidizing agents into the biochar breaks the aromatic carbon structure and
increases the porosity and surface area of the carbon [375]. For lignocellulosic biomass
above 250 °C and up to 350 °C pyrolysis and depolymerization of cellulose occurs, above
350 °C aromatic carbon is seen with growing graphene sheets, and above 600 °C the
remaining non-carbon is expelled and the graphene structures coalesce to form the
carbonized matter [361]. As Ioannidou et al. has explained, AC is often heated for
excessive amounts of time (1-8 hours) at temperatures exceeding 600 °C, optimized per
material, and this allows the assumption that the heating is homogenous across the
biochar and has undergone both pyrolytic and carbonization temperatures [376].
Activated carbon itself is a minor hazard, particularly powders due to
combustibility, and it can also be an irritant. As an irritant it does have exposure limits,
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however oral rat studies have shown that the LD50 was >10,000 mg/kg indicating that it
is a minimal hazard because it is likely that a human would either see or taste the AC in
the water prior to being able to consume enough for it to be a major health hazard [377,
378]. However, AC is not intended to become part of the product, rather it is a foodcontact surface [379]. Therefore, if AC were continuously seeping into the water it was
purifying that would be a major defect of the water purifier or a mistake of the granularity
of the AC supplied. From this, AC itself is neither a likely or harmful hazard.

6.4 Allergenic Hazards of Walnut Hulls
Walnuts are a major allergen and part of eight classes of allergenic foods that
comprise 90% of US food allergies as designated by the Food Allergen Labeling and
Consumer Protection Act of 2004 [204]. Tree nuts can cause IgE-mediated reactions with
symptoms ranging from oral allergy syndrome to anaphylaxis and are a major source of
food allergy related fatalities [380, 381]. Among tree nuts, walnut allergy is the most
common [382]. Allergic cross-reactivity can be seen across walnut cultivars and across
tree nuts [383, 384]. Walnut hulls contain approximately 15% protein by dry wright
[385]. Threshold doses for the walnut allergic population to have an allergic reaction
have been determined such that 3.1 mg of walnut protein would be sufficient to cause an
allergic reaction in 5% of the walnut allergic population (ED05) [386]. Assuming a soldier
drinks 11.4 liters of water per day, a protein concentration of 0.28 µg/mL would be
theoretically meet the ED05 for walnut allergic individuals while holding the overconservative assumptions that all walnut proteins are equivalent and that an allergic
reaction could be elicited by accumulation across an entire day [387].
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6.5 Effects of Thermal Processing on Allergens
Allergenic proteins elicit symptoms through a pair antibody binding epitopes on
the protein, which are either bound to a conformational or linear epitope of the allergen
[70]. Therefore, both unfolding and destruction of peptide bonds are necessary to
eliminate allergenic potential. Protein denaturation temperatures vary by protein but can
occur as high as 108 °C [388]. Protein pyrolysis and decomposition occur above 200 °C
with volatile nitrogenous decomposition continuing through 400 °C [388, 389].
Thermogravimetric analysis has been applied to peptides [390], milk [391],
collagen [392], and microalgae [393] to show at what temperatures that gross
decomposition of proteins occurs. Amino acid decomposition has been found to follow
first-order rates [394]. Synthesized peptides were largely found to represent proteins
where temperatures below 200 °C evaporated surrounding water and between 200 °C and
500 °C degraded the peptides through decarboxylation, deamination, and
depolymerization with rate maxima at 235 °C and 299 °C [390]. Camel and cow’s milk
were indicated to have combined degradation of protein and fat around 380 °C [391].
Collagen decomposition has been indicated to occur between 220 and 380 °C with
maximum rates between 285 and 300 °C with combustion occurring at 350 °C [392].
Another investigation of collagen found that through 100 °C absorbed water is
evaporated and between 280 °C and 400 °C bound water is released [395]. Modeling
theoretical thermogravimetry of microalgae has demonstrated that protein largely degrade
upon heating to 350 °C [393]. However, decomposition has been found to proceed at a
lower rate than hydrolysis and therefore hydrolysis can be expected to occur first [396].
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Destruction of peptide bonds has been investigated in terms of spontaneous
hydrolysis. Hydrolysis of peptides has been found to be a first-order process and has been
calculated to have a half-life of approximately 6 minutes at 250 °C and neutral pH [396].
Although pH can affect the rate of hydrolysis, the rate only increases in acid or alkali
[397]. The minimum length of peptide needed to elicit clinical symptoms has been
suggested to be as little as 29 amino acids long [398]. Under the aforementioned
conditions, it would theoretically take 66 minutes to reduce titin (approximately 35,000
residues) to having no peptides over 29 amino acids. Properly processed AC is unlikely
to have sufficient epitopes nor free amino acids remaining to cause allergic reactions,
even if processed at relatively low temperatures.

6.6 Allergen Labeling of Activated Carbon Derived from Walnut Hulls
The Federal Food, Drug, and Cosmetic Act in the U.S. under section 409 (h)
states “the term ‘food contact substance’ is any substance intended for use as a
component of materials used in manufacturing, packing, packaging, transporting, or
holding food if such use is not intended to have any technical effect in such food” [204].
The Food and Drug Administration has also clarified that AC is a food-contact substance
as defined in section 409. Lastly, because the Food Allergen Labeling and Consumer
Protection Act in the U.S. section 403 (w) requires labeling of products with ingredients
that contain tree nuts it would typically require labeling of products made after use with
the AC, however because by definition the carbon cannot become part of the food itself,
it is not an ingredient and not subject to allergen labeling [204].
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6.7 Chemical Hazards of Walnut Hulls
Walnut hulls contain a number of phenolic compounds including ellagitannins
and 1,4-naphthoquinones [399, 400]. The ellagitannin ellagic acid has been described as
being present in walnut kernels up to 18% by dry weight and the 1,4-naphthoquinone
juglone has been described as being present in walnut hulls up to 1.5% by dry weight
[400-402].
Walnut hulls contain several similar 1,4-naphthoquinones including juglone,
plumbagin, and 1,4-naphthoquinone. Naphthoquinones, including juglone and
plumbagin, are known to be cytotoxic whereby they will bind DNA and inhibit
replication, inhibit enzymes, and disturb membranes and are able to reduce cell viability
in vitro at a concentration of 1 µM [403, 404]. Lawsone, an isomer of juglone, has an
identified no-observed-adverse-effect level (NOAEL) of 2 mg/kg which corresponds to
an acceptable daily intake of 1.4 mg for a 70 kg individual and assuming a soldier’s water
intake of 11.4 L/day we find that 0.12 µg/ml or 130 ppb of total 1,4-naphthoquinones can
be in the water and not be expected to be harmful [387, 405]. Data for decomposition
temperatures are not available for juglone, however it is noted that it sublimes at 155 °C
and therefore could be removed with the volatile gasses during production [406].
Similarly, plumbagin melts at 76 °C and 1,4-naphthoquinone melts at 121 °C, which
generally indicates that the class of 1,4-naphthoquinones present could be separated out
from the biochar and not be present in the produced AC [407, 408].
Walnut hulls also contain a number of ellagitannins including ellagic acid [400,
409]. Ellagic acid has been subject of a 90-day sub-chronic oral rat (F344) study and
showed that female rats had a NOAEL level of 3254 mg/kg while male rats were
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estimated to have a no-observed-effect level of 3011mg/kg (NOEL) where the only major
effect was a decrease in female bodyweight and no changes in histopathology were
observed [409, 410]. Using the NOAEL for ellagic acid, we can derive an ADI of 2278
mg/day for a 70 kg individual and taking a soldier’s maximum daily water intake of 11.4
L/day then we find that 0.2 mg/ml or 200 ppm of ellagic acid can be in the water and not
be expected to harmful [387]. However, this assumes that ellagic acid is not removed or
destroyed by heating. Ellagic acid melts at 300 °C, so this compound could be separated
from the biochar and not be present in processed AC [411].

6.8 Conclusions
Use of walnut hulls to make AC is not a significant risk provided that the hulls are
processed to at least 400 °C with a holding time to result in nitrogenous decomposition.
Through a heating of this magnitude, allergenic and chemical hazards will have been
destroyed or removed as liquids or gasses such that no significant hazards will be present
from the walnut hulls. Therefore, if AC made from walnut hulls is produced to the
standard of a food-contact substance, it is unlikely to contain any significant risks.
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CHAPTER 7: LITERATURE-BASED RISK ASSESSMENT OF ALLERGENS IN
SMOKE DERIVED FROM TREE NUT WOOD

7.1 Summary
Smoking is a time-tested means to preserve food as well as improve flavor. Wood
used for smoking includes wood from trees that produce tree nuts, which may pose a risk
to tree nut allergic individuals. Due to differences in protein profiles between wood and
tree nuts there is no demonstrated presence of tree nut allergens in the wood. Tree nut
wood smoke is not a significant source of allergic risk.

7.2 Background
Smoke is an aerosol emitted upon combustion or pyrolysis of a material and is
composed of water, gasses, and particulate matter [412, 413]. Wood smoke has desirable
effects on food including color, flavor, and has antioxidant and antimicrobial effects
[414]. Common woods for smoking include mesquite, fruitwood (e.g. apple, cherry), and
tree nut wood (e.g. pecan, hickory) [415]. In this work, “tree nut wood” refers to wood
derived from trees that produce tree nuts defined as major food allergens by the Food
Allergen Labeling and Consumer Protection Act of 2004 with further clarification by the
U.S. Food & Drug Administration: almond, beech, Brazil, butternut, cashew, chestnut,
chinquapin, coconut, hazelnut, ginko, hickory, lichee, macadamia, pecan, pine, pili,
pistachio, shea, and walnut [204, 416]. Tree nuts are part of the eight classes of allergenic
foods that comprise 90% of U.S. food allergies and the presence of which in food must be
labelled [204]. Tree nuts can cause IgE-mediated reactions with symptoms ranging from
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oral allergy syndrome to anaphylaxis and are a major source of food allergy related
fatalities [380, 381]. It is unclear if the use of tree nut wood to produce smoke is a risk to
tree nut allergic individuals.

7.3 Wood, Trees, and Logging
Wood is formed from the secondary xylem of woody plants [417]. The wood and
bark are segregated by the vascular cambium, which wraps around the secondary xylem.
Bark is then all tissues surrounding the vascular cambium including the phloem. Wood is
predominantly formed from cellulose, hemicellulose, lignin, and extractives that include
a number of classes of compounds such as flavonoids, isoprenoids, and tannins [418].
Trees are divided into angiosperms and gymnosperms called hardwoods and softwoods
respectively [419]. These differ in their lignin, hemicellulose, bark thickness, and
seasonal senescence and abscission of foliage. Hardwood lignin subunits have a single
methoxyl group as opposed to two of softwood, both have the hemicellulose xylan but
hardwoods lack galactoglucomannan, hardwood bark tends to be thinner, and hardwoods
tend to lose their foliage seasonally.
Members of the genus Populus are hardwoods that are regarded as model trees
[420-422] and includes poplar, aspen, and cottonwood species [423, 424]. In Populus,
nitrogen in the tree varies seasonally and is stored in the form of proteins and free amino
acids principally as arginine, glutamine, and asparagine [425]. In autumn, leaf proteins
are broken down and amino acids are transported to bark and wood to produce bark
storage proteins. In spring, bark storage proteins are broken down and moved to
reproductive tissues, buds, and leaves. Amino acids have been regarded as a major means
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of nitrogen both storage and transport in Populus [426], but also peach trees [427]. In
peach trees, total nitrogen and soluble protein in wood is low and seasonally stable
whereas the bark stores most of both nitrogen and soluble protein. Wood soluble protein
was found to be approximately 1 mg.g-1 dry weight year-round whereas phloem soluble
protein ranged from approximately 5 and 25 mg.g-1 dry weight varying by season.
Broadly, the nitrogen content of wood has been found to vary among tree species, has
been found to be generally proteinaceous, and a sampling of a variety of trees were found
to average approximately 0.1% nitrogen in wood [428]. The protein composition of wood
is not similar to that of nuts, with woods lacking seed storage proteins associated with
commonly consumed plant parts [429-431].
Processing wood for smoking begins with standing trees. Trees are felled and they
may optionally undergo limbing and bucking where the whole trees have their limbs
removed and are then segmented into logs respectively [432]. If limbed, the branches are
predominantly left by the stump and so not used [433]. Logs may then be debarked and
either used as is or processed into wood chips [432]. Wood chips and sawdust are also
obtained as byproducts of processing lumber [434]. Both wood chips and sawdust are
commonly used in industrial smoke production [435].

7.4 Industrial Smoke Production, Processing, and Usage
The type of wood, temperature of burning, and method of burning can alter the
qualities of resultant smoke [436]. Hardwoods are preferred over softwoods to produce
smoke as softwoods contain higher levels of resin acids causing the smoke to impart
more soot and acidic flavor [437]. Hardwood typically consists of 40-60% cellulose and
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20-30% of hemicellulose and lignin each where the balance of these primary components
affects the pyrolysis product balance of the smoke. The specific wood used for smoking
can alter the color and flavor imparted on the food [435], but the smoke composition can
also vary with the temperature and availability of oxygen [438].
Upon heating, the wood will dry up to 170 °C and hemicellulose, cellulose, and
lignin generally undergo pyrolysis between 200-260 °C, 260-320 °C, and 310-500 °C
respectively [414, 437]. The desirable products stem from both primary pyrolysis and
secondary breakdown of primary products. Incorporation of some oxygen during
smoldering is important to high quality smoke as oxygen assists with secondary reactions
[414]. Temperatures that are too low will not efficiently smoke whereas too high
increases production of toxic polycyclic aromatic hydrocarbons [413]. However, if the
wood is allowed too much oxygen at high enough temperature, then self-sustaining
combustion or self-ignition of wood can result [439, 440], which results in a loss of
consistency as well as quality.
Industrial production of smoke most commonly uses smoldering generators where
a tray is heated to around 350 °C, fed either wood chips or sawdust, and sustained with
air blown from underneath to feed oxygen, control temperatures, and prevent selfsustaining combustion [435]. The temperature of the wood varies according to the
temperature of the plate, air flow, and the size of the wood used. The wood is often added
continuously, so keeping the wood in a particular shape (e.g. cone) maintains a constant
air flow to wood surface area to improve the consistency of the smoke and further hinder
self-ignition [437].
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Alternative smoke generators include friction generators and steam condensers.
Friction generators grind wood against a rotating barrel for short bursts resulting in
contact temperatures up to 380 °C [441]. Steam condensers pass sawdust into overheated
steam held between 300 and 450 °C to generate smoke, which is subsequently cooled
[413].
Uses of produced smoke can be divided into direct smoking, where emanating
smoke is used on exposed product, or indirect smoking, where smoke is passed though
water, distilled, refined, and concentrated and applied as a dip or mist [437]. Direct
smoking can be separated into hot smoking, where products are smoked while cooked, or
cold smoking, where the products are smoked without cooking [436]. Indirect smoking
aims to reduce tar and soot content through washing and filtration steps as well as
concentrating desirable flavor [414]. Smoke produced by passing it through water as in
indirect smoking is referred to as liquid smoke. Cooling and condensing the water can be
used with distillation or gravity to induce phase separation into oily resin, water soluble,
and water insoluble phases [437]. The water soluble and insoluble phases can be then
used as source materials for functional compounds to produce liquid smoke depending on
product identity and desired qualities.
Liquid smoke can be further processed into a dry powder either by plating or
spray-drying [442]. Plating uses a carrier molecule to embed a liquid flavor onto a solid
carrier such as salt, lactose, starch, or maltodextrin. Spray-drying incorporates the liquid
flavor and solid carrier into a slurry and atomizes the mixture where volatiles and water
evaporate.
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7.5 Smoke as a Medium for Allergen Transport
Although a number of tree nuts have been investigated, many do not have
quantitative data regarding eliciting doses that cause reactions [443]. In light of this,
hazelnut has been suggested as a placeholder for tree nuts in these cases. The reference
dose for hazelnut via quantitative risk assessment was set at 0.1 mg of hazelnut protein
based from the eliciting dose of 1% of the population (ED01), where this reference dose
was set to protect 99% of the allergic population from objective reactions [316].
Inhalant allergens have been identified in the cedar wood (Juniperus ashei),
however allergens were not identified in wood smoke by SDS-PAGE, cedar-pollen
sensitive IgE, nor monoclonal antibody [444]. Mesquite wood smoke (genus Prosopis)
has been investigated using SDS-PAGE and IgE immunoblots using sera from mesquitepollen SPT positive and self-reported mesquite-smoke-sensitive patients [445]. From an
undescribed quantity of mesquite smoke passed through water and concentrated, More et
al. identified protein bands by SDS-PAGE and immunoreactive bands were found in both
sets of sera. This indicates that some amount of proteins and allergens from wood can be
aerosolized and retain reactivity.
The largest body of work regarding smoke, its composition, and effects on
humans has been though tobacco cigarettes. In a study by Becker et al., an 18 kDa
glycoprotein was purified from cured tobacco leaves and injected to a mix of smoker and
non-smokers and demonstrated positive skin tests in a subset of both groups [446]. The
purified protein was analyzed by polyacrylamide gel along with extracts purified
similarly but starting with either cigarette smoke condensate (tar) or cigarette smoke
saline (cigarette smoke passed through phosphate-buffered saline). The purified proteins
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were found to be similar according to hemagglutination inhibition assay and were also
cross-reactive. Similarly cross-reactive proteins were also found to be present in other
members of Solanaceae including eggplant, green pepper, potato, and tomato. In the tar,
the concentration of the protein was found to be between 1.8 and 3.6 mg/g and was used
to extrapolate a range of 720 and 1440 µg of antigen per packet of 20 cigarettes assuming
20 mg of tar per cigarette. Concentration of antigen in cigarette smoke saline was not
determined. This study suggests that a quantity of proteins can be found and purified
from smoke and therefore smoke can act as a medium for allergen transport. Neither the
degree of transport relative to source material nor how ubiquitous the aerosolization is
across proteins is not addressed.
A study by Voisine et al. investigated the transfer of protein into tobacco smoke
using cigarettes spiked with the subtilisin enzyme savinase [447], where subtilisins are
used as detergent enzymes known to aerosolize and cause IgE-mediated allergy [448].
Savinase was detected by immunostaining method allowing detection of savinsae transfer
down to 0.009% in mainstream smoke (directly smoked) or 0.054% in sidestream smoke
(second hand). Detectible transfer was not found in any scenario and it was concluded
that there was no significant protein transfer via smoke. This contradicts Becker et al. to a
degree, however together these suggest that there is a low level of protein transfer. Liu et
al. contextualized the study by Voisine et al. and explains that the upper limit of savinase
transfer into mainstream smoke was found to be <0.009%, however a more rigorous
smoking regimen to increase tar yield (from 15 mg to 35 mg tar) could increase the
transfer to <0.021% or at most 4.4 ng savinase per cigarette with 700 mg of tobacco
spiked at 6000 ppm savinase [449].
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A number of assumptions would be required to appropriately apply this
information to the transfer of tree nut allergens using smoke to food, which are not
limited to: wood is a perfect substitute for tobacco, conditions to burn wood are
functionally identical to experimental conditions to transfer savinase in tobacco smoke,
no functional differences between the aerosolizability of wood proteins vs savinase, and
tree nut allergens or immunoreactive homologues are present in wood at approximately
6000 ppm. Wood and seeds do not share the same protein profile and so the main source
of tree nut allergens in the wood would be tree nuts themselves, but processed wood
would not carry tree nuts after limbing and debarking. The key assumption of allergen
presence is not met in processed wood that would be used for smoking food.

7.6 Effects of Thermal Processing on Allergens
Allergenic proteins elicit symptoms through a pair of antibody binding epitopes
on the protein, which are either bound to a conformational or linear epitope of the
allergen [70]. Therefore, both unfolding and destruction of peptide bonds are necessary to
eliminate allergenic potential. Protein denaturation temperatures vary by protein but can
occur as high as 108 °C [388]. Protein pyrolysis and decomposition occur above 200 °C
with volatile nitrogenous decomposition continuing through 400 °C [388, 389].
Thermogravimetric analysis has been applied to peptides [390], milk [391],
collagen [392], and microalgae [393] to show at what temperatures that gross
decomposition of proteins occurs. Amino acid decomposition has been found to follow
first-order rates [396]. Synthesized peptides were largely found to represent proteins
where temperatures below 200 °C evaporated surrounding water and between 200 °C and
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500 °C degraded the peptides through decarboxylation, deamination, and
depolymerization with rate maxima at 235 °C and 299 °C [390]. Camel and cow’s milk
were indicated to have combined degradation of protein and fat around 380 °C [391].
Collagen decomposition has been indicated to occur between 220 and 380 °C with
maximum rates between 285 and 300 °C with combustion occurring at 350 °C [392].
Another investigation of collagen found that through 100 °C absorbed water is
evaporated and between 280 °C and 400 °C bound water is released [395]. Modeling
theoretical thermogravimetry of microalgae has demonstrated that proteins largely
decompose upon heating to 350 °C [393]. However, decomposition has been found to
proceed at a slower rate than hydrolysis and therefore hydrolysis can be expected to occur
first [396].
Destruction of peptide bonds has been investigated in terms of spontaneous
hydrolysis. Hydrolysis of peptides has been found to be a first-order process and has been
calculated to have a half-life of approximately 6 minutes at 250 °C and neutral pH [396].
Although pH can affect the rate of hydrolysis, the rate only increases in acid or alkali
[397]. The minimum length of peptide needed to elicit clinical symptoms has been
suggested to be as low as 29 amino acids long [398]. Under the aforementioned
conditions, it would theoretically take 66 minutes to reduce titin (approximately 35,000
residues) to having no peptides over 29 amino acids.
In context of burning wood, some of the protein can be expected to be partially
degraded as the wood burns. However, it cannot be assumed that all of the protein will be
degraded. For example, it is known that after smoke has been produced it will rapidly
cool to the surrounding temperatures [414]. This further indicates that the focus on the
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study of Voisine et al. controls for conditions such as protein degradation during protein
transfer and therefore is not necessary to account for in the prior calculations.

7.7 Allergen Labelling of Products Produced in Part with Smoke from Tree Nut
Wood
The Federal Food, Drug, and Cosmetic Act in the U.S. under section 201 (qq)
defines major food allergens includes tree nuts and also stipulates labeling as defined in
section 403 (w) [204]. Notably the requirement is that labeling is stipulated on the food
ingredient containing protein derived from a major allergen, which requires both that tree
nut protein be included in the wood and that tree nut protein transfer to the final product.
It is not unreasonable to assume some tree nut is included in the wood, however here we
have failed to demonstrate that transfer of protein in smoke is significant. Therefore,
labeling products smoked with wood derived from trees that produce tree nuts is not
necessary.

7.8 Conclusions on the risks associated with Smoke derived from Tree Nut Wood
Use of wood from tree nut trees is not a significant risk to allergic consumers of
smoked foods. There is evidence that a low level of protein transfer can occur through
smoke, however wood proteins differ from tree nut allergens and precludes concerns of
tree nut allergens transferring from the wood in smoke. Labeling is unnecessary because
of the very low levels of expected protein transfer.
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CHAPTER 8: SUMMARY AND CONCLUSIONS ON NOVEL SOURCES OF
FOOD ALLERGENS

Novel foods and novel sources of food allergens require investigation to evaluate
present proteins and their associations with known allergens. Mass spectrometry has the
capacity to evaluate novel sources of food allergens and can inform qualitative and
quantitative assessments of risk. This set of works had the following aims:
1. Explore novel foods, foods processed in novel ways, and novel means of exposure
as novel sources of food allergens;
2. Develop methodologies for incorporating mass spectrometry into allergen risk
assessment;
3. Evaluate how conventional risk assessment methodologies can be leveraged to
determine the qualitative and quantitative allergic risks posed by novel sources of
food allergens.

The first aim was accomplished using literature reviews and experimental
evaluations using liquid chromatography-electrospray ionization-mass spectrometry to
explore Acheta domesticus, the house cricket, and Tenebrio molitor, the yellow
mealworm; extensively thermally processed walnut hulls and peanuts, as well as smoke
from the wood of tree nut trees and E-cigarette liquids. While many foods are wellcharacterized, there are many non-novel foods that are not well-characterized despite
associations with food allergies. Novel foods and novel sources of food allergens are
generally not well-characterized and therefore contain many unknowns such as the
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identities of present proteins, the quantity of those proteins, and the associations those
proteins with known allergens. To understand risks associated, the hazard must first be
identified and characterized.
The second aim was accomplished during experimental investigation of subject
novel sources of food allergens during the analysis of mass spectrometry data to annotate
and predict the allergenic proteins present in both A. domesticus and T. molitor,
determine theoretically viable IgE-binding lengths present in extensively thermally
processed peanuts, and analysis of E-liquids in terms of both food allergen and
respiratory risk assessments. Mass spectrometry is currently growing as a field of
analysis particularly regarding data analysis. Unlike other methods of food allergen
detection and quantification, such as ELISA that produces a single measure of allergen
presence, mass spectrometry is far more open-ended regarding the amount of data that
can be generated without clear boundaries regarding which data are meaningful.
However, mass spectrometry also affords the opportunity for use of this greater amount
of information generated to inform more complex questions in so far as the data analysis
methodology is validated. Currently mass spectrometry is limited by a lack of clear data
analysis workflows relative to the inherent integration of ELISA data, which forces mass
spectrometry to act as secondary validation of ELISA as opposed to a direct alternative
analytical technique.
The third aim was accomplished by incorporating assumptions into conventional
risk assessment workflows to allow for the use of mass spectrometry data and inform
risk. Assumptions are a critical point of risk assessment. A hazard that is impossible to
encounter is no risk. Framing the circumstances that a hazard may become a risk is
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therefore an important feature of risk assessment. In mass spectrometry, a critical
assumption in data analysis is that individual peptide identifications indicate the presence
of their progenitor protein and/or allergen. Incorporation of excessive assumptions into an
analysis increases the likelihood that the resultant answer be regarded as insufficient,
incorrect, or flawed. To ensure the future utility of mass spectrometry in a risk
assessment workflow, a consensus among stakeholders is necessary on what conditions,
circumstances, and assumptions are permissible.
Novel foods and ingredients will continue to be developed and discovered as will
novel sources of food allergens. Stakeholders need to be sufficiently informed to make
well-reasoned decisions as to which risks they are willing to undertake. Mass
spectrometry will continue to improve and generate large amounts of data and therefore
there is a need for further research into how mass spectrometry can be utilized in the
workflow of allergen risk assessment.
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Güray, M.Z., S. Zheng, and A.A. Doucette, Mass spectrometry of intact proteins
reveals+ 98 u chemical artifacts following precipitation in acetone. Journal of
proteome research, 2017. 16(2): p. 889-897.
Mol, M., et al., Advanced lipoxidation end products (ALEs) as RAGE binders:
Mass spectrometric and computational studies to explain the reasons why. Redox
biology, 2019. 23: p. 101083.
Nursten, H.E., Other Physiological Aspects, in The Maillard Reaction: Chemistry,
Biochemistry and Implications. 2007, Royal Society of Chemistry: Cambridge,
UK.
De Jongh, H.H., et al., Digestibility and IgE-binding of glycosylated codfish
parvalbumin. BioMed research international, 2013. 2013.
Huby, R.D., R.J. Dearman, and I. Kimber, Why are some proteins allergens?
Toxicological Sciences, 2000. 55(2): p. 235-246.
Schmitt, D.A., et al., Processing can alter the properties of peanut extract
preparations. Journal of Agricultural and Food Chemistry, 2010. 58(2): p. 11381143.
Comstock, S.S., S.J. Maleki, and S.S. Teuber, Boiling and frying peanuts
decreases soluble peanut (Arachis hypogaea) allergens Ara h 1 and Ara h 2 but
does not generate hypoallergenic peanuts. PloS one, 2016. 11(6).
Sen, M., et al., Protein structure plays a critical role in peanut allergen stability
and may determine immunodominant IgE-binding epitopes. The journal of
immunology, 2002. 169(2): p. 882-887.
Tomita, S. and K. Shiraki, Why do solution additives suppress the heat‐induced
inactivation of proteins? Inhibition of chemical modifications. Biotechnology
progress, 2011. 27(3): p. 855-862.

197
331.

332.

333.
334.
335.

336.

337.
338.
339.

340.
341.

342.

343.

344.
345.
346.

347.

Gavage, M., et al., High-resolution mass spectrometry-based selection of peanut
peptide biomarkers considering food processing and market type variation. Food
chemistry, 2020. 304: p. 125428.
Catak, S., et al., Computational study on nonenzymatic peptide bond cleavage at
asparagine and aspartic acid. The Journal of Physical Chemistry A, 2008.
112(37): p. 8752-8761.
van Boekel, M.A., Heat-induced deamidation, dephosphorylation and breakdown
of caseinate. International Dairy Journal, 1999. 9(3-6): p. 237-241.
Dai, H. and A.M. Leventhal, Prevalence of e-cigarette use among adults in the
United States, 2014-2018. Jama, 2019. 322(18): p. 1824-1827.
Chen, J.C., Flavored e-cigarette use and cigarette smoking reduction and
cessation—a large national study among young adult smokers. Substance use &
misuse, 2018. 53(12): p. 2017-2031.
Baur, X., Z. Chen, and V. Liebers, Exposure-response relationships of
occupational inhalative allergens. Clinical and Experimental Allergy, 1998.
28(5): p. 537-544.
O'B Hourihane, J., The threshold concept in food safety and its applicability to
food allergy. Allergy, 2001. 56: p. 86-90.
Ramirez, D.A. and S.L. Bahna, Food hypersensitivity by inhalation. Clinical and
Molecular Allergy, 2009. 7(1): p. 1-6.
Tzortzi, A., et al., A systematic literature review of e-cigarette-related illness and
injury: not just for the respirologist. International journal of environmental
research and public health, 2020. 17(7): p. 2248.
Palmer, L.K., et al., Persistence of peanut allergen-derived peptides throughout
excessive dry thermal processing. LWT, 2020: p. 109903.
Noble, K.A., et al., A Cherry Seed‐Derived Spice, Mahleb, is Recognized by Anti‐
Almond Antibodies Including Almond‐Allergic Patient IgE. Journal of food
science, 2017. 82(8): p. 1786-1791.
Albillos, S.M., et al., Purification, crystallization and preliminary X-ray
characterization of prunin-1, a major component of the almond (Prunus dulcis)
allergen amandin. Journal of agricultural and food chemistry, 2008. 56(13): p.
5352-5358.
Willison, L.N., et al., Cloning, expression and patient IgE reactivity of
recombinant Pru du 6, an 11S globulin from almond. International archives of
allergy and immunology, 2011. 156(3): p. 267-281.
Willison, L.N., et al., Conformational epitope mapping of Pru du 6, a major
allergen from almond nut. Molecular immunology, 2013. 55(3-4): p. 253-263.
Talih, S., et al., “Juice Monsters”: Sub-ohm vaping and toxic volatile aldehyde
emissions. Chemical Research in Toxicology, 2017. 30(10): p. 1791-1793.
Boeniger, M.F., et al., Exposure to protein aeroallergens in egg processing
facilities. Applied occupational and environmental hygiene, 2001. 16(6): p. 660670.
Taylor, A.V., et al., Detection and quantitation of raw fish aeroallergens from an
open-air fish market. Journal of allergy and clinical immunology, 2000. 105(1): p.
166-169.

198
348.
349.
350.

351.

352.
353.

354.

355.

356.
357.

358.

359.

360.
361.
362.

363.

364.

Brough, H.A., et al., Distribution of peanut protein in the home environment.
Journal of allergy and clinical immunology, 2013. 132(3): p. 623-629.
Salvatori, N., et al., Asthma induced by inhalation of flour in adults with food
allergy to wheat. Clinical & Experimental Allergy, 2008. 38(8): p. 1349-1356.
Armentia, A., et al., Why can patients with baker's asthma tolerate wheat flour
ingestion? Is wheat pollen allergy relevant? Allergologia et immunopathologia,
2009. 37(4): p. 203-204.
Salcedo, G., S. Quirce, and A. Diaz-Perales, 1 Wheat Allergens Associated With
Baker's Asthma. Journal of Investigational Allergology and Clinical Immunology,
2011. 21(2): p. 81.
Wu, J.-Z., et al., Effects of particulate matter on allergic respiratory diseases.
Chronic diseases and translational medicine, 2018. 4(2): p. 95-102.
Pourchez, J., et al., Impact of power level and refill liquid composition on the
aerosol output and particle size distribution generated by a new-generation ecigarette device. Aerosol Science and technology, 2018. 52(4): p. 359-369.
Son, Y., et al., Investigating E-Cigarette Particle Emissions and Human Airway
Depositions under Various E-Cigarette-Use Conditions. Chemical Research in
Toxicology, 2019. 33(2): p. 343-352.
Baldacci, S., et al., Allergy and asthma: Effects of the exposure to particulate
matter and biological allergens. Respiratory medicine, 2015. 109(9): p. 10891104.
Scott, A., et al., Pro-inflammatory effects of e-cigarette vapour condensate on
human alveolar macrophages. Thorax, 2018. 73(12): p. 1161-1169.
Brough, H.A., et al., Atopic dermatitis increases the effect of exposure to peanut
antigen in dust on peanut sensitization and likely peanut allergy. Journal of
Allergy and Clinical Immunology, 2015. 135(1): p. 164-170. e4.
Ahmedna, M., et al., Potential of agricultural by-product-based activated carbons
for use in raw sugar decolourisation. Journal of the Science of Food and
Agriculture, 1997. 75(1): p. 117-124.
Nieto-Delgado, C., M. Terrones, and J.R. Rangel-Mendez, Development of highly
microporous activated carbon from the alcoholic beverage industry organic byproducts. Biomass and Bioenergy, 2011. 35(1): p. 103-112.
Pal, P., Industrial Water Treatment Process Technology. 2017: Elsevier Science.
Lehmann, J. and S. Joseph, Biochar for Environmental Management: Science and
Technology. 2012: Earthscan.
Bae, W., J. Kim, and J. Chung, Production of granular activated carbon from
food-processing wastes (walnut shells and jujube seeds) and its adsorptive
properties. Journal of the Air & Waste Management Association, 2014. 64(8): p.
879-886.
Satya Sai, P.M., J. Ahmed, and K. Krishnaiah, Production of Activated Carbon
from Coconut Shell Char in a Fluidized Bed Reactor. Industrial & Engineering
Chemistry Research, 1997. 36(9): p. 3625-3630.
Buyukada, M., Uncertainty estimation by Bayesian approach in thermochemical
conversion of walnut hull and lignite coal blends. Bioresour Technol, 2017. 232:
p. 87-92.

199
365.

366.
367.

368.
369.
370.
371.
372.
373.

374.
375.

376.

377.
378.
379.

380.

381.
382.

383.

Duerr, S., The Handbook of Natural Plant Dyes: Personalize Your Craft with
Organic Colors from Acorns, Blackberries, Coffee, and Other Everyday
Ingredients. 2010: Timber Press.
Meuninck, J., Basic Illustrated Medicinal Plants. 2014: Falcon Guides.
Wolfe, D. and R.A. Gauthier, Longevity Now: A Comprehensive Approach to
Healthy Hormones, Detoxification, Super Immunity, Reversing Calcification, and
Total Rejuvenation. 2013: North Atlantic Books.
USDA, U.S.D.o.A. Germplasm Resources Information Network. 151128 [cited
2017 April 20]; Available from: http://www.ars-grin.gov/.
Costa, J., et al., Walnut allergens: molecular characterization, detection and
clinical relevance. Clin Exp Allergy, 2014. 44(3): p. 319-41.
Plumlee, K., Clinical Veterinary Toxicology - E-Book. 2003: Elsevier Health
Sciences.
Mohan, D.P., C.U.; Steele, P.H., Pyrolysis of Wood/Biomass for Bio-oil: A
Critical Review. Energy & Fuels, 2006. 20: p. 848-889.
Pütün, A.E., et al., Fixed-bed pyrolysis of cotton stalk for liquid and solid
products. Fuel Processing Technology, 2005. 86(11): p. 1207-1219.
Azargohar, R. and A.K. Dalai, Steam and KOH activation of biochar:
Experimental and modeling studies. Microporous and Mesoporous Materials,
2008. 110(2–3): p. 413-421.
del-Campo, B.G., et al., Optimizing the production of activated carbon from fast
pyrolysis char. TECHNOLOGY, 2015. 03(02n03): p. 104-113.
Pendyal, B., et al., Removal of sugar colorants by granular activated carbons
made from binders and agricultural by-products. Bioresource Technology, 1999.
69(1): p. 45-51.
Ioannidou, O. and A. Zabaniotou, Agricultural residues as precursors for
activated carbon production—A review. Renewable and Sustainable Energy
Reviews, 2007. 11(9): p. 1966-2005.
ScienceLab.com, Material Safety Data Sheet Charcoal, Acitvated, Powder MSDS.
2013.
Corp., G.C., Safety Data Sheet: GC Activated Carbon. 2017.
Food and Drug Administration, RE: Interin Final Rule - Registration of Food
Facilities Under the Public Health Security and Bioterrorism Preparedness and
Response Ace of 2002 [Docket No. 02N-0276], I.A.C.M. Association, Editor.
2003: Division of Dockets Management (HFA-305).
Bock, S.A., A. Muñoz-Furlong, and H.A. Sampson, Further fatalities caused by
anaphylactic reactions to food, 2001-2006. Journal of Allergy and Clinical
Immunology, 2007. 119(4): p. 1016-1018.
Burks, A.W., et al., ICON: food allergy. J Allergy Clin Immunol, 2012. 129(4): p.
906-20.
Sicherer, S.H., et al., A voluntary registry for peanut and tree nut allergy:
Characteristics of the first 5149 registrants. Journal of Allergy and Clinical
Immunology, 2001. 108(1): p. 128-132.
Comstock, S.S., et al., Extensive in vitro cross-reactivity to seed storage proteins
is present among walnut (Juglans) cultivars and species. Clin Exp Allergy, 2004.
34(10): p. 1583-90.

200
384.

385.

386.
387.
388.
389.
390.

391.

392.

393.
394.

395.
396.
397.
398.
399.

400.
401.
402.
403.

Wallowitz, M.L., et al., Cross-reactivity of walnut, cashew, and hazelnut legumin
proteins in tree nut allergic patients. Journal of Allergy and Clinical
Immunology. 113(2): p. S156.
Ramos, D.E., Walnut Production Manual. 1997: University of California,
Division of Agriculture and Natural Resources, Communication Services-Publications.
Blankestijn, M.A., et al., Threshold Dose Distribution in Walnut Allergy. J
Allergy Clin Immunol Pract, 2017. 5(2): p. 376-380.
Montain, S.J.E., M.;, Water Requirements and Soldier Hydration, in Borden
Institute Monograph Series, W.R.F. Santee, K.E.;, Editor. 2012, Borden Institute.
Damodaran, S., K.L. Parkin, and O.R. Fennema, Fennema's Food Chemistry,
Fourth Edition. 2007: CRC Press.
Russell, J.D., et al., Thermal decomposition of protein in soil organic matter.
Geoderma, 1974. 11(1): p. 63-66.
Dandurand, J., et al., Conformational and thermal characterization of a synthetic
peptidic fragment inspired from human tropoelastin: Signature of the amyloid
fibers. Pathol Biol (Paris), 2014. 62(2): p. 100-7.
Sunooj, K., et al., Thermal degradation and decomposition kinetics of freeze dried
cow and camel milk as well as their constituents. Journal of Food Science and
Engineering, 2011. 1(2): p. 77.
Samouillan, V., et al., Thermal analysis characterization of aortic tissues for
cardiac valve bioprostheses. Journal of Biomedical Materials Research, 1999.
46(4): p. 531-538.
Bach, Q.-V. and W.-H. Chen, A comprehensive study on pyrolysis kinetics of
microalgal biomass. Energy Conversion and Management, 2017. 131: p. 109-116.
Qian, Y., et al., Kinetics of peptide hydrolysis and amino acid decomposition at
high temperature. Geochimica et Cosmochimica Acta, 1993. 57(14): p. 32813293.
Sionkowska, A., et al., Chemical and thermal cross-linking of collagen and
elastin hydrolysates. Int J Biol Macromol, 2010. 47(4): p. 570-7.
Qian, Y., et al., Kinetics of peptide hydrolysis and amino acid decomposition at
high temperature. Geochim Cosmochim Acta, 1993. 57(14): p. 3281-93.
Smith, R.M.H., D.E., The pH-Rate Profile for the Hydrolysis of a Peptide Bond.
Journal of the American Chemical Association, 1988. 120: p. 8910-8913.
Zempleni, J. and H. Daniel, Molecular Nutrition. 2003: CABI Pub.
Cosmulescu, S.T., Ion; Achim, Gheorghe; Botu, Mihai; Baciu, Adrian; Gruia,
Marius, Phenolics of Green Husk in Mature Walnut Fruits. Notulae Botanicae
Horti Agrobotanici Cluj-Napoca, 2010.
Shahidi, F. and M. Naczk, Phenolics in Food and Nutraceuticals. 2003: CRC
Press.
Alasalvar, C. and F. Shahidi, Tree Nuts: Composition, Phytochemicals, and
Health Effects. 2008: CRC Press.
Stampar, F., et al., Traditional walnut liqueur – cocktail of phenolics. Food
Chemistry, 2006. 95(4): p. 627-631.
Babula, P., et al., [Naphthoquinones and their pharmacological properties].
Ceska Slov Farm, 2007. 56(3): p. 114-20.

201
404.

405.
406.
407.
408.
409.
410.

411.
412.

413.
414.
415.
416.

417.
418.
419.
420.
421.

Inbaraj, J.J. and C.F. Chignell, Cytotoxic Action of Juglone and Plumbagin: A
Mechanistic Study Using HaCaT Keratinocytes. Chemical Research in
Toxicology, 2004. 17(1): p. 55-62.
SCCNFP (Scientific Committee On Cosmetic Products And Non-Food Products),
Evaluation and opinion on lawsone. 2002: SCCNFP/0583/02.
Santa Cruz Biotechnology Inc., Juglone Material Safety Data Sheet. 2010, Santa
Cruz Biotechnology, Inc.
Santa Cruz Biotechnology Inc., Plumbagin Material Safety Data Sheet. 2016,
Santa Cruz Biotechnology, Inc.
Santa Cruz Biotechnology Inc., 1,4 Naphthoquinone Material Safety Data Sheet.
2010, Santa Cruz Biotechnology, Inc.
Ismail, T., et al., Ellagitannins in Cancer Chemoprevention and Therapy. Toxins
(Basel), 2016. 8(5).
Tasaki, M., et al., Safety assessment of ellagic acid, a food additive, in a
subchronic toxicity study using F344 rats. Food and Chemical Toxicology, 2008.
46(3): p. 1119-1124.
Santa Cruz Biotechnology Inc., Ellagic acid Material Safety Data Sheet. 2016,
Santa Cruz Biotechnology, Inc.
Centers for Disease Control and Prevention (US), National Center for Chronic
Disease Prevention and Health Promotion (US),, Office on Smoking and Health
(US),,, Chemistry and Toxicology of Cigarette Smoke and Biomarkers of
Exposure and Harm, in How Tobacco Smoke Causes Disease: The Biology and
Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon
General. 2010, Centers for Disease Control and Prevention (US): Atlanta, GA.
Feiner, G., Meat Products Handbook: Practical Science and Technology. 2006:
Elsevier Science.
Chichester, C.O., E.M. Mrak, and G.F. Stewart, Advances in Food Research.
1984: Elsevier Science.
Devine, C. and M. Dikeman, Encyclopedia of Meat Sciences. 2014: Elsevier
Science.
U.S. Food & Drug Administration. Section 201(qq) of the Act defines the term
"major food allergen" to include "tree nuts." In addition to the three examples
provided in section 201(qq) (almonds, pecans, and walnuts), what nuts are
considered "tree nuts?". FDA Basics For Industry 2016 05/22/2016 [cited 2017
06/26/2017].
Mauseth, J.D., Botany. 2016: Jones & Bartlett Learning.
Hon, D.N.S. and N. Shiraishi, Wood and Cellulosic Chemistry, Second Edition,
Revised, and Expanded. 2000: Taylor & Francis.
Barton, G., Definition of biomass samples involving wood, bark and foliage.
Biomass, 1984. 4(4): p. 311-314.
Cronk, Q.C.B., Plant eco-devo: the potential of poplar as a model organism. New
Phytologist, 2005. 166(1): p. 39-48.
Ellis, B., et al., Why and How Populus Became a “Model Tree”, in Genetics and
Genomics of Populus, S. Jansson, R. Bhalerao, and A. Groover, Editors. 2010,
Springer New York: New York, NY. p. 3-14.

202
422.
423.

424.
425.
426.

427.

428.
429.
430.

431.

432.
433.
434.
435.
436.
437.
438.
439.
440.
441.

Jansson, S. and C.J. Douglas, Populus: a model system for plant biology. Annu.
Rev. Plant Biol., 2007. 58: p. 435-458.
Lexer, C., et al., Barrier to gene flow between two ecologically divergent Populus
species, P. alba (white poplar) and P. tremula (European aspen): the role of
ecology and life history in gene introgression. Molecular ecology, 2005. 14(4): p.
1045-1057.
Tuskan, G.A., et al., The genome of black cottonwood, Populus trichocarpa (Torr.
& Gray). science, 2006. 313(5793): p. 1596-1604.
Rennenberg, H., H. Wildhagen, and B. Ehlting, Nitrogen nutrition of poplar trees.
Plant Biology, 2010. 12(2): p. 275-291.
Couturier, J., et al., Glutamine, arginine and the amino acid transporter PtCAT11 play important roles during senescence in poplar. Annals of Botany,
2010. 105(7): p. 1159-1169.
Gomez, L. and M. Faurobert, Contribution of vegetative storage proteins to
seasonal nitrogen variations in the young shoots of peach trees (Prunus persica
L. Batsch). Journal of Experimental Botany, 2002. 53(379): p. 2431-2439.
Veverka, P.J., et al., On the form of nitrogen in wood and its fate during kraft
pulping. 1993.
Arora, R., Adaptations and Responses of Woody Plants to Environmental
Stresses. 2004: Taylor & Francis.
Beardmore, T., et al., Characterization of seed storage proteins in Populus and
their homology with Populus vegetative storage proteins. Tree physiology, 1996.
16(10): p. 833-840.
Zhu, B. and G.D. Coleman, The poplar bark storage protein gene (Bspa)
promoter is responsive to photoperiod and nitrogen in transgenic poplar and
active in floral tissues, immature seeds and germinating seeds of transgenic
tobacco. Plant molecular biology, 2001. 46(4): p. 383-394.
Grebner, D.L., P. Bettinger, and J.P. Siry, Introduction to Forestry and Natural
Resources. 2012: Elsevier Science.
Vogt, D.J., et al., Forest Certification: Roots, Issues, Challenges, and Benefits.
1999: Taylor & Francis.
Fonseca, M.A., The Measurement of Roundwood: Methodologies and Conversion
Ratios. 2005: CABI.
Toldrá, F., Handbook of Meat Processing. 2010: Wiley.
Hui, Y.H., W.K. Nip, and R. Rogers, Meat Science and Applications. 2001: CRC
Press.
Hui, Y.H., Handbook of Meat and Meat Processing, Second Edition. 2012: Taylor
& Francis.
Purser, D., R. Maynard, and J. Wakefield, Toxicology, Survival and Health
Hazards of Combustion Products. 2015: Royal Society of Chemistry.
Beji, T., Fluid Mechanics Aspects of Fire and Smoke Dynamics in Enclosures.
2016: CRC Press.
Klass, D.L., Biomass for Renewable Energy, Fuels, and Chemicals. 1998:
Elsevier Science.
Pandey, A., et al., Current Developments in Biotechnology and Bioengineering:
Food and Beverages Industry. 2016: Elsevier Science.

203
442.
443.
444.
445.

446.
447.

448.

449.

Berger, R.G., Flavours and Fragrances: Chemistry, Bioprocessing and
Sustainability. 2007: Springer Berlin Heidelberg.
Blankestijn, M.A., et al., Threshold Dose Distribution in Walnut Allergy. The
Journal of Allergy and Clinical Immunology: In Practice, 2017. 5(2): p. 376-380.
Goetz, D.W., M.A. Goetz, and B.A. Whisman, Mountain cedar allergens found in
nonpollen tree parts. Ann Allergy Asthma Immunol, 1995. 75(3): p. 256-60.
More, D., et al., Identification of specific IgE to mesquite wood smoke in
individuals with mesquite pollen allergy. Journal of allergy and clinical
immunology, 2002. 110(5): p. 814-816.
Becker, C., T. Dubin, and H.P. Wiedemann, Hypersensitivity to tobacco antigen.
Proceedings of the National Academy of Sciences, 1976. 73(5): p. 1712-1716.
Voisine, R., et al., Protein transfer in mainstream and sidestream cigarette
smoke. Beiträge zur Tabakforschung/Contributions to Tobacco Research, 2004.
21(1): p. 9-14.
Nielsen, G.D., et al., Experiences from Occupational Exposure Limits Set on
Aerosols Containing Allergenic Proteins. The Annals of Occupational Hygiene,
2012. 56(8): p. 888-900.
Liu, C., et al., The use of a novel tobacco treatment process to reduce toxicant
yields in cigarette smoke. Food and Chemical Toxicology, 2011. 49(9): p. 19041917.

204
APPENDIX A SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER
2: PREDICTED ALLERGENS AND QUANTITIATIVE PROTEOMICS FROM
LIFE STAGES OF THE HOUSE CRICKET, ACHETA DOMESTICUS

Appendix A Figure 2.1.1 A. domesticus life stages

Images of A. domesticus life stages in order of development from pinheads to adults.
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Appendix A Table 2.1.1 Life stage replicate characteristics

Life stage
Pinhead

1 Week

1/3 Grown

2 Weeks

1/2 Grown

2/3 Grown

Adult Male

Adult Female

Replicate
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

#specimens
>50
>50
>50
50
50
50
25
25
25
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1

Replicate sample
weight (mg)
215
211
202
208
207
216
211
214
204
217
178
186
234
373
327
209
203
257
376
382
416
557
556
606

µg protein
per 25 µg wet
tissue
1.06
1.19
1.17
1.15
1.32
1.01
1.10
1.04
0.98
0.99
1.21
1.13
0.88
1.11
1.34
0.75
0.99
1.29
1.23
0.93
1.45
1.51
1.93
1.41

Percentage
protein
(wet basis)
5.64
6.37
6.26
6.13
7.05
5.39
5.26
6.46
6.02
5.84
5.55
5.20
4.72
5.94
7.17
4.02
5.28
6.87
6.56
4.97
7.74
8.06
10.29
7.53
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Appendix A Figure 2.1.2 SDS-PAGE of extracts from A. domesticus life stages
SDS-PAGE of 8 life stages of A. domesticus. Lanes were loaded with protein
equivalent to 500 µg of wet tissue per life stage. Lanes were as follows: (L) molecular
weight standards, (1) Pinhead, (2) 1 week, (3) 1/3 grown, (4) 2 weeks, (5) 1/2 grown,
(6) 2/3 grown, (7) Adult male, (8) Adult female. Numbers are in order of development
rather than lane loading order.

Appendix A Table 2.1.2 Mass spectrometry multi-round search metadata

# MS scans
#MS/MS scans
Peptide-Spectrum matches at FDR < 0.01
Peptides
Peptide FDR
Proteins
Protein Groups
Protein FDR
# De novo only scans

Round
1
926192
425738
145671
4219
0.8%
5446
481
6.5%
40737

Round
2
926192
40737
20087
1161
0.8%
609
340
1.5%
14808

Round
3
926192
14808
1955
287
1.0%
66
46
4.3%
12807

Round
4
926192
12807
290
71
<0.1%
8
8
<0.1%
12514
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Appendix A Figure 2.1.3 Spectra of peptides with posttranslational modifications
and relevant unmodified forms

904.3942
940.8854
450.7672

918.4099
592.3174

D(+42.01)DDVAALVVDNGSGMC(+57.02)K

D(+42.01)DDVAALVVDN(+.98)GSGMC(+57.02)K

QLATK(+42.01)AAR

D(+42.01)EEVAALVVDNGSGMC(+57.02)K

NKDPLNDTVVDQFK(+14.02)K

3

2

2

2

2

z
3
3

45.6

52.13

28.93

51.94

51.52

RT
49.56
50.69

59.6

51.59

31.86

59.89

62.58

-10lgP
71.65
71.68

2.5

-1.4

1

-2.2

-1.4

ppm
1
1.3

K880 Methylation

H74 Methylation
D3 Acetylation, C18
Carbamidomethylation
D3 Acetylation, N13
Deamidation, C18
Carbamidomethylation
K24 Acetylation
D3 Acetylation, C18
Carbamidomethylation

PTM*

*PTM: Posttranslational modification

m/z
654.3091
658.9813

YPIEHGIITNWDDMEK
YPIEH(+14.02)GIITNWDDMEK

ANN17471.RA

ANN06657.RA

ANN25863.RA

ANN23215.RA

ANN23215.RA

Accession
ANN23215.RA
ANN23215.RA

Appendix A Table 2.1.3 Peptide posttranslational modification characteristics

Myosin heavy
chain, Muscle
isoform X15

Actin-5C

Histone H3

Actin, muscle

Actin, muscle

Description
Actin, muscle
Actin, muscle
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Appendix A Figure 2.1.4 Phylogeny of the origin species of allergen predictions
Phylogenetic tree of species produced with IcyTree whose allergenic sequences were
significant matches to A. domesticus proteins. Branch length is arbitrary. Numbers to
the right of each species represents the number of hits attributed to the species.

210
Appendix A Table 2.1.4 Enriched Gene Ontology (GO) terms for the top 10% most
abundant proteins per life stage
Pinhead
GO ID
GO:0035639
GO:0051015
GO:0032555
GO:0003774
GO:0016459
GO:0099513
GO:0006936
GO:0006996
GO:0003924
GO:0005200

GO name
purine ribonucleoside
triphosphate binding
actin filament binding
purine ribonucleotide
binding
motor activity
myosin complex
polymeric cytoskeletal fiber
muscle contraction
organelle organization
GTPase activity
structural constituent of
cytoskeleton

Go
Category

FDR

P-value

Nr
Test

Nr
Reference

MF
MF

1.12E-03
1.12E-03

6.84E-06
6.13E-06

20
7

67
4

MF
MF
CC
CC
BP

1.12E-03
5.96E-03
5.96E-03
3.70E-02
4.78E-02

6.84E-06
5.02E-05
5.02E-05
3.64E-04
6.05E-04

20
6
6
7
3

67
4
4
11
0

BP
MF

4.78E-02
4.78E-02

6.03E-04
5.38E-04

12
7

39
12

MF

4.78E-02

5.45E-04

6

8

Go
Category

FDR

P-value

Nr
Test

Nr
Reference

MF

1.09E-02

6.14E-05

6

4

MF

1.09E-02

5.05E-05

19

68

MF
CC
MF

1.09E-02
1.09E-02
2.07E-02

5.05E-05
6.14E-05
1.26E-04

19
6
6

68
4
5

Nr
Test

Nr
Reference

1 Week
GO ID

GO name

GO:0003774

motor activity
purine ribonucleoside
triphosphate binding
purine ribonucleotide
binding
myosin complex
actin filament binding

GO:0035639
GO:0032555
GO:0016459
GO:0051015
1/3 Grown
GO ID

GO name

Go
Category

FDR

P-value

GO:0003774

motor activity

MF

1.64E-02

6.14E-05

6

4

GO:0016459
GO:0051015

myosin complex
actin filament binding
purine ribonucleoside
triphosphate binding
purine ribonucleotide
binding
supramolecular fiber
metabolic process

CC
MF

1.64E-02
2.98E-02

6.14E-05
1.26E-04

6
6

4
5

MF

3.33E-02

1.87E-04

18

69

MF
CC
BP

3.33E-02
4.15E-02
4.53E-02

1.87E-04
2.91E-04
3.39E-04

18
8
13

69
14
279

Go
Category

FDR

P-value

Nr
Test

Nr
Reference

GO:0035639
GO:0032555
GO:0099512
GO:0008152
2 Weeks
GO ID

GO name

211

GO:0004503
GO:0042302
GO:0044237
GO:0044238
GO:0003774
GO:0016459
GO:0051015
GO:0071704

monophenol
monooxygenase activity
structural constituent of
cuticle
cellular metabolic process
primary metabolic process
motor activity
myosin complex
actin filament binding
organic substance metabolic
process

MF

2.76E-03

5.17E-06

5

0

MF
BP
BP
MF
CC
MF

3.20E-03
5.68E-03
6.50E-03
9.20E-03
9.20E-03
1.64E-02

7.49E-06
2.97E-05
3.96E-05
6.78E-05
6.78E-05
1.39E-04

16
7
6
6
6
6

40
228
210
4
4
5

BP

1.66E-02

1.48E-04

7

213

Go
Category

FDR

P-value

Nr
Test

Nr
Reference

MF
CC
MF
BP
BP

1.64E-02
1.64E-02
2.69E-02
3.36E-02
3.78E-02

6.14E-05
6.14E-05
1.26E-04
1.73E-04
2.33E-04

6
6
6
8
7

4
4
5
227
209

MF

3.78E-02

2.65E-04

4

1

Go
Category

FDR

P-value

Nr
Test

Nr
Reference

1/2 Grown
GO ID

GO name

GO:0003774
GO:0016459
GO:0051015
GO:0044237
GO:0044238

motor activity
myosin complex
actin filament binding
cellular metabolic process
primary metabolic process
monophenol
monooxygenase activity

GO:0004503
2/3 Grown
GO ID

GO name

GO:0003774
GO:0016459

MF
CC

1.30E-02
1.30E-02

3.66E-05
3.66E-05

6
6

4
4

GO:0042302
GO:0051015

motor activity
myosin complex
structural constituent of
cuticle
actin filament binding

MF
MF

1.45E-02
2.01E-02

4.76E-05
7.54E-05

14
6

42
5

GO:0044237
GO:0044238

cellular metabolic process
primary metabolic process

BP
BP

4.31E-02
4.77E-02

1.82E-04
2.41E-04

7
6

228
210

GO ID

GO name

Go
Category

FDR

P-value

Nr
Test

Nr
Reference

GO:0003774
GO:0016459
GO:0051015
GO:0008152

motor activity
myosin complex
actin filament binding
metabolic process

MF
CC
MF
BP

1.39E-02
1.39E-02
2.31E-02
4.26E-02

2.61E-05
2.61E-05
5.40E-05
2.19E-04

6
6
6
10

4
4
5
282

GO ID

GO name

Go
Category

FDR

P-value

Nr
Test

Nr
Reference

GO:0006869
GO:0005319

lipid transport
lipid transporter activity

BP
MF

3.57E-07
5.37E-07

1.67E-10
7.55E-10

13
12

9
8

Adult Male

Adult Female

212
GO:0009987
GO:0003774

cellular process
motor activity

BP
MF

3.67E-03
4.13E-03

1.38E-05
2.32E-05

9
6

306
4

GO:0016459
GO:0051015
GO:0044238

myosin complex
actin filament binding
primary metabolic process

CC
MF
BP

4.13E-03
7.34E-03
3.07E-02

2.32E-05
4.81E-05
2.44E-04

6
6
5

4
5
211

Go categories: MF, Molecular function; BP, Biological Process; CC, Cellular
Component. Red and green highlighted GO IDs indicate over and underrepresented in
test group, respectively.
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APPENDIX B ANNOTATIONS OF QUANTIFIED PROTEINS FROM ACHETA
DOMESTICUS (XLSX, 380 KB)

Annotations of
quantified proteins from acheta domesticus.xlsx
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APPENDIX C SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER
3: PROTEOMIC EVALUATION OF YELLOW MEALWORM, TENEBRIO
MOLITOR, WITH EXPERIMENTAL GENETIC MODIFICATIONS

Appendix C Table 3.1.1 Tribolium castaneum tropomyosin-2 exon
structure utilized to manually curate T. molitor protein sequences
TM#
1
1
2
3
4
5
6
7
8
9
10
11
12
13

2

3

4

TM exons utilized per isoform
5 6 7 8 9 10 11 12 13

14 15

16

7
8
9
10
11
12
13
14
15
16

6

5

4

3

2

Exon
#
1

Nucleotide sequences are from the reverse strand of contigs JABDTM010019790.1 and JABDTM010018031.1.

ATGGACGCGATCAAGAAGAAGATGCAAGCGATGAAGCTTGAGAAGGATAACGCTTTGGACCGTGCCATCCAGAACGAACAGCAAGC
CAAAGACGCCAACCTTCGCGGAGAAAAA
CTCGAAGAGGAGGCCCGCACTCTCCAGAAGAAGATCCAGACCATTGAGAATGAACTCGATCAGACCCAGGAACAGCTCACCCAAGT
CAACGGCAAACTGGAAGAGAAGGAGAAGGCCCTCCAGACC
ATGACGACGAACATACAGCAGGGCTCCCTCCTGGACGTgctcaagaaaaaaatgaggCAGACCAAGGAGGAGATGGAACGTTACAA
GGACGAGTGCGAAGAGTACAACAAACGACTTCATGCGGAATGCATGCGGAGAGAGGAA
GCCGAGTCAGAAGTTGCGGCCCTCAACCGCCGCATCCAACTCCTGGAGGAAGACTTGGAGCGTTCGGAAGAACGCTTGGCCACTGC
CACCGCCAAATTGGCCGAAGCTTCCGCCGCCGCCGACGAGAGCGAAAG
GATACGCAAAGCCTTAGAAAACAGGACCAACATGGAAGACGATAGAGTAGCCGTCTTGGAAAGTCAACTGTCCCAAGCGAAACTAA
TAGCCGAAGAGGCCGACAAAAAATACGAAGAG
GCAACGCAAGGTTCTCGAGAACCGCTCCCTCGCCGATGAAGAGCGCATGGATGCCCTAGAAAACCAGCTAAAGGAAGCCCGTTTCT
TGGCTGAAGAAGCCGATAAAAAATACGATGAG
GTAGCTCGTAAATTGGCCATGGTTGAAGCCGACTTGGAGAGAGCAGAAGAACGCGCCGAAACAGGAGAATC
GTTGCCCGAAAATTGGTTCTTATGGAACAAGACTTAGAACGAGCCGAAGAACGCGCTGAACAGAGCGAGAG
CAAAATCGTAGAGCTTGAGGAGGAACTTCGCGTCGTTGGCAACAACTTGAAGTCCCTAGAAGTGTCCGAGGAAAAG
GCCAACCAACGCGAAGAAGAgtacaaaaatcaaattaagaACTTGACCACCCGTCTAAAGGAG
GCGGCTGTTACCAGAGAACATAGCGAGGATAAAATCCGTTCCATCTCAGATAAACTGCGTGAA
GCTACGTTAAAAGAGGAGGAATATTCGGTTACCCTGAAACAGGTGGATCAACGATTGCAAGAG
GCTGAGGCTCGCGCCGAGTTTGCCGAACGTTCGGTACAGAAACTCCAGAAGGAGGTCGACAGACTAGAAG
ACGATCTCTTGGCAGAAAAGGAAAAGAACAAACTGTTATCCGACGAGATGGAAGCTACATTGCATGATATCCAAAATATG
ATGAGCTCGTCGCCGAAAAGGAGCGTTACAAGGAAATCGGCGACGACTTGGACACGGCTTTCGTCGAACTCATCTTG
ATGAACTAGTCGACGAGAAGGGCAAGTACAAGGCCATCGCCGACGAGATGGACCAGACGATGGCCGACTTGGCTGGATAT

Exon nucleotide sequence

Appendix C Table 3.1.2 T. molitor tropomyosin-2 exon nucleotide sequences
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Appendix C Figure 3.1.1 Alignments and sequence coverage for arginine kinase and
tropomyosins

A. Arginine kinase
XP_971800.2
g5623t1

MVDAAVLEKLEAGFKKLEASDSKSLLKKYLTRELFDKLKTKKTSFGSTLLDVIQSGLENH
MVDAAVLEKLEAGFKKLEASDSKSLLKKYLTRELFDNLKTKKTSFGSTLLDVIQSGLENH
************************************:***********************

60
60

XP_971800.2
g5623t1

DSGIGIYAPDADSYSVFADLFDPIIEDYHGGFKKTDKHPPKDWGDVNAFGNLDPAGEFVV
DSGIGIYAPDAEAYSVFSDLFDPIIEDYHGGFKKSDKHPPKNWGDTSVFGNLDPAGEYIV
***********::****:****************:******:***...*********::*

120
120

XP_971800.2
g5623t1

STRVRCGRSLEGYPFNPCLTEEQYKEMEQKVSSTLSGLEGELKGTFYPLTGMSKEVQQKL
STRVRCGRSLEGYPFNPCLTEEQYKEMEQKVSSTLSGLEGELKGTFYPLTGMSKEVQQKL
************************************************************

180
180

XP_971800.2
g5623t1

IDDHFLFKEGDRFLQAANACRFWPTGRGIFHNDAKTFLVWCNEEDHLRIISMQMGGDLGQ
IDDHFLFKEGDRFLQAANACRFWPSGRGIFHNDAKTFLVWCNEEDHLRIISMQMGGDLGQ
************************:***********************************

240
240

XP_971800.2
g5623t1

VYRRLVTGVNDIEKRLPFSHSDRFGFLTFCPTNLGTTVRASVHIKVPKLAANKAKLDEVA
VYRRLVTAVNDIEKRIPFSHSDRFGFLTFCPTNLGTTVRASVHIKVPKLSANKAKLDEVA
*******.*******:*********************************:**********

300
300

XP_971800.2
g5623t1

AKFNLQVRGTRGEHTEAEGGVYDISNKRRMGLTEFDAVKEMYDGISEIIKMEKEL
GKFNLQVRGTRGEHTEAEGGVYDISNKRRMGLTEYDAVKEMYDGIAEIIKIEKEL
.*********************************:**********:****:****

355
355

B. Tropomyosin-1
g11661t1
XP_967128.1

MDAIKKKMQAMKLEKDNAQDKADAMEGQAKDANLRVEKLNEELRDLQKKLAQVEGDFSST
MDAIKKKMQAMKLEKDNAQDKADAMEGQAKDANLRVEKLNEELRELQKKLSQVEGDLTTT
********************************************:*****:*****:::*

60
60

g11661t1
XP_967128.1

KNNLEQANKDLEEKEKTLTNAESEMAALNRKVQLIEEDLERSEERLTTATTKLAEASQAA
KNSLEQANKDLEEKEKTLTNAEAEMASLNRKVQTIEEDLERSEERLATATTKLAEASQAA
**.*******************:***:****** ************:*************

120
120

g11661t1
XP_967128.1

DESFRMCKVLENRSQQDEERMDQLTNQLKEARLLAEDADNKSDEVSRKLAFVEDELEVAE
DESSRMCKVLENRSQQDEERMDQLTNQLKEARLLAEDADNKSDEVSRKLAFVEDELEVAE
*** ********************************************************

180
180

g11661t1
XP_967128.1

DRVKGGDAKIMELEEELKVVGNSLKSLEVSEEKANQRVEEFKKQLKTLTVKLKEAEARAE
DRVKGGDAKIMELEEELKVVGNSLKSLEVSEEKANQRVEEFKKQLKTLTVKLKEAEARAE
************************************************************

240
240

g11661t1
XP_967128.1

YAEKTVKKLQKEVDRLEDELGINKDRYKSLADEMDSTFAELAGY
YAEKTVKKLQKEVDRLEDELGINKDRYKSLADEMDSTFAELAGY
********************************************

284
284

C. Tropomyosin-2 isoform
ManualTM1.2.n

MDAIKKKMQAMKLEKDNALDRAIQNEQQAKDANLRGEKLEEEARTLQKKIQTIENELDQT

60
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XP_008198924.1

MDAIKKKMQAMKLEKDNALDRAIFNEQQAKDANLRAEKLEEEARTLQKKIQTIENELDQT
*********************** ***********.************************

60

ManualTM1.2.n
XP_008198924.1

QEQLTQVNGKLEEKEKALQTAESEVAALNRRIQLLEEDLERSEERLATATAKLAEASAAA
QEQLTQVNGKLEEKEKALQTAESEVAALNRRIQLLEEDLERSEERLATATAKLAEASAAA
************************************************************

120
120

ManualTM1.2.n
XP_008198924.1

DESERQRKVLENRSLADEERMDALENQLKEARFLAEEADKKYDEVARKLAMVEADLERAE
DESERQRKVLENRSLADEERMDALENQLKEARFLAEEADKKYDEVARKLAMVEADLERAE
************************************************************

180
180

ManualTM1.2.n
XP_008198924.1

ERAETGESKIVELEEELRVVGNNLKSLEVSEEKANQREEEYKNQIKNLTTRLKEAEARAE
ERAEAGESKIVELEEELRVVGNNLKSLEVSEEKANQREEEYKNQIKNLTTRLKEAEARAE
****:*******************************************************

240
240

ManualTM1.2.n
XP_008198924.1

FAERSVQKLQKEVDRLEDELVAEKERYKEIGDDLDTAFVELIL
FAERSVQKLQKEVDRLEDELVAEKERYKEIGDDLDTAFVELIL
*******************************************

283
283

Appendix C Figure 3.1.1 Alignments and sequence coverage for arginine kinase and
tropomyosins
Alignments of identified T. molitor (A) arginine kinase and (B) tropomyosin 1 predicted
by Augustus and (C) a manually curated tropomyosin 2 isoform aligned to the top hits
identified from Tribolium castaneum using Clustal Omega (12.4). Peptide coverage per
protein is represented by red font.
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Appendix C Table 3.1.3 Mass spectrometry multi-round search metadata

# MS scans
#MS/MS scans
Peptide-Spectrum matches at FDR < 0.01
Peptides
Peptide FDR
Proteins
Protein Groups
Protein FDR
# De novo only scans

Round
1
154096
208046
76377
5478
0.7%
1010
873
12.3%
22772

Round
2
154096
24772
1473
144
0.7%
149
130
59.3%
19134

Round
3
154096
19134
1334
159
0.6%
217
172
14.3%
17486

Round
4
154096
17486
760
119
<0.1%
118
106
66.7%
16723
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Appendix C Figure 3.1.2 Spectra of peptides with posttranslational modifications
and relevant unmodified forms

662.8601
669.8672
904.3957

904.8878

912.3936

658.9808

NLLISASSQYTK
NLLISASS(+14.02)QYTK
D(+42.01)DDVAALVVDNGSGMC(+57.02)K

D(+42.01)DDVAALVVDN(+.98)GSGMC(+57.02)K

D(+42.01)DDVAALVVDNGSGM(+15.99)C(+57.02)K

YPIEH(+14.02)GIITNWDDMEK

3

2

2

2
2
2

z
2

45.94

45.86

47.38

41.28
41.8
48.86

RT
33.96

85.75

74.65

71.38

51.47
51.17
82.71

-10lgP
75.95

0.7

0.7

0.4

0.3
0.5
0.3

ppm
-0.3

S666 Methylation
D3 Acetylation,
C18
Carbamidomethyl
D3 Acetylation,
N13 Deamidation,
C18
Carbamidomethyl
D3 Acetylation,
M17 Oxidation,
C18
Carbamidomethyl
H74 Methylation

PTM*
A2 Acetylation,
C11
Carbamidomethyl

*PTM: Posttranslational modification

m/z
560.7686

Peptide
A(+42.01)SGVTVADAC(+57.02)K

g4024t1

g4024t1

g4024t1

g13695t1
g13695t1
g4024t1

Accession
A0A678P951

Appendix C Table 3.1.4 Peptide posttranslational modification characteristics

Actin, muscle

Actin, muscle

Actin, muscle

Description
Cofilin/actindepolymerizing
factor
Transferrin
Transferrin
Actin, muscle
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Appendix C Figure 3.1.3 Phylogeny of the origin species of allergen predictions
Phylogenetic tree of species produced with IcyTree whose allergenic sequences were
significant matches to A. domesticus proteins. Branch length is arbitrary. Numbers to
the right of each species represents the number of hits attributed to the species.

Appendix C Table 3.1.5 Enriched Gene Ontology (GO) terms of the top 10% most
abundant proteins per sample against all proteins
Wildtype
GO ID
GO:0042302
GO:0005737
GO:0043231
GO:0019538
GO:0031012
GO:0044249

Go Name
structural constituent of
cuticle
cytoplasm
intracellular membranebounded organelle
protein metabolic process
extracellular matrix
cellular biosynthetic
process

Go
Category

FDR

P-value

NR
test

NR
reference

MF
CC

9.97E-06
7.94E-05

3.17E-08
2.84E-07

17
8

29
284

CC
BP
CC

5.58E-04
0.009885
0.01602

3.11E-06
7.08E-05
1.27E-04

2
1
8

171
124
12

BP

0.024143

2.02E-04

1

115

222
GO:0005488
GO:0016491
GO:0044281

binding
oxidoreductase activity
small molecule metabolic
process

MF
MF

0.033049
0.034324

2.89E-04
3.41E-04

15
1

304
111

BP

0.034324

3.41E-04

1

111

Go
Category
MF

FDR
6.18E-06

P-value
9.83E-09

NR
test
9

NR
reference
311

MF
CC

2.36E-05
8.35E-05

7.50E-08
2.99E-07

17
9

29
283

CC
BP
CC

2.61E-04
0.006375
0.023341

1.14E-06
4.56E-05
1.86E-04

2
1
8

171
124
12

BP

0.041788

3.49E-04

1

105

Go
Category
CC
MF

FDR
2.04E-05
2.04E-05

P-value
5.53E-08
5.69E-08

NR
test
8
10

NR
reference
284
310

MF

2.09E-05

7.50E-08

17

29

CC
BP
CC

2.61E-04
6.75E-03
2.33E-02

1.14E-06
4.56E-05
1.86E-04

2
1
8

171
124
12

BP

4.18E-02

3.49E-04

1

105

BP

4.76E-02

4.16E-04

2

120

Genetically
modified 1
GO ID
GO:0003824
GO:0042302
GO:0005737
GO:0043231
GO:0019538
GO:0031012
GO:0044260

Go Name
catalytic activity
structural constituent of
cuticle
cytoplasm
intracellular membranebounded organelle
protein metabolic process
extracellular matrix
cellular macromolecule
metabolic process

Genetically
modified 2
GO ID
GO:0005737
GO:0003824
GO:0042302
GO:0043231
GO:0019538
GO:0031012
GO:0044260
GO:0034641

Go Name
cytoplasm
catalytic activity
structural constituent of
cuticle
intracellular membranebounded organelle
protein metabolic process
extracellular matrix
cellular macromolecule
metabolic process
cellular nitrogen
compound metabolic
process

Go categories: MF, Molecular function; BP, Biological Process; CC, Cellular
Component. Red and green highlighted GO IDs indicate over and underrepresented in
test group, respectively.
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Appendix C Table 3.1.6 Enriched Gene Ontology (GO) terms of the top 10% most
abundant proteins per sample against robust proteins

Wildtype
GO ID
GO:0003824
GO:0005737
GO:0042302
GO:0043231
GO:0005488
GO:0044249
GO:0019538
GO:0044281

Go Name
catalytic activity
cytoplasm
structural constituent of
cuticle
intracellular membranebounded organelle
binding
cellular biosynthetic
process
protein metabolic process
small molecule metabolic
process

Go
Category
MF
CC

FDR
1.55E-06
4.18E-05

P-value
2.69E-09
1.45E-07

NR
test
5
7

NR
reference
241
238

MF

6.51E-05

2.54E-07

16

26

CC
MF

0.005361
0.010576

3.71E-05
7.78E-05

2
13

129
253

BP
BP

0.02062
0.030571

1.61E-04
2.78E-04

1
1

100
99

BP

0.030571

2.77E-04

1

95

Go
Category
MF
CC

FDR
6.28E-06
6.28E-06

P-value
2.09E-08
2.18E-08

NR
test
6
6

NR
reference
240
239

MF

6.51E-05

2.54E-07

16

26

CC
MF

8.29E-04
0.00899

5.38E-06
7.78E-05

1
13

130
253

BP
CC

0.009744
0.01131

9.28E-05
1.17E-04

1
8

105
10

BP
BP

0.01562
0.023778

1.69E-04
2.78E-04

0
1

82
99

BP

0.023778

2.77E-04

1

95

Go
Category
MF
CC

FDR
8.03E-06
4.18E-05

P-value
2.09E-08
1.45E-07

NR
test
6
7

NR
reference
240
238

MF

4.68E-04

1.82E-06

15

27

CC
CC

0.005361
0.01508

3.71E-05
1.17E-04

2
8

129
10

BP
BP

0.019534
0.029182

1.61E-04
2.78E-04

1
1

100
99

Genetically
modified 1
GO ID
GO:0003824
GO:0005737
GO:0042302
GO:0043231
GO:0005488
GO:1901576
GO:0031012

GO:0044271
GO:0019538
GO:0044281

Go Name
catalytic activity
cytoplasm
structural constituent of
cuticle
intracellular membranebounded organelle
binding
organic substance
biosynthetic process
extracellular matrix
cellular nitrogen
compound biosynthetic
process
protein metabolic process
small molecule metabolic
process

Genetically
modified 2
GO ID
GO:0003824
GO:0005737
GO:0042302
GO:0043231
GO:0031012
GO:0044249
GO:0019538

Go Name
catalytic activity
cytoplasm
structural constituent of
cuticle
intracellular membranebounded organelle
extracellular matrix
cellular biosynthetic
process
protein metabolic process
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GO:0044281

small molecule metabolic
process

BP

0.029182

2.77E-04

1

95

Go categories: MF, Molecular function; BP, Biological Process; CC, Cellular
Component. Red and green highlighted GO IDs indicate over and underrepresented in
test group, respectively.

120
120
120
120
120
180
180
180
180
180

240
240
240
240
240

KNNLEQANKDLEEKEKTLTNAESEMAALNRKVQLIEEDLERSEERLTTATTKLAEASQAA
QEQLSAANTKLEEKEKALQTAEGDVAALNRRIQLIEEDLERSEERLKIATAKLEEASQSA
QESLLKANIQLVEKDKALSNAEGEVAALNRRIQLLEEDLERSEERLNTATTKLAEASQAA
MEQLMQVNAKLDEKDKALQNAESEVAALNRRIQLLEEDLERSEERLATATAKLAEASQAA
QEQLTQVNGKLEEKEKALQTAESEVAALNRRIQLLEEDLERSEERLATATAKLAEASAAA
:.* .* .* **:*:* .**.::*****::**:*********** **:** *** :*
DESFRMCKVLENRSQQDEERMDQLTNQLKEARLLAEDADNKSDEVSRKLAFVEDELEVAE
DESERMRKMLEHRSITDEERMEGLENQLKEARMMAEDADRKYDEVARKLAMVEADLERAE
DESERMRKVLENRSLSDEERMDALENQLKEARFLAEEADRKYDEVARKLAMVEADLERAE
DESERARKILESKGLADEERMDALENQLKEARFMAEEADKKYDEVARKLAMVEADLERAE
DESERQRKVLENRSLADEERMDALENQLKEARFLAEEADKKYDEVARKLAMVEADLERAE
*** * *:** :. *****: * *******::**:**.* ***:****:** :** **

DRVKGGDAKIMELEEELKVVGNSLKSLEVSEEKANQRVEEFKKQLKTLTVKLKEAEARAE
ERAETGESKIVELEEELRVVGNNLKSLEVSEEKAQQREEAHEQQIRIMTTKLKEAEARAE
ERAETGESKIVELEEELRVVGNNLKSLEVSEEKANQREEAYKEQIKTLTNKLKAAEARAE
ERAESGESKIVELEEELRVVGNNLKSLEVSEEKANLREEEYKQQIKTLTTRLKEAEARAE
ERAETGESKIVELEEELRVVGNNLKSLEVSEEKANQREEEYKNQIKNLTTRLKEAEARAE
:*.: *::**:******:****.***********: * * .::*:: :* :** ******
YAEKTVKKLQKEVDRLEDELGINKDRYKSLADEMDSTFAELAGY
FAERSVQKLQKEVGRLEDELVHEKEKYKSISDELDQTFAELTGY
FAERSVQKLQKEVDRLEDELVNEKEKYKSITDELDQTFSELSGY
FAERSVQKLQKEVDRLEDELVHEKEKYKFICDDLDMTFTELIGI
FAERSVQKLQKEVDRLEDELVAEKERYKEIGDDLDTAFVELIL:**::*:******.****** :*::** : *::* :* **

g11661t1
sp|O18416|TPM_DERPT
sp|A1KYZ2|TPM_PENMO
sp|P0DSM7|TPM02_PERAM
ManualTM1.2.n

g11661t1
sp|O18416|TPM_DERPT
sp|A1KYZ2|TPM_PENMO
sp|P0DSM7|TPM02_PERAM
ManualTM1.2.n

g11661t1
sp|O18416|TPM_DERPT
sp|A1KYZ2|TPM_PENMO
sp|P0DSM7|TPM02_PERAM
ManualTM1.2.n

g11661t1
sp|O18416|TPM_DERPT
sp|A1KYZ2|TPM_PENMO
sp|P0DSM7|TPM02_PERAM
ManualTM1.2.n

T. moltior tropomyosins (g11661t1 and ManualTM1.2.n) were aligned with allergenic tropomyosins from shrimp
(Penaeus modon, Pen m 1, Uniprot A1KYZ2), house dust mite (Dermatophagoides pteronyssinus, Der p 10, Uniprot
O18416), and cockroach (Periplaneta americana, Per a 7.0102, Uniprot P0DSM7) using Clustal Omega (1.2.4).

Appendix C Figure 3.1.4 Alignment of T. molitor identified tropomyosins with known allergenic tropomyosins

284
284
284
284
283

60
60
60
60
60

MDAIKKKMQAMKLEKDNAQDKADAMEGQAKDANLRVEKLNEELRDLQKKLAQVEGDFSST
MEAIKNKMQAMKLEKDNAIDRAEIAEQKARDANLRAEKSEEEVRALQKKIQQIENELDQV
MDAIKKKMQAMKLEKDNAMDRADTLEQQNKEANNRAEKSEEEVHNLQKRMQQLENDLDQV
MDAIKKKMQAMKLEKDNAMDRALLCEQQARDANLRAEKAEEEARSLQKKIQQIENDLDQT
MDAIKKKMQAMKLEKDNALDRAIQNEQQAKDANLRGEKLEEEARTLQKKIQTIENELDQT
* : ::** * ** :** : ***:: :*.::...
*:***:************ *:*

g11661t1
sp|O18416|TPM_DERPT
sp|A1KYZ2|TPM_PENMO
sp|P0DSM7|TPM02_PERAM
ManualTM1.2.n

225

226

Appendix C Figure 3.1.5 Identity matrix of alignment of T. moltior tropomyosins
with known allergenic tropomyosins
T. moltior tropomyosins (g11661t1 and ManualTM1.2.n) were aligned with allergenic
tropomyosins from shrimp (Penaeus modon, Pen m 1, Uniprot A1KYZ2), house dust
mite (Dermatophagoides pteronyssinus, Der p 10, Uniprot O18416), and cockroach
(Periplaneta americana, Per a 7.0102, Uniprot P0DSM7) using Clustal Omega
(1.2.4).
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APPENDIX D ANNOTATIONS OF QUANTIFIED PROTEINS FROM
TENEBRIO MOLITOR (XLSX, 337 KB)

Annotations of
quantified proteins from tenebrio molitor.xlsx
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APPENDIX E SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER
4: PERSISTENCE OF PEANUT ALLERGEN-DERIVED PEPTIDES
THROUGHOUT EXCESSIVE DRY THERMAL PROCESSING

Appendix E Table 4.1.1 Posttranslational modifications added to PTM search

Name
Hydroxynonenal - Michael adduct
Hydroxynonenal - 2-pentilpyrrole
Hydroxynonenal - Dehydropentylfuran
(CHRK)
Hydroxynonenal - Shiff base (RK)
Malondialdehyde - Dihydropyridinelysine
Malondialdehyde - Argpyrimidine
Malondialdehyde – N-propenal-Lysine
Acrolein - Michael Adduct
Acrolein - N-2 (4 hydroxy-tetrahydropyrimidyl) Ornitine
Acrolein - Double Michael Adduct
Acrolein - Schiff Base
Acrolein - Formyl-dehydro-piperidyllysine
Acrolein - Methylpyridine-lysine
Glyoxal-derived Hydroimidazolone
Methylglyoxal-derived Hydroimidazolone
Imidazolonylornithine
Glyoxal-derived Hemiaminal (RK)
Glyoxal-derived Dihydroxyimidazoline
(R)
Nω-carboxymethylarginine (R)
Carboxymethyl Lysine (K)
Glycollolysine (K)
Triosone Hydroimisazolone
Methylglyoxal-derived Hemiaminal (RK)
Carboxyethyllysine (K)
Methylglyoxal-derived
Dihydroxyimidazoline (R)
Argpyrimidine
Triosone-derived Hemiaminal (RK)
Triosone-derived Dihydroxyimidazoline
(R)
Triosidine-carbaldehyde
Pyrraline
3-Deoxy-pentosone Hydroimidazolone
Trihydroxy-triosidine
Dihydropyrimidine Ornithine
Pronyl-lysine

Monoisotopic
mass
156.11500
120.09390

Specificity
CHKR
RK

Formula
C9H16O2
C9H12O0

C
9
9

H
16
12

O
2
0

138.10450

CHKR

C9H14O1

9

14

1

134.03680
36.00000
54.01056
56.02621

K
R
K
CHK

C8H6O2
C3H0O0
C3H2O1
C3H4O1

8
3
3
3

6
0
2
4

2
0
1
1

56.02621
112.05240
38.01565

R
K
K

C3H4O1
C6H8O2
C3H2O0

3
6
3

4
8
2

1
2
0

94.04186
77.03913
39.99491

K
K
R

C6H6O1
C6H5O0
C2H0O1

6
6
2

6
5
0

1
0
1

54.01056

R

C3H2O1

3

2

1

58.00548
70.00548

RK
R

C2H2O2
C3H2O2

2
3

2
2

2
2

72.02113
80.02621

RK
R

C3H4O2
C5H4O1

3
5

4
4

2
1

88.01604
93.03404
108.02110
114.03170
125.02390
126.03170
126.03170

RK
K
K
R
K
R
K

C3H4O3
C6H5O1
C6H4O2
C5H6O3
C6H5O3
C6H6O3
C6H6O3

3
6
6
5
6
6
6

4
5
4
6
5
6
6

3
1
2
3
3
3
3

229
Hexose Didehydrate
3-Deoxypentosone-derived hemiaminal
(RK)
3-Deoxypentosone-derived
Dihydroxyimidazoline (R)
Nε-(5,6-dihydroxy-2,3-dioxohexyl)-Lys
Hexose Dehydrate
3-deoxyglucosone-derived
Hydroimidazolone
Tetrahydropyrimidine Ornithine
3-deoxyglucosone-derived Hemiaminal
(RK)
3-deoxyglucosone-derived
Dihydroxyimidazoline (R)
Hexose (K)
Glucosone-derived Hemiaminal
Alkyl Formyl Diglycosyl Pyrrole
Acetone aldol condensation

132.04230

RK

C5H8O4

5

8

4

144.04230

K

C6H8O4

6

8

4

144.04230

R

C6H8O4

6

8

4

162.05280
178.04770
270.07400
98.07320

RK
RK
K
KHR

C6H10O5
C6H10O6
C12H14O7
C6H10O1

6
6
12
6

10
10
14
10

5
6
7
1

Appendix E Table 4.1.2 Lists of peptides used for quantification of peanut allergens
Allergen or
isoform
Ara h 1
Isoforms
1/2

Ara h 2
Isoforms
1/2
Ara h 6
Isoforms
1/2
Ara h 3
Isoforms
4/5/10/
13/17/20
Ara h 3
Isoforms
1/11

Ara h 3
Isoforms
2/12

Ara h 3
Isoforms
8/15
Ara h 3

Peptide
NNPFYFPSR
IPSGFISYILNR
SFNLDEGHALR
NTLEAAFNAEFNEIR
GTGNLELVAVR
C(+57.02)MC(+57.02)EALQQIMENQSDR
NLPQQC(+57.02)GLR
C(+57.02)C(+57.02)NELNEFENNQR
ANLRPC(+57.02)EQHLMQK
C(+57.02)DLDVSGGR
ELMNLPQQC(+57.02)NFR
VNLKPC(+57.02)EQHIMQR
WLGLSAEYGNLYR
RPFYSNAPQEIFIQQGR
FNLAGNHEQEFLR
SPDIYNPQAGSLK
LNALTPDNR
GIPADVLINAFGLR
EGQILLVPQNFAVGK
IESQGGITETWNSNHPELR
FYLAGNPEEEHPETQQQQPQTR
GGHITSLNTPNMAVLQYLQLGLDR
EAQEGNVFSGLALETLIGSFNVQR
TSDNPIINTLAGELSLVR
GVMEIVVTGC(+57.02)R
AGSDAFDWVAIK
VLPVDVVANMYQVSR
LPILADLQLSAER
NIVMVEGGLDVVRPEPGSR
FYIAGNTEDEHGEGGR
VFDEELQEGHVLVLPQNFAVAVR

Robust in:
Raw
Roasted
peanut
peanut
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

Mass
1140.5352
1378.7609
1257.6101
1737.8322
1127.6299
2011.822
1084.5448
1725.6835
1623.7974
977.4236
1548.7177
1651.8286
1540.7673
2050.0383
1573.7637
1388.6936
1012.5302
1454.8245
1611.8984
2167.0293
2626.2048
2610.3589
2578.3027
1912.0265
1219.6053
1278.6244
1688.892
1437.8191
2023.052
1750.7546
2608.3647
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Isoform
18

Ara h 3
Isoform
3/6/19
Ara h 3
Isoform
7/16
Ara h 3
Isoform
9/14

ILSPEREEFDGR
EIVQNLR
IDSEGGFIETWNPK
QEQEFLQYQHQHGGPR
TVNELDLPILNR
SQSEHFLYVAFK
LGLSAEYGSIHR
NAMFVPHYTLNAH
SSNPDIYNPQAGSLR
VYDEELQEGHVLVVPQNFAVAAK
AQSENYEYLAFK
GLLLPHYINAPR
EGQILIVPQQFVVAK
NDQFQC(+57.02)VGVSALR

X
X
X
X
X
X
X
X
X
X
X
X

X
X

X
X
X
X
X
X
X
X
X

1446.7102
870.4923
1591.7518
1980.9191
1395.7721
1454.7194
1301.6727
1513.7136
1617.7747
2554.3066
1461.6776
1362.7771
1667.9609
1492.7092

Appendix E Figure 4.1.1 Peanut kernel halves over thermal processing
Peanut kernel halves roasted for times between 0 and 480 minutes at 176 °C (top) and
260 °C (bottom).

231

Appendix E Figure 4.1.2 Extracts of peanuts heated at 176 °C and 260 °C
Resultant defatted powders from peanut kernel halves roasted at 176 °C (top) and 260 °C
(bottom) for times between 0 and 480 minutes.
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Appendix E Figure 4.1.3 Extracts of peanuts heated at 176 °C and 260 °C
Extracts produced from peanut kernel halves roasted at 176 °C (top) and 260 °C (bottom)
for times between 0 and 480 minutes.

Appendix E Figure 4.1.4 Peanut allergenic profile for peanuts heated at 176 °C
The sum of peanut allergens Ara h 1, 2, 3, 6 per time point are graphed to the left Y-axis
and the proportion of each allergen are graphed to the right Y-axis (N=5). For clarity, the
peanut allergen profile is presented without CVs but is tabulated elsewhere. Sums of
allergenic proteins that have different letters are significantly different via two-way
ANOVA (p<0.05) and two-stage linear step-up method of Benjamini, Krieger, and
Yekutieli (FDR<0.05).
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Appendix E Figure 4.1.5 Persistence
of peanut allergen peptides at 176 °C
Unmodified peptides (circles) and
post-translationally modified peptides
(bars) per Ara h 1, 2, 3, and 6 scaled to
each peptide’s maximum value
observed over time. Data are
represented as averages of 5 replicates
without CV for clarity. Average %,
pooled CV, and N of peptides per time
point: 0 (85.3%, 21.1%, 358), 15
(87.2%, 22.4%, 390), 30 (68.1%,
33.1%, 364), 60 (54.3%, 56.3%, 312),
120 (13.5%, 130.3%, 112), 240 (9.4%,
187.8%, 84), and 480 (6.0%, 232.6%,
42).
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Appendix E Figure 4.1.6 Negative control immunoblots
Control Immunoblots probed using non-atopic unsensitized serum. Transferred
immunoblots were loaded volumetrically relative to 30 µg of raw peanut (approximately
1.7 µl) and dot blots were prepared with either 0.5 or 0.25 µl of extracts. Dot blot
negative control was bovine serum albumin heated at 260 °C for 8 hours and extracted
while positive control was directly applied Morinaga anti-peanut IgG.
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APPENDIX F COMPLETE PEPTIDE LIST FOR ROASTED PEANUTS (XLSX,
4853 KB)

Complete peptide
list for roasted peanuts.xlsx
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APPENDIX G SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER
5: DETECTION OF FOOD ALLERGEN-DERIVED PEPTIDES FROM
EXTRACTIVE-BASED E-CIGARETTE LIQUIDS

Sequence
R.QSQLSPQNQC(+57.02)QLNQLQAR.E
K.FYLAGNPENEFNQQGQSQPR.Q
R.NQIIQVR.G
R.GNLDFVQPPR.G
N.GLEETFC(+57.02)SLR.L
R.ADIFSPR.A
R.ISTLNSHNLPILR.F
K.TEENAFINTLAGR.T
R.ALPDEVLANAYQISR.E
R.QETIALSSSQQR.R
R.NLQGQNDNR.N
R.LSQNIGDPSR.A
R.VQVVNENGDPILNDEVR.E
R.TDENGFTNTLAGR.T

Score
71.68
29.66
27.57
58.15
31.42
34.08
57.19
62.1
31.14
51.9
27.01
36.64
32.49
39.98

Error
Mass
(ppm)
2140.0444
-0.3
2323.0618
-1.4
869.5083
0.3
1141.588
0.9
1210.5652
0.4
804.413
0.5
1476.8412
0.4
1434.7103
-0.5
1658.8628
-0.4
1346.679
0.2
1057.4901
1.4
1085.5465
1.0
1908.9541
0.1
1394.6426
-0.5
Z
3
2
2
2
2
2
3
2
2
2
2
2
2
2

RT
40.51
46.05
36.61
44.02
46.56
40.06
46.52
48.46
52.77
35.23
14.73
31.9
45.09
40.35

Start
23
242
322
329
368
388
398
493
511
536
63
138
208
253

End
PTMs
40 C10: Carbamidomethyl
261
328
338
377 C7: Carbamidomethyl
394
410
505
525
547
71
147
224
265

Appendix G Table 5.1.1 Comprehensive peptide identifications
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12.96
6.50
4.43
7.68

R.NLQGQNDNR.N

R.LSQNIGDPSR.A
R.VQVVNENGDPILNDEVR.E
R.TDENGFTNTLAGR.T

3.19

In-solution digest
In-gel digest
(fmol)
(fmol)
Sequence
Almond Coconut Peach Almond Coconut
R.QSQLSPQNQC(+57.02)QLNQLQAR.E
59.92
K.FYLAGNPENEFNQQGQSQPR.Q
4.11
R.NQIIQVR.G
197.78
R.GNLDFVQPPR.G
129.63
3.49
N.GLEETFC(+57.02)SLR.L
117.89
R.ADIFSPR.A
206.01
42.39
29.69
R.ISTLNSHNLPILR.F
109.27
K.TEENAFINTLAGR.T
160.18
4.26
2.15
R.ALPDEVLANAYQISR.E
R.QETIALSSSQQR.R
91.25
14.28
9.37
10.11
3.58
13.69

25.43

Peach

Appendix G Table 5.1.2 Normalized sample wise peptide presence and quantity

Accession
Q43607
Q43607
Q43607
Q43607
Q43607
Q43607
Q43607
Q43607
Q43607
Q43607
Q43607,
A0A5E4FK23
A0A5E4FK23
A0A5E4FK23
A0A5E4FK23
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Appendix G Figure 5.1.1 Annotated Peptide spectra
In-solution digest of Almond, protein Q43607
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Appendix G Figure 5.1.1 Annotated Peptide spectra

In-solution digest of Almond, protein A0A5E4FK23
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Appendix G Figure 5.1.1 Annotated Peptide spectra

In-solution digest of Peach, protein Q43607

In-gel digestion of Almond, protein Q43607

242
In-gel digestion of Coconut, protein Q43607

In-gel digestion of Peach, protein Q43607

Appendix G Figure 5.1.1 Annotated Peptide spectra

A0A5E4FK23

Q43607

Accession
174.97

Score

172.92

84.49
83.65
79.71
79.06

Q43608
E3SH29
M5VL85

90.28

164.92

A0A4Y1S2I9

M5W7Y2

A0A251N1T8 164.92

E3SH28

A0A5E4FFS0 174.97

Alternative
accession
Almond
22%
(10/9)
22%
(10/9)
20%
(9/8)
19%
(8/7)
18%
(8/7)
15%
(4/3)
6%
(3/2)
8%
(3/3)
5%
(2/2)
7%
(3/2)

Coconut
2%
(1/1)
2%
(1/1)
2%
(1/1)
2%
(1/1)
2%
(1/1)
0%
(0/0)
0%
(0/0)
0%
(0/0)
0%
(0/0)
0%
(0/0)

Peach
4%
(2/2)
4%
(2/2)
4%
(2/2)
4%
(2/2)
4%
(2/2)
0%
(0/0)
0%
(0/0)
0%
(0/0)
0%
(0/0)
0%
(0/0)

In-solution digest protein
coverage %
(Peptides/unique)
Almond Coconut
3%
3%
(2/2)
(2/2)
3%
3%
(2/2)
(2/2)
3%
3%
(2/2)
(2/2)
3%
3%
(2/2)
(2/2)
3%
3%
(2/2)
(2/2)
3%
0%
(1/1)
(0/0)
2%
0%
(1/1)
(0/0)
2%
0%
(1/1)
(0/0)
2%
0%
(1/1)
(0/0)
2%
0%
(1/1)
(0/0)

Peach
9%
(4/4)
9%
(4/4)
9%
(4/4)
9%
(4/4)
9%
(4/4)
0%
(0/0)
0%
(0/0)
0%
(0/0)
0%
(0/0)
0%
(0/0)

In-gel digest protein
coverage %
(Peptides/unique)

Appendix G Table 5.1.3 Comprehensive protein identifications

Uncharacterized
protein

Prunin 2 (fragment)

RmlC-like cupins
superfamily protein
Pru2 protein
(fragment)

Predicted legumin

Prunin 1 Pru du
6.0101
Uncharacterized
protein
Uncharacterized
protein

Predicted legumin

Prunin 1 Pru du 6

Accession
description
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